,entity 1,entity 1 label,entity 2,entity 2 label,type,source
0,psilocybin,DRUG,psychological distress,OUTCOME,POSITIVELY IMPACTS,f624d5abadc6418f41ea425eb53506e811e19f239c768100097c78295dadf858
1,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,f624d5abadc6418f41ea425eb53506e811e19f239c768100097c78295dadf858
2,psilocybin,DRUG,suicidality,OUTCOME,POSITIVELY IMPACTS,f624d5abadc6418f41ea425eb53506e811e19f239c768100097c78295dadf858
3,mystical-type experience,SUBJECTIVE,anxiety,HEALTH,POSITIVELY IMPACTS,f624d5abadc6418f41ea425eb53506e811e19f239c768100097c78295dadf858
4,mystical-type experience,SUBJECTIVE,suicidality,OUTCOME,POSITIVELY IMPACTS,f624d5abadc6418f41ea425eb53506e811e19f239c768100097c78295dadf858
5,mystical-type experience,SUBJECTIVE,anxiety,HEALTH,POSITIVELY IMPACTS,f624d5abadc6418f41ea425eb53506e811e19f239c768100097c78295dadf858
6,mystical-type experience,SUBJECTIVE,suicidality,OUTCOME,POSITIVELY IMPACTS,f624d5abadc6418f41ea425eb53506e811e19f239c768100097c78295dadf858
7,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,f624d5abadc6418f41ea425eb53506e811e19f239c768100097c78295dadf858
8,psilocybin,DRUG,suicidality,OUTCOME,POSITIVELY IMPACTS,f624d5abadc6418f41ea425eb53506e811e19f239c768100097c78295dadf858
9,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,f624d5abadc6418f41ea425eb53506e811e19f239c768100097c78295dadf858
10,psilocybin,DRUG,suicidality,OUTCOME,POSITIVELY IMPACTS,f624d5abadc6418f41ea425eb53506e811e19f239c768100097c78295dadf858
11,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,f624d5abadc6418f41ea425eb53506e811e19f239c768100097c78295dadf858
12,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,f624d5abadc6418f41ea425eb53506e811e19f239c768100097c78295dadf858
13,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,f624d5abadc6418f41ea425eb53506e811e19f239c768100097c78295dadf858
14,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,f624d5abadc6418f41ea425eb53506e811e19f239c768100097c78295dadf858
15,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,f624d5abadc6418f41ea425eb53506e811e19f239c768100097c78295dadf858
16,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,f624d5abadc6418f41ea425eb53506e811e19f239c768100097c78295dadf858
17,psilocybin,DRUG,psilocin,DRUG,POSITIVELY IMPACTS,f624d5abadc6418f41ea425eb53506e811e19f239c768100097c78295dadf858
18,psilocybin,DRUG,psilocin,DRUG,POSITIVELY IMPACTS,f624d5abadc6418f41ea425eb53506e811e19f239c768100097c78295dadf858
19,psilocybin,DRUG,no untoward cardiovascular sequelae,OUTCOME,THOUGHT TO CAUSE,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
20,hallucinogens,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
21,psilocybin,DRUG,transient effect,OUTCOME,NO RELATIONSHIP FOUND BETWEEN,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
22,psilocybin,DRUG,adverse psychological effects,OUTCOME,NO RELATIONSHIP FOUND BETWEEN,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
23,psilocybin,DRUG,anxiety,HEALTH,NO RELATIONSHIP FOUND BETWEEN,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
24,psilocybin,DRUG,bad trip,OUTCOME,NO RELATIONSHIP FOUND BETWEEN,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
25,hallucinogens,DRUG,tolerated the treatment sessions well,OUTCOME,POSITIVELY IMPACTS,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
26,hallucinogens,DRUG,modest effects,OUTCOME,POSITIVELY IMPACTS,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
27,hallucinogens,DRUG,terminal cancer,HEALTH,POSITIVELY IMPACTS,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
28,hallucinogens,DRUG,"therapeutic outcome.10,12",OUTCOME,POSITIVELY IMPACTS,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
29,hallucinogens,DRUG,examining how Common illness had impacted Common lives,OUTCOME,POSITIVELY IMPACTS,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
30,hallucinogens,DRUG,relationships with family and close friends,OUTCOME,POSITIVELY IMPACTS,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
31,hallucinogens,DRUG,sense of ontological security,OUTCOME,POSITIVELY IMPACTS,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
32,hallucinogens,DRUG,powerful empathic cathexis to close friends and family members,OUTCOME,POSITIVELY IMPACTS,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
33,hallucinogens,DRUG,how subjects wished to address subjects limited life expectancy,OUTCOME,POSITIVELY IMPACTS,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
34,hallucinogens,DRUG,pronounced therapeutic effects,OUTCOME,POSITIVELY IMPACTS,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
35,psilocybin,DRUG,therapeutic benefit,OUTCOME,POSITIVELY IMPACTS,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
36,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
37,psilocybin,DRUG,stress,HEALTH,POSITIVELY IMPACTS,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
38,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
39,psilocybin,DRUG,mood,OUTCOME,POSITIVELY IMPACTS,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
40,positive outcome,OUTCOME,mood,OUTCOME,POSITIVELY IMPACTS,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
41,psilocybin,DRUG,mood,OUTCOME,POSITIVELY IMPACTS,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
42,psilocybin,DRUG,mood,OUTCOME,POSITIVELY IMPACTS,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
43,psilocybin,DRUG,robust reductions in pain perception,OUTCOME,NEEDS MORE RESEARCH BETWEEN,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
44,psilocybin,DRUG,mood-elevating effects,OUTCOME,POSITIVELY IMPACTS,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
45,psilocybin,DRUG,robust reductions in pain perception,OUTCOME,NEEDS MORE RESEARCH BETWEEN,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
46,psilocybin,DRUG,lessened need for narcotic pain medication,OUTCOME,NO RELATIONSHIP FOUND BETWEEN,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
47,psilocybin,DRUG,therapeutic effects,OUTCOME,THOUGHT TO CAUSE,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
48,psilocybin,DRUG,strong therapeutic bonds,OUTCOME,POSITIVELY IMPACTS,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
49,psilocybin,DRUG,ameliorating underlying psychological demoralization,OUTCOME,POSITIVELY IMPACTS,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
50,psilocybin,DRUG,existential anxiety,HEALTH,POSITIVELY IMPACTS,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
51,psilocybin,DRUG,despair,HEALTH,POSITIVELY IMPACTS,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
52,psilocybin,DRUG,existential anxiety,HEALTH,POSITIVELY IMPACTS,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
53,psilocybin,DRUG,despair,HEALTH,POSITIVELY IMPACTS,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
54,safety and promise,OUTCOME,existential anxiety,HEALTH,POSITIVELY IMPACTS,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
55,safety and promise,OUTCOME,despair,HEALTH,POSITIVELY IMPACTS,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
56,hallucinogenic compounds,DRUG,existential anxiety,HEALTH,POSITIVELY IMPACTS,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
57,hallucinogenic compounds,DRUG,despair,HEALTH,POSITIVELY IMPACTS,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
58,psilocybin,DRUG,existential anxiety,HEALTH,POSITIVELY IMPACTS,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
59,psilocybin,DRUG,despair,HEALTH,POSITIVELY IMPACTS,9a11e128760948c78f95d7f0d9f5369790b83f686c75aef444d9e5c7429c6ff6
60,LSD,DRUG,therapeutic improvement,OUTCOME,POSITIVELY IMPACTS,ac9c65712e00a2d59a49e1f0b04580c9e8adeeae5bb32e40cec97c57d55023d5
61,LSD,DRUG,therapeutic improvement,OUTCOME,POSITIVELY IMPACTS,ac9c65712e00a2d59a49e1f0b04580c9e8adeeae5bb32e40cec97c57d55023d5
62,LSD,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,ac9c65712e00a2d59a49e1f0b04580c9e8adeeae5bb32e40cec97c57d55023d5
63,LSD,DRUG,depression,HEALTH,POSITIVELY IMPACTS,ac9c65712e00a2d59a49e1f0b04580c9e8adeeae5bb32e40cec97c57d55023d5
64,LSD,DRUG,therapeutic improvement,OUTCOME,POSITIVELY IMPACTS,ac9c65712e00a2d59a49e1f0b04580c9e8adeeae5bb32e40cec97c57d55023d5
65,psilocybin,DRUG,remained in remission,OUTCOME,THOUGHT TO CAUSE,fc18f984870e883325f9e5b23857d46b3508cfc96984fe37c899f699430857ab
66,psilocybin,DRUG,favourable toxicity profile,OUTCOME,POSITIVELY IMPACTS,fc18f984870e883325f9e5b23857d46b3508cfc96984fe37c899f699430857ab
67,psilocybin,DRUG,not associated with compulsive drug-seeking behaviours,OUTCOME,POSITIVELY IMPACTS,fc18f984870e883325f9e5b23857d46b3508cfc96984fe37c899f699430857ab
68,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,fc18f984870e883325f9e5b23857d46b3508cfc96984fe37c899f699430857ab
69,ketamine,DRUG,smokers,HEALTH,POSITIVELY IMPACTS,fc18f984870e883325f9e5b23857d46b3508cfc96984fe37c899f699430857ab
70,ketamine,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,fc18f984870e883325f9e5b23857d46b3508cfc96984fe37c899f699430857ab
71,ketamine,DRUG,depression,HEALTH,POSITIVELY IMPACTS,fc18f984870e883325f9e5b23857d46b3508cfc96984fe37c899f699430857ab
72,psilocybin,DRUG,smokers,HEALTH,POSITIVELY IMPACTS,fc18f984870e883325f9e5b23857d46b3508cfc96984fe37c899f699430857ab
73,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,fc18f984870e883325f9e5b23857d46b3508cfc96984fe37c899f699430857ab
74,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,fc18f984870e883325f9e5b23857d46b3508cfc96984fe37c899f699430857ab
75,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,fc18f984870e883325f9e5b23857d46b3508cfc96984fe37c899f699430857ab
76,psilocybin,DRUG,clinical improvements,OUTCOME,POSITIVELY IMPACTS,fc18f984870e883325f9e5b23857d46b3508cfc96984fe37c899f699430857ab
77,expectancy bias,OUTCOME,some improvement in all patients depressive symptoms,OUTCOME,NEEDS MORE RESEARCH BETWEEN,fc18f984870e883325f9e5b23857d46b3508cfc96984fe37c899f699430857ab
78,expectancy,OUTCOME,suggestibility,OUTCOME,NEEDS MORE RESEARCH BETWEEN,fc18f984870e883325f9e5b23857d46b3508cfc96984fe37c899f699430857ab
79,suggestibility,OUTCOME,antidepressant,ANTIDEPRESSANT_DRUG,POSITIVELY IMPACTS,fc18f984870e883325f9e5b23857d46b3508cfc96984fe37c899f699430857ab
80,expectancy,OUTCOME,suggestibility,OUTCOME,NEEDS MORE RESEARCH BETWEEN,fc18f984870e883325f9e5b23857d46b3508cfc96984fe37c899f699430857ab
81,Serotonergic antidepressants,ANTIDEPRESSANT_DRUG,expectancy,OUTCOME,NEGATIVELY IMPACTS,fc18f984870e883325f9e5b23857d46b3508cfc96984fe37c899f699430857ab
82,Serotonergic antidepressants,ANTIDEPRESSANT_DRUG,expectancy,OUTCOME,NEGATIVELY IMPACTS,fc18f984870e883325f9e5b23857d46b3508cfc96984fe37c899f699430857ab
83,Serotonergic antidepressants,ANTIDEPRESSANT_DRUG,psilocybin,DRUG,NEGATIVELY IMPACTS,fc18f984870e883325f9e5b23857d46b3508cfc96984fe37c899f699430857ab
84,psychedelics,DRUG,novel pharmacological action,OUTCOME,POSITIVELY IMPACTS,fc18f984870e883325f9e5b23857d46b3508cfc96984fe37c899f699430857ab
85,psilocybin,DRUG,novel pharmacological action,OUTCOME,POSITIVELY IMPACTS,fc18f984870e883325f9e5b23857d46b3508cfc96984fe37c899f699430857ab
86,Psilocybin,DRUG,antidepressant,ANTIDEPRESSANT_DRUG,POSITIVELY IMPACTS,fc18f984870e883325f9e5b23857d46b3508cfc96984fe37c899f699430857ab
87,Psilocybin,DRUG,novel pharmacological action,OUTCOME,POSITIVELY IMPACTS,fc18f984870e883325f9e5b23857d46b3508cfc96984fe37c899f699430857ab
88,psilocybin,DRUG,global increase in glucose metabolism,OUTCOME,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
89,psilocybin,DRUG,decreases in resting state LFP power,OUTCOME,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
90,serotonin receptor agonist,NEURAL,decreases in resting state LFP power,OUTCOME,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
91,serotonin receptor agonist,NEURAL,block the subjective effects,OUTCOME,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
92,psychedelics,DRUG,subjective and behavioral effects,OUTCOME,POSITIVELY IMPACTS,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
93,5-HT2A,NEURAL,block the subjective effects,OUTCOME,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
94,5-HT2A,NEURAL,GABAergic transmission,NEURAL,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
95,5-HT2A,NEURAL,pyramidal cell inhibition,NEURAL,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
96,5-HT2A receptor,NEURAL,deactivations observed,OUTCOME,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
97,5-HT2A receptor,NEURAL,block the subjective effects,OUTCOME,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
98,5-HT2A receptor,NEURAL,GABAergic transmission,NEURAL,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
99,5-HT2A receptor,NEURAL,pyramidal cell inhibition,NEURAL,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
100,5-HT2A receptor potency,NEURAL,block the subjective effects,OUTCOME,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
101,5-HT2A receptor potency,NEURAL,pyramidal cell inhibition,NEURAL,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
102,5-HT2A antagonists,NEURAL,block the subjective effects,OUTCOME,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
103,5-HT2A antagonists,NEURAL,GABAergic transmission,NEURAL,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
104,5-HT2A antagonists,NEURAL,pyramidal cell inhibition,NEURAL,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
105,stimulation of 5-HT2A receptors,NEURAL,block the subjective effects,OUTCOME,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
106,stimulation of 5-HT2A receptors,NEURAL,GABAergic transmission,NEURAL,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
107,stimulation of 5-HT2A receptors,NEURAL,pyramidal cell inhibition,NEURAL,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
108,GABAergic transmission,NEURAL,pyramidal cell inhibition,NEURAL,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
109,5-HT1A receptor,NEURAL,pyramidal cell inhibition,NEURAL,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
110,5-HT2A receptors,NEURAL,block the subjective effects,OUTCOME,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
111,5-HT2A receptors,NEURAL,pyramidal cell inhibition,NEURAL,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
112,5-HT2A receptors,NEURAL,increases excitation in the host cell,OUTCOME,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
113,Stimulation of the 5-HT2A receptor,NEURAL,GABAergic transmission,NEURAL,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
114,Stimulation of the 5-HT2A receptor,NEURAL,pyramidal cell inhibition,NEURAL,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
115,Stimulation of the 5-HT2A receptor,NEURAL,increases excitation in the host cell,OUTCOME,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
116,Stimulation of the 5-HT2A receptor,NEURAL,pyramidal cells,NEURAL,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
117,5-HT2A receptor,NEURAL,increases excitation in the host cell,OUTCOME,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
118,5-HT2A receptor,NEURAL,pyramidal cells,NEURAL,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
119,5-HT2A receptor,OUTCOME,increases excitation in the host cell,OUTCOME,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
120,5-HT2A receptor,OUTCOME,pyramidal cells,NEURAL,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
121,receptor,NEURAL,mPFC,NEURAL,NEEDS MORE RESEARCH BETWEEN,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
122,receptor,NEURAL,brain,NEURAL,NEEDS MORE RESEARCH BETWEEN,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
123,psilocybin,DRUG,pyramidal cells,NEURAL,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
124,psilocybin,DRUG,decreased the PCC blood flow,OUTCOME,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
125,psilocybin,DRUG,default-mode network,NEURAL,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
126,psilocybin,DRUG,default-mode network,NEURAL,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
127,PCC,NEURAL,self,SUBJECTIVE,POSITIVELY IMPACTS,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
128,DMN,NEURAL,ego,SUBJECTIVE,POSITIVELY IMPACTS,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
129,DMN,NEURAL,ego,SUBJECTIVE,POSITIVELY IMPACTS,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
130,connector hubs,OUTCOME,self,SUBJECTIVE,POSITIVELY IMPACTS,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
131,connector hubs,OUTCOME,ego,SUBJECTIVE,POSITIVELY IMPACTS,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
132,connector hubs,OUTCOME,efficient information transfer,OUTCOME,POSITIVELY IMPACTS,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
133,connector hubs,OUTCOME,allowing communication between different regions,OUTCOME,POSITIVELY IMPACTS,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
134,psilocybin,DRUG,efficient information transfer,OUTCOME,POSITIVELY IMPACTS,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
135,psilocybin,DRUG,allowing communication between different regions,OUTCOME,POSITIVELY IMPACTS,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
136,mPFC,NEURAL,asymmetrical change in coupling,OUTCOME,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
137,psilocybin,DRUG,asymmetrical change in coupling,OUTCOME,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
138,mPFC,NEURAL,mPFC was consistently deactivated,OUTCOME,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
139,psilocybin,DRUG,mPFC was consistently deactivated,OUTCOME,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
140,subjective effects,OUTCOME,mPFC was consistently deactivated,OUTCOME,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
141,cognition is rigidly pessimistic,OUTCOME,mPFC was consistently deactivated,OUTCOME,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
142,deficient 5-HT2A receptor stimulation,NEURAL,mPFC was consistently deactivated,OUTCOME,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
143,deficient 5-HT2A receptor stimulation,NEURAL,subjective well-being,OUTCOME,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
144,mPFC,NEURAL,mPFC was consistently deactivated,OUTCOME,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
145,mPFC hyperactivity,NEURAL,mPFC was consistently deactivated,OUTCOME,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
146,psilocybin,DRUG,“overstable” state,SUBJECTIVE,POSITIVELY IMPACTS,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
147,psilocybin,DRUG,subjective well-being,OUTCOME,POSITIVELY IMPACTS,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
148,psilocybin,DRUG,trait openness,OUTCOME,POSITIVELY IMPACTS,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
149,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
150,psilocybin,DRUG,terminal cancer patients,HEALTH,POSITIVELY IMPACTS,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
151,psilocybin,DRUG,decreased CBF in the hypothalamus,OUTCOME,POSITIVELY IMPACTS,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
152,decreased mPFC activity via 5-HT2A receptor stimulation,OUTCOME,subjective well-being,OUTCOME,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
153,decreased mPFC activity via 5-HT2A receptor stimulation,OUTCOME,Increased hypothalamic CBF,OUTCOME,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
154,psilocybin,DRUG,mPFC,NEURAL,NEEDS MORE RESEARCH BETWEEN,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
155,psilocybin,DRUG,depression,HEALTH,NEEDS MORE RESEARCH BETWEEN,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
156,psychedelics,DRUG,terminal cancer patients,HEALTH,POSITIVELY IMPACTS,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
157,psychedelics,DRUG,decreased CBF in the hypothalamus,OUTCOME,POSITIVELY IMPACTS,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
158,psychedelics,DRUG,cluster headaches,HEALTH,POSITIVELY IMPACTS,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
159,Increased hypothalamic CBF,OUTCOME,cluster headaches,HEALTH,POSITIVELY IMPACTS,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
160,psychedelic state,SUBJECTIVE,cluster headaches,HEALTH,POSITIVELY IMPACTS,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
161,decreased activity and connectivity in the brain's connector hubs,OUTCOME,psychedelic state,SUBJECTIVE,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
162,decreased activity and connectivity in the brain's connector hubs,OUTCOME,unconstrained style of cognition,OUTCOME,THOUGHT TO CAUSE,232ea895a7605df532195586be15c479340d7cce246a7052ddc33ae6cf19c449
163,psilocybin,DRUG,"rapid, robust, and sustained clinical benefits",OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
164,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
165,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
166,psilocybin,DRUG,clinical benefits,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
167,psilocybin,DRUG,cancer-related anxiety,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
168,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
169,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
170,psilocybin,DRUG,cancer-related anxiety,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
171,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
172,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
173,psilocybin,DRUG,cancer-related anxiety,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
174,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
175,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
176,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
177,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
178,psilocybin,DRUG,cancer-related anxiety,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
179,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
180,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
181,psilocybin,DRUG,anti-depressant effects,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
182,psilocybin,DRUG,anti-depressant effects,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
183,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
184,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
185,psilocybin,DRUG,clinical outcomes,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
186,psilocybin,DRUG,anti-depressant effects,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
187,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
188,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
189,psilocybin,DRUG,rapid anti-depressant and anxiolytic clinical benefits,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
190,psilocybin,DRUG,clinical outcomes,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
191,psilocybin,DRUG,anti-depressant effects,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
192,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
193,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
194,psilocybin,DRUG,rapid anti-depressant and anxiolytic clinical benefits,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
195,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
196,psilocybin,DRUG,clinical outcomes,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
197,psilocybin,DRUG,anti-depressant response rates,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
198,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
199,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
200,psilocybin,DRUG,clinical outcomes,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
201,Psilocybin,DRUG,rapid anti-depressant and anxiolytic clinical benefits,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
202,Psilocybin,DRUG,clinical outcomes,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
203,Psilocybin,DRUG,anti-depressant response rates,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
204,Psilocybin,DRUG,cancer-related depression,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
205,Psilocybin,DRUG,anti-depressants,DRUG,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
206,Psilocybin,DRUG,cancer-related demoralization,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
207,psilocybin,DRUG,decreased quality of life,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
208,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
209,psilocybin,DRUG,improved attitudes and adaptations to death,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
210,psilocybin,DRUG,highly meaningful and spiritual,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
211,Psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
212,Psilocybin,DRUG,improved attitudes and adaptations to death,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
213,Psilocybin,DRUG,highly meaningful and spiritual,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
214,psilocybin,DRUG,increased rates of mental illness,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
215,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
216,serotoninergic psychedelic,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
217,ayahuasca,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
218,ayahuasca,DRUG,rapid and sustained anti-depressant effects,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
219,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
220,ayahuasca,DRUG,suicidality,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
221,selective serotonin reuptake inhibitors,ANTIDEPRESSANT_DRUG,depression,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
222,selective serotonin reuptake inhibitors,ANTIDEPRESSANT_DRUG,suicidality,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
223,selective serotonin reuptake inhibitors,ANTIDEPRESSANT_DRUG,depressed patients,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
224,selective serotonin reuptake inhibitors,ANTIDEPRESSANT_DRUG,tricyclic anti-depressants),ANTIDEPRESSANT_DRUG,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
225,ketamine,DRUG,anti-depressant mechanisms of action,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
226,ketamine,DRUG,anti-depressant treatment,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
227,ketamine,DRUG,anti-depressant mechanisms of action,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
228,ketamine,DRUG,decreased connectivity,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
229,brain structure activity and network connectivity,NEURAL,default mode network,NEURAL,THOUGHT TO CAUSE,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
230,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
231,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
232,mystical-type experiences,SUBJECTIVE,anxiety,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
233,mystical-type experiences,SUBJECTIVE,depression,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
234,subjective mystical experience,SUBJECTIVE,anxiety,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
235,subjective mystical experience,SUBJECTIVE,depression,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
236,mystical experience,SUBJECTIVE,cancer patients,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
237,mystical experience,SUBJECTIVE,clinical benefit,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
238,mystical experience,SUBJECTIVE,anxiety,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
239,mystical experience,SUBJECTIVE,depression,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
240,mystical experience,SUBJECTIVE,terminal cancer,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
241,mystical experience,SUBJECTIVE,improved clinical outcomes,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
242,psilocybin,DRUG,clinical benefit,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
243,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
244,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
245,psilocybin,DRUG,terminal cancer,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
246,psilocybin,DRUG,tobacco addiction,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
247,psilocybin,DRUG,alcoholism,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
248,psilocybin,DRUG,improved clinical outcomes,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
249,psilocybin,DRUG,psycho-spiritual mechanism of action,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
250,psilocybin,DRUG,mystical state of consciousness,SUBJECTIVE,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
251,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
252,mystical experience,SUBJECTIVE,improved clinical outcomes,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
253,mystical experience,SUBJECTIVE,improved clinical outcomes,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
254,mystical experience,SUBJECTIVE,improved clinical outcomes,OUTCOME,POSITIVELY IMPACTS,b95aa0485a68024014ed5ef42c08bbb901a2c1492ac7b682dd48705e04589666
255,psychedelic,DRUG,self,SUBJECTIVE,POSITIVELY IMPACTS,766b0219500aa7c0df4d6ef4143cc3334a2d4a78e2a77255fcdbb6c13615c7ab
256,Psychedelics,DRUG,self,SUBJECTIVE,POSITIVELY IMPACTS,766b0219500aa7c0df4d6ef4143cc3334a2d4a78e2a77255fcdbb6c13615c7ab
257,personal conflicts,OUTCOME,ego,SUBJECTIVE,POSITIVELY IMPACTS,766b0219500aa7c0df4d6ef4143cc3334a2d4a78e2a77255fcdbb6c13615c7ab
258,personal conflicts,OUTCOME,self,SUBJECTIVE,POSITIVELY IMPACTS,766b0219500aa7c0df4d6ef4143cc3334a2d4a78e2a77255fcdbb6c13615c7ab
259,profound existential or “peak” experiences,OUTCOME,self,SUBJECTIVE,POSITIVELY IMPACTS,766b0219500aa7c0df4d6ef4143cc3334a2d4a78e2a77255fcdbb6c13615c7ab
260,lasting positive impact on behavior and outlook,OUTCOME,self,SUBJECTIVE,POSITIVELY IMPACTS,766b0219500aa7c0df4d6ef4143cc3334a2d4a78e2a77255fcdbb6c13615c7ab
261,nature,SUBJECTIVE,ego,SUBJECTIVE,POSITIVELY IMPACTS,766b0219500aa7c0df4d6ef4143cc3334a2d4a78e2a77255fcdbb6c13615c7ab
262,nature,SUBJECTIVE,self,SUBJECTIVE,POSITIVELY IMPACTS,766b0219500aa7c0df4d6ef4143cc3334a2d4a78e2a77255fcdbb6c13615c7ab
263,psychedelics,DRUG,self,SUBJECTIVE,POSITIVELY IMPACTS,766b0219500aa7c0df4d6ef4143cc3334a2d4a78e2a77255fcdbb6c13615c7ab
264,disintegration,OUTCOME,self,SUBJECTIVE,POSITIVELY IMPACTS,766b0219500aa7c0df4d6ef4143cc3334a2d4a78e2a77255fcdbb6c13615c7ab
265,psychedelics,DRUG,self,SUBJECTIVE,POSITIVELY IMPACTS,766b0219500aa7c0df4d6ef4143cc3334a2d4a78e2a77255fcdbb6c13615c7ab
266,psychoanalysis,NEURAL,considerable explanatory value,OUTCOME,POSITIVELY IMPACTS,766b0219500aa7c0df4d6ef4143cc3334a2d4a78e2a77255fcdbb6c13615c7ab
267,AYA,DRUG,antidepressive effects,OUTCOME,POSITIVELY IMPACTS,41fd8d622fd8b617376fe0e31e401525fa74b30cb4a2ddec2740edd234e22be8
268,AYA,DRUG,depression,HEALTH,POSITIVELY IMPACTS,41fd8d622fd8b617376fe0e31e401525fa74b30cb4a2ddec2740edd234e22be8
269,AYA,DRUG,therapeutic action,OUTCOME,POSITIVELY IMPACTS,41fd8d622fd8b617376fe0e31e401525fa74b30cb4a2ddec2740edd234e22be8
270,AYA,DRUG,depression,HEALTH,POSITIVELY IMPACTS,41fd8d622fd8b617376fe0e31e401525fa74b30cb4a2ddec2740edd234e22be8
271,AYA,DRUG,therapeutic action,OUTCOME,POSITIVELY IMPACTS,41fd8d622fd8b617376fe0e31e401525fa74b30cb4a2ddec2740edd234e22be8
272,AYA,DRUG,faster reductions in depressive symptoms,OUTCOME,POSITIVELY IMPACTS,41fd8d622fd8b617376fe0e31e401525fa74b30cb4a2ddec2740edd234e22be8
273,ketamine,DRUG,depression,HEALTH,POSITIVELY IMPACTS,41fd8d622fd8b617376fe0e31e401525fa74b30cb4a2ddec2740edd234e22be8
274,ketamine,DRUG,antidepressive effects,OUTCOME,POSITIVELY IMPACTS,41fd8d622fd8b617376fe0e31e401525fa74b30cb4a2ddec2740edd234e22be8
275,ketamine,DRUG,increased synaptogenesis,NEURAL,THOUGHT TO CAUSE,41fd8d622fd8b617376fe0e31e401525fa74b30cb4a2ddec2740edd234e22be8
276,ketamine,DRUG,spine formation,NEURAL,THOUGHT TO CAUSE,41fd8d622fd8b617376fe0e31e401525fa74b30cb4a2ddec2740edd234e22be8
277,ketamine,DRUG,brain-derived neurotrophic factor,NEURAL,POSITIVELY IMPACTS,41fd8d622fd8b617376fe0e31e401525fa74b30cb4a2ddec2740edd234e22be8
278,THH,DRUG,brain-derived neurotrophic factor,NEURAL,POSITIVELY IMPACTS,41fd8d622fd8b617376fe0e31e401525fa74b30cb4a2ddec2740edd234e22be8
279,THH,DRUG,systems - MAO,NEURAL,POSITIVELY IMPACTS,41fd8d622fd8b617376fe0e31e401525fa74b30cb4a2ddec2740edd234e22be8
280,THH,DRUG,elevated levels of brain serotonin,OUTCOME,POSITIVELY IMPACTS,41fd8d622fd8b617376fe0e31e401525fa74b30cb4a2ddec2740edd234e22be8
281,THH,DRUG,antidepressant effects,OUTCOME,POSITIVELY IMPACTS,41fd8d622fd8b617376fe0e31e401525fa74b30cb4a2ddec2740edd234e22be8
282,AYA,DRUG,depressed patients,HEALTH,POSITIVELY IMPACTS,41fd8d622fd8b617376fe0e31e401525fa74b30cb4a2ddec2740edd234e22be8
283,AYA,DRUG,Vomiting,OUTCOME,NEGATIVELY IMPACTS,41fd8d622fd8b617376fe0e31e401525fa74b30cb4a2ddec2740edd234e22be8
284,AYA,DRUG,Vomiting,OUTCOME,NEGATIVELY IMPACTS,41fd8d622fd8b617376fe0e31e401525fa74b30cb4a2ddec2740edd234e22be8
285,AYA,DRUG,experience as pleasant despite the occurrence of vomiting,OUTCOME,POSITIVELY IMPACTS,41fd8d622fd8b617376fe0e31e401525fa74b30cb4a2ddec2740edd234e22be8
286,AYA,DRUG,nausea,OUTCOME,NEGATIVELY IMPACTS,41fd8d622fd8b617376fe0e31e401525fa74b30cb4a2ddec2740edd234e22be8
287,AYA,DRUG,vomiting,OUTCOME,NEGATIVELY IMPACTS,41fd8d622fd8b617376fe0e31e401525fa74b30cb4a2ddec2740edd234e22be8
288,AYA,DRUG,simultaneous diarrhea,OUTCOME,NEGATIVELY IMPACTS,41fd8d622fd8b617376fe0e31e401525fa74b30cb4a2ddec2740edd234e22be8
289,AYA,DRUG,vomiting,OUTCOME,NEGATIVELY IMPACTS,41fd8d622fd8b617376fe0e31e401525fa74b30cb4a2ddec2740edd234e22be8
290,purgative effects,OUTCOME,cleansing,OUTCOME,POSITIVELY IMPACTS,41fd8d622fd8b617376fe0e31e401525fa74b30cb4a2ddec2740edd234e22be8
291,AYA,DRUG,adverse effects,OUTCOME,NEEDS MORE RESEARCH BETWEEN,41fd8d622fd8b617376fe0e31e401525fa74b30cb4a2ddec2740edd234e22be8
292,AYA,DRUG,depression,HEALTH,POSITIVELY IMPACTS,41fd8d622fd8b617376fe0e31e401525fa74b30cb4a2ddec2740edd234e22be8
293,AYA,DRUG,depression,HEALTH,POSITIVELY IMPACTS,41fd8d622fd8b617376fe0e31e401525fa74b30cb4a2ddec2740edd234e22be8
294,AYA,DRUG,antidepressive potentials,OUTCOME,POSITIVELY IMPACTS,41fd8d622fd8b617376fe0e31e401525fa74b30cb4a2ddec2740edd234e22be8
295,AYA,DRUG,faster therapeutic actions,OUTCOME,POSITIVELY IMPACTS,41fd8d622fd8b617376fe0e31e401525fa74b30cb4a2ddec2740edd234e22be8
296,AYA,DRUG,making antidepressive treatment more effective,OUTCOME,POSITIVELY IMPACTS,41fd8d622fd8b617376fe0e31e401525fa74b30cb4a2ddec2740edd234e22be8
297,psychedelics,DRUG,plasticity related processes,OUTCOME,POSITIVELY IMPACTS,862b66a879c8708dc9cfefea8d3d8f5625dc2d6bb44486751b9bc233cdd89dfc
298,compounds,DRUG,MDMA,DRUG,POSITIVELY IMPACTS,862b66a879c8708dc9cfefea8d3d8f5625dc2d6bb44486751b9bc233cdd89dfc
299,compounds,DRUG,medicinal value,OUTCOME,POSITIVELY IMPACTS,862b66a879c8708dc9cfefea8d3d8f5625dc2d6bb44486751b9bc233cdd89dfc
300,psychedelic,DRUG,enhancing plasticity and adaptability,OUTCOME,POSITIVELY IMPACTS,862b66a879c8708dc9cfefea8d3d8f5625dc2d6bb44486751b9bc233cdd89dfc
301,psychedelics,DRUG,self-consciousness,SUBJECTIVE,POSITIVELY IMPACTS,862b66a879c8708dc9cfefea8d3d8f5625dc2d6bb44486751b9bc233cdd89dfc
302,psychedelics,DRUG,self,SUBJECTIVE,POSITIVELY IMPACTS,862b66a879c8708dc9cfefea8d3d8f5625dc2d6bb44486751b9bc233cdd89dfc
303,psychedelics,DRUG,sense of self,SUBJECTIVE,POSITIVELY IMPACTS,862b66a879c8708dc9cfefea8d3d8f5625dc2d6bb44486751b9bc233cdd89dfc
304,psilocybe,DRUG,sense of self,SUBJECTIVE,POSITIVELY IMPACTS,862b66a879c8708dc9cfefea8d3d8f5625dc2d6bb44486751b9bc233cdd89dfc
305,brain serotonin,NEURAL,resilience,OUTCOME,POSITIVELY IMPACTS,862b66a879c8708dc9cfefea8d3d8f5625dc2d6bb44486751b9bc233cdd89dfc
306,serotonin,NEURAL,engagement of 5-HT receptor subtypes,NEURAL,POSITIVELY IMPACTS,862b66a879c8708dc9cfefea8d3d8f5625dc2d6bb44486751b9bc233cdd89dfc
307,serotonin,NEURAL,mood,OUTCOME,POSITIVELY IMPACTS,862b66a879c8708dc9cfefea8d3d8f5625dc2d6bb44486751b9bc233cdd89dfc
308,serotonergic psychedelics,DRUG,changes in mood,OUTCOME,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
309,serotonergic psychedelics,DRUG,brain function,NEURAL,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
310,drugs,DRUG,changes in mood,OUTCOME,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
311,drugs,DRUG,brain function,NEURAL,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
312,psychedelics,DRUG,changes in mood,OUTCOME,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
313,psychedelics,DRUG,brain function,NEURAL,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
314,psychedelics,DRUG,brain function,NEURAL,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
315,psychedelics,DRUG,transiently increasing the size of dendritic spines on cortical neurons,OUTCOME,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
316,DOI,DRUG,cell line of neuronal lineage,NEURAL,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
317,psychedelics,DRUG,cell line of neuronal lineage,NEURAL,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
318,ketamine,DRUG,tryptamine,DRUG,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
319,ketamine,DRUG,GLYX-13,NEURAL,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
320,LSD,DRUG,invertebrate,DRUG,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
321,psychedelics,DRUG,invertebrate,DRUG,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
322,psychedelics,DRUG,brain,NEURAL,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
323,psychedelics,DRUG,promote changes in the density of dendritic spines,OUTCOME,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
324,psychedelics,DRUG,spontaneous EPSCs,NEURAL,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
325,ketamine,DRUG,cortical neuron spine density,NEURAL,THOUGHT TO CAUSE,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
326,compounds,DRUG,spontaneous EPSCs,NEURAL,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
327,5-HT2A receptors,NEURAL,promotes fear extinction learning,OUTCOME,THOUGHT TO CAUSE,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
328,psychedelics,DRUG,profound perceptual disturbances,OUTCOME,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
329,compounds,DRUG,profound perceptual disturbances,OUTCOME,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
330,compounds,DRUG,promoting plasticity,OUTCOME,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
331,compounds,DRUG,neuropsychiatric diseases,HEALTH,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
332,TrkB,NEURAL,promoting plasticity,OUTCOME,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
333,TrkB,NEURAL,neuropsychiatric diseases,HEALTH,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
334,psychedelics,DRUG,profound perceptual disturbances,OUTCOME,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
335,psychedelics,DRUG,non-hallucinogenic analogs,DRUG,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
336,psychedelics,DRUG,promoting plasticity,OUTCOME,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
337,psychedelics,DRUG,neuropsychiatric diseases,HEALTH,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
338,psychedelics,DRUG,therapeutic effects,OUTCOME,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
339,psychedelics,DRUG,promoting plasticity,OUTCOME,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
340,psychedelics,DRUG,neuropsychiatric diseases,HEALTH,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
341,psychedelics,DRUG,therapeutic effects,OUTCOME,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
342,psychedelics,DRUG,promoting plasticity,OUTCOME,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
343,psychedelics,DRUG,neuropsychiatric diseases,HEALTH,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
344,psychedelics,DRUG,therapeutic effects,OUTCOME,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
345,non-hallucinogenic analogs,DRUG,promoting plasticity,OUTCOME,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
346,non-hallucinogenic analogs,DRUG,neuropsychiatric diseases,HEALTH,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
347,psychedelics,DRUG,profound perceptual disturbances,OUTCOME,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
348,psychedelics,DRUG,promoting plasticity,OUTCOME,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
349,psychedelics,DRUG,neuropsychiatric diseases,HEALTH,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
350,psychedelics,DRUG,therapeutic effects,OUTCOME,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
351,psychedelics,DRUG,promoting the growth of both neurites and dendritic spines,OUTCOME,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
352,compounds,DRUG,promoting plasticity,OUTCOME,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
353,compounds,DRUG,neuropsychiatric diseases,HEALTH,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
354,psychedelics,DRUG,promoting plasticity,OUTCOME,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
355,psychedelics,DRUG,neuropsychiatric diseases,HEALTH,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
356,psychedelics,DRUG,promoting the growth of both neurites and dendritic spines,OUTCOME,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
357,ketamine,DRUG,promoting the growth of both neurites and dendritic spines,OUTCOME,POSITIVELY IMPACTS,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
358,5-HT2A signaling,NEURAL,structural and functional plasticity,OUTCOME,THOUGHT TO CAUSE,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
359,5-HT2A signaling,NEURAL,neurotherapeutics,DRUG,THOUGHT TO CAUSE,b6660610840cd03e3789e5bfdbe4082b91ca610ef77d98144fd790d054a6591e
360,efficacy,OUTCOME,depression,HEALTH,POSITIVELY IMPACTS,8ea12dda20e4653c973c2887fcc1e9f254e8f1d2c39eaedb1eb3345fa0ad7fc4
361,efficacy,OUTCOME,anxiety,HEALTH,POSITIVELY IMPACTS,8ea12dda20e4653c973c2887fcc1e9f254e8f1d2c39eaedb1eb3345fa0ad7fc4
362,psychedelic,DRUG,cost-effectiveness,OUTCOME,POSITIVELY IMPACTS,8ea12dda20e4653c973c2887fcc1e9f254e8f1d2c39eaedb1eb3345fa0ad7fc4
363,psilocybin,DRUG,therapeutic actions,OUTCOME,POSITIVELY IMPACTS,8ea12dda20e4653c973c2887fcc1e9f254e8f1d2c39eaedb1eb3345fa0ad7fc4
364,SSRIs,ANTIDEPRESSANT_DRUG,therapeutic actions,OUTCOME,POSITIVELY IMPACTS,8ea12dda20e4653c973c2887fcc1e9f254e8f1d2c39eaedb1eb3345fa0ad7fc4
365,ayahuasca,DRUG,rapid and sustained antidepressive effects,OUTCOME,POSITIVELY IMPACTS,aa2bd07816b33d3a6c3b6f660c1f53113876c681fb307849e3d5315792c8b68d
366,ayahuasca,DRUG,subgenual area,NEURAL,POSITIVELY IMPACTS,aa2bd07816b33d3a6c3b6f660c1f53113876c681fb307849e3d5315792c8b68d
367,ayahuasca,DRUG,brain,NEURAL,POSITIVELY IMPACTS,aa2bd07816b33d3a6c3b6f660c1f53113876c681fb307849e3d5315792c8b68d
368,ayahuasca,DRUG,drug effects,OUTCOME,POSITIVELY IMPACTS,aa2bd07816b33d3a6c3b6f660c1f53113876c681fb307849e3d5315792c8b68d
369,ayahuasca,DRUG,depressed mood,HEALTH,POSITIVELY IMPACTS,aa2bd07816b33d3a6c3b6f660c1f53113876c681fb307849e3d5315792c8b68d
370,ayahuasca,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,aa2bd07816b33d3a6c3b6f660c1f53113876c681fb307849e3d5315792c8b68d
371,ayahuasca,DRUG,feelings of guilt,OUTCOME,POSITIVELY IMPACTS,aa2bd07816b33d3a6c3b6f660c1f53113876c681fb307849e3d5315792c8b68d
372,ayahuasca,DRUG,drug effects,OUTCOME,POSITIVELY IMPACTS,aa2bd07816b33d3a6c3b6f660c1f53113876c681fb307849e3d5315792c8b68d
373,ayahuasca,DRUG,depressed mood,HEALTH,POSITIVELY IMPACTS,aa2bd07816b33d3a6c3b6f660c1f53113876c681fb307849e3d5315792c8b68d
374,ayahuasca,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,aa2bd07816b33d3a6c3b6f660c1f53113876c681fb307849e3d5315792c8b68d
375,ayahuasca,DRUG,feelings of guilt,OUTCOME,POSITIVELY IMPACTS,aa2bd07816b33d3a6c3b6f660c1f53113876c681fb307849e3d5315792c8b68d
376,ayahuasca,DRUG,emotional withdrawal,OUTCOME,POSITIVELY IMPACTS,aa2bd07816b33d3a6c3b6f660c1f53113876c681fb307849e3d5315792c8b68d
377,ayahuasca,DRUG,bipolar disorder,HEALTH,POSITIVELY IMPACTS,aa2bd07816b33d3a6c3b6f660c1f53113876c681fb307849e3d5315792c8b68d
378,ayahuasca,DRUG,bipolar disorder,HEALTH,POSITIVELY IMPACTS,aa2bd07816b33d3a6c3b6f660c1f53113876c681fb307849e3d5315792c8b68d
379,ayahuasca,DRUG,antidepressive effects.13–17,OUTCOME,POSITIVELY IMPACTS,aa2bd07816b33d3a6c3b6f660c1f53113876c681fb307849e3d5315792c8b68d
380,ayahuasca,DRUG,subgenual area,NEURAL,THOUGHT TO CAUSE,aa2bd07816b33d3a6c3b6f660c1f53113876c681fb307849e3d5315792c8b68d
381,ayahuasca,DRUG,default mode network,NEURAL,THOUGHT TO CAUSE,aa2bd07816b33d3a6c3b6f660c1f53113876c681fb307849e3d5315792c8b68d
382,DMT,DRUG,brain,NEURAL,NEEDS MORE RESEARCH BETWEEN,aa2bd07816b33d3a6c3b6f660c1f53113876c681fb307849e3d5315792c8b68d
383,LSD,DRUG,antidepressive effects.13–17,OUTCOME,POSITIVELY IMPACTS,aa2bd07816b33d3a6c3b6f660c1f53113876c681fb307849e3d5315792c8b68d
384,LSD,DRUG,ayahuasca25,DRUG,POSITIVELY IMPACTS,aa2bd07816b33d3a6c3b6f660c1f53113876c681fb307849e3d5315792c8b68d
385,ayahuasca,DRUG,psychoactive effects,OUTCOME,POSITIVELY IMPACTS,aa2bd07816b33d3a6c3b6f660c1f53113876c681fb307849e3d5315792c8b68d
386,ketamine,DRUG,antidepressant drug,ANTIDEPRESSANT_DRUG,POSITIVELY IMPACTS,30c5953dc5832756f2aba5b4d63a011901cdd5166ed9f59724e9eabf25b63b2c
387,ketamine,DRUG,depression,HEALTH,POSITIVELY IMPACTS,30c5953dc5832756f2aba5b4d63a011901cdd5166ed9f59724e9eabf25b63b2c
388,ketamine,DRUG,depression,HEALTH,POSITIVELY IMPACTS,30c5953dc5832756f2aba5b4d63a011901cdd5166ed9f59724e9eabf25b63b2c
389,ketamine,DRUG,immediate effects on many behavioral tests,OUTCOME,POSITIVELY IMPACTS,30c5953dc5832756f2aba5b4d63a011901cdd5166ed9f59724e9eabf25b63b2c
390,ketamine,DRUG,depression,HEALTH,POSITIVELY IMPACTS,30c5953dc5832756f2aba5b4d63a011901cdd5166ed9f59724e9eabf25b63b2c
391,ketamine,DRUG,immediate effects on many behavioral tests,OUTCOME,POSITIVELY IMPACTS,30c5953dc5832756f2aba5b4d63a011901cdd5166ed9f59724e9eabf25b63b2c
392,ketamine,DRUG,depression,HEALTH,POSITIVELY IMPACTS,30c5953dc5832756f2aba5b4d63a011901cdd5166ed9f59724e9eabf25b63b2c
393,ketamine,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,30c5953dc5832756f2aba5b4d63a011901cdd5166ed9f59724e9eabf25b63b2c
394,ketamine,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,30c5953dc5832756f2aba5b4d63a011901cdd5166ed9f59724e9eabf25b63b2c
395,ketamine,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,30c5953dc5832756f2aba5b4d63a011901cdd5166ed9f59724e9eabf25b63b2c
396,ketamine,DRUG,stress,HEALTH,THOUGHT TO CAUSE,30c5953dc5832756f2aba5b4d63a011901cdd5166ed9f59724e9eabf25b63b2c
397,ketamine,DRUG,rapid and sustained molecular alterations,OUTCOME,POSITIVELY IMPACTS,30c5953dc5832756f2aba5b4d63a011901cdd5166ed9f59724e9eabf25b63b2c
398,BCl,DRUG,rapid and sustained molecular alterations,OUTCOME,POSITIVELY IMPACTS,30c5953dc5832756f2aba5b4d63a011901cdd5166ed9f59724e9eabf25b63b2c
399,ketamine,DRUG,neuronal survival,NEURAL,POSITIVELY IMPACTS,30c5953dc5832756f2aba5b4d63a011901cdd5166ed9f59724e9eabf25b63b2c
400,ketamine,DRUG,neuronal survival,NEURAL,POSITIVELY IMPACTS,30c5953dc5832756f2aba5b4d63a011901cdd5166ed9f59724e9eabf25b63b2c
401,ketamine,DRUG,neuronal survival,NEURAL,POSITIVELY IMPACTS,30c5953dc5832756f2aba5b4d63a011901cdd5166ed9f59724e9eabf25b63b2c
402,TRD,HEALTH,neuronal survival,NEURAL,POSITIVELY IMPACTS,30c5953dc5832756f2aba5b4d63a011901cdd5166ed9f59724e9eabf25b63b2c
403,TRD,HEALTH,mTOR,NEURAL,POSITIVELY IMPACTS,30c5953dc5832756f2aba5b4d63a011901cdd5166ed9f59724e9eabf25b63b2c
404,TRD,HEALTH,synaptic plasticity,NEURAL,POSITIVELY IMPACTS,30c5953dc5832756f2aba5b4d63a011901cdd5166ed9f59724e9eabf25b63b2c
405,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,26eff9914f08e819db1dabf37af833977b44fd0a5bd3449d61742eccd7691144
406,psilocybin,DRUG,hallucinogen,DRUG,POSITIVELY IMPACTS,26eff9914f08e819db1dabf37af833977b44fd0a5bd3449d61742eccd7691144
407,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,26eff9914f08e819db1dabf37af833977b44fd0a5bd3449d61742eccd7691144
408,psilocybin,DRUG,less positive clinical outcomes,OUTCOME,POSITIVELY IMPACTS,26eff9914f08e819db1dabf37af833977b44fd0a5bd3449d61742eccd7691144
409,psilocybin,DRUG,long-term positive clinical outcomes,OUTCOME,POSITIVELY IMPACTS,26eff9914f08e819db1dabf37af833977b44fd0a5bd3449d61742eccd7691144
410,catharsis,DRUG,emotional insight,OUTCOME,POSITIVELY IMPACTS,26eff9914f08e819db1dabf37af833977b44fd0a5bd3449d61742eccd7691144
411,catharsis,DRUG,closure,OUTCOME,POSITIVELY IMPACTS,26eff9914f08e819db1dabf37af833977b44fd0a5bd3449d61742eccd7691144
412,5-HT2A receptor,NEURAL,enhanced sensitivity to context,OUTCOME,THOUGHT TO CAUSE,26eff9914f08e819db1dabf37af833977b44fd0a5bd3449d61742eccd7691144
413,5-HT2A receptor,NEURAL,enhanced sensitivity to context,OUTCOME,THOUGHT TO CAUSE,26eff9914f08e819db1dabf37af833977b44fd0a5bd3449d61742eccd7691144
414,5-HT2A receptor signaling,NEURAL,enhanced sensitivity to context,OUTCOME,THOUGHT TO CAUSE,26eff9914f08e819db1dabf37af833977b44fd0a5bd3449d61742eccd7691144
415,5-HT2A receptor signaling,NEURAL,psychedelic state,SUBJECTIVE,THOUGHT TO CAUSE,26eff9914f08e819db1dabf37af833977b44fd0a5bd3449d61742eccd7691144
416,5-HT2A receptor signaling,NEURAL,ego-dissolution,SUBJECTIVE,THOUGHT TO CAUSE,26eff9914f08e819db1dabf37af833977b44fd0a5bd3449d61742eccd7691144
417,mystical-type experience,SUBJECTIVE,brain systems,NEURAL,POSITIVELY IMPACTS,26eff9914f08e819db1dabf37af833977b44fd0a5bd3449d61742eccd7691144
418,psychedelic,DRUG,post-acute brain effects,OUTCOME,POSITIVELY IMPACTS,8ac4a4a8e965db87c2b35cb893beed40116d1ee8a4cc281014d8c539bb9a3e85
419,psychedelic,DRUG,"modular disintegration14,15,28",OUTCOME,POSITIVELY IMPACTS,8ac4a4a8e965db87c2b35cb893beed40116d1ee8a4cc281014d8c539bb9a3e85
420,psychedelic,DRUG,depression,HEALTH,POSITIVELY IMPACTS,8ac4a4a8e965db87c2b35cb893beed40116d1ee8a4cc281014d8c539bb9a3e85
421,psychedelic,DRUG,decreased CBF,OUTCOME,POSITIVELY IMPACTS,8ac4a4a8e965db87c2b35cb893beed40116d1ee8a4cc281014d8c539bb9a3e85
422,LSD14,DRUG,decreased CBF,OUTCOME,POSITIVELY IMPACTS,8ac4a4a8e965db87c2b35cb893beed40116d1ee8a4cc281014d8c539bb9a3e85
423,LSD14,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,8ac4a4a8e965db87c2b35cb893beed40116d1ee8a4cc281014d8c539bb9a3e85
424,LSD14,DRUG,depressed mood,HEALTH,POSITIVELY IMPACTS,8ac4a4a8e965db87c2b35cb893beed40116d1ee8a4cc281014d8c539bb9a3e85
425,sgACC,NEURAL,depressed mood,HEALTH,POSITIVELY IMPACTS,8ac4a4a8e965db87c2b35cb893beed40116d1ee8a4cc281014d8c539bb9a3e85
426,ECT,ANTIDEPRESSANT_DRUG,depression,HEALTH,POSITIVELY IMPACTS,8ac4a4a8e965db87c2b35cb893beed40116d1ee8a4cc281014d8c539bb9a3e85
427,amygdala45,NEURAL,amygdala,NEURAL,POSITIVELY IMPACTS,8ac4a4a8e965db87c2b35cb893beed40116d1ee8a4cc281014d8c539bb9a3e85
428,increased CBF,OUTCOME,metabolism in,ANTIDEPRESSANT_DRUG,POSITIVELY IMPACTS,8ac4a4a8e965db87c2b35cb893beed40116d1ee8a4cc281014d8c539bb9a3e85
429,increased CBF,OUTCOME,"mood disorders25,43,44",HEALTH,POSITIVELY IMPACTS,8ac4a4a8e965db87c2b35cb893beed40116d1ee8a4cc281014d8c539bb9a3e85
430,increased CBF,OUTCOME,amygdala,NEURAL,POSITIVELY IMPACTS,8ac4a4a8e965db87c2b35cb893beed40116d1ee8a4cc281014d8c539bb9a3e85
431,increased CBF,OUTCOME,increase in CBF,OUTCOME,POSITIVELY IMPACTS,8ac4a4a8e965db87c2b35cb893beed40116d1ee8a4cc281014d8c539bb9a3e85
432,increased CBF,OUTCOME,decreased CBF,OUTCOME,POSITIVELY IMPACTS,8ac4a4a8e965db87c2b35cb893beed40116d1ee8a4cc281014d8c539bb9a3e85
433,increased CBF,OUTCOME,increases in brain absolute CBF30,OUTCOME,POSITIVELY IMPACTS,8ac4a4a8e965db87c2b35cb893beed40116d1ee8a4cc281014d8c539bb9a3e85
434,increased CBF,OUTCOME,depression,HEALTH,POSITIVELY IMPACTS,8ac4a4a8e965db87c2b35cb893beed40116d1ee8a4cc281014d8c539bb9a3e85
435,LSD15,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,8ac4a4a8e965db87c2b35cb893beed40116d1ee8a4cc281014d8c539bb9a3e85
436,increased glucose metabolism,OUTCOME,amygdala,NEURAL,POSITIVELY IMPACTS,8ac4a4a8e965db87c2b35cb893beed40116d1ee8a4cc281014d8c539bb9a3e85
437,citalopram,ANTIDEPRESSANT_DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,8ac4a4a8e965db87c2b35cb893beed40116d1ee8a4cc281014d8c539bb9a3e85
438,psilocybin,DRUG,neuropsychiatric disorders,HEALTH,POSITIVELY IMPACTS,2556e0f8b43935793d31ee2e8bb31f196a16650ea7562a2f9e6388a2a707eedc
439,psilocybin,DRUG,biases emotional processing,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
440,ketanserin,ANTIDEPRESSANT_DRUG,biases emotional processing,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
441,ketanserin,ANTIDEPRESSANT_DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
442,ketanserin,ANTIDEPRESSANT_DRUG,mood effects,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
443,psilocybin,DRUG,biases emotional processing,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
444,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
445,psilocybin,DRUG,mood effects,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
446,Psilocybin,DRUG,increase in the positive affect but not negative affect,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
447,Psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
448,Psilocybin,DRUG,mood effects,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
449,Psilocybin,DRUG,tryptophan depletion,NEURAL,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
450,ketanserin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
451,ketanserin,DRUG,mood effects,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
452,ketanserin,DRUG,tryptophan depletion,NEURAL,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
453,ketanserin,DRUG,mood,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
454,ketanserin,DRUG,mood-enhancing effects,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
455,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
456,psilocybin,DRUG,mood,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
457,ketanserin,DRUG,mood,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
458,ketanserin,DRUG,5-HT2A antagonist,NEURAL,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
459,ketanserin,DRUG,mood-enhancing effects,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
460,ketanserin,DRUG,mood effects,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
461,ketanserin,DRUG,5-HT2A,NEURAL,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
462,ketanserin,DRUG,5-HT2C receptors,NEURAL,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
463,ketanserin,DRUG,Mental Health,HEALTH,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
464,ketanserin,DRUG,serotonin 2B/5-HT2C agonist,NEURAL,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
465,ketanserin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
466,ketanserin,DRUG,mood effects,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
467,ketanserin,DRUG,serotonin 2B/5-HT2C agonist,NEURAL,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
468,ketanserin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
469,ketanserin,DRUG,mood effects,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
470,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
471,5-HT2A receptors,NEURAL,eye,NEURAL,THOUGHT TO CAUSE,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
472,psilocybin,DRUG,increase in reaction times to negative and neutral,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
473,psilocybin,DRUG,decreased reaction times,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
474,psilocybin,DRUG,event-related potentials,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
475,psilocybin,DRUG,word valence,SUBJECTIVE,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
476,psilocybin,DRUG,attention,SUBJECTIVE,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
477,psilocybin,DRUG,enhanced P3 component,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
478,psilocybin,DRUG,enhanced P3 component,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
479,psilocybin,DRUG,enhanced P3 component,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
480,ketanserin,DRUG,event-related potentials,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
481,ketanserin,DRUG,word valence,SUBJECTIVE,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
482,ketanserin,DRUG,attention,SUBJECTIVE,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
483,ketanserin,DRUG,enhanced P3 component,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
484,ketanserin,DRUG,decreased the P300 component,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
485,psilocybin,DRUG,enhanced P3 component,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
486,psilocybin,DRUG,word valence,SUBJECTIVE,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
487,psilocybin,DRUG,attention,SUBJECTIVE,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
488,psilocybin,DRUG,N2,NEURAL,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
489,psilocybin,DRUG,enhanced P3 component,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
490,psilocybin,DRUG,decreased the P300 component,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
491,psilocybin,DRUG,valence-dependent P300 decrease,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
492,psilocybin,DRUG,attentional performance,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
493,psilocybin,DRUG,attenuate the allocation of attentional resources to neutral and negative stimuli,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
494,psilocybin,DRUG,attentional performance,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
495,psilocybin,DRUG,attenuate the allocation of attentional resources to neutral and negative stimuli,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
496,psilocybin,DRUG,attenuate the allocation of attentional resources to neutral and negative stimuli,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
497,5-HT2A receptors,NEURAL,processing of positive emotions,OUTCOME,THOUGHT TO CAUSE,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
498,psilocybin,DRUG,attenuate the allocation of attentional resources to neutral and negative stimuli,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
499,psilocybin,DRUG,attenuate the allocation of attentional resources to neutral and negative stimuli,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
500,5-HT2A receptors,NEURAL,processing of positive emotions,OUTCOME,THOUGHT TO CAUSE,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
501,5-HT2A receptors,NEURAL,processing of positive emotions,OUTCOME,THOUGHT TO CAUSE,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
502,5-HT2A receptors,NEURAL,increased RTs,OUTCOME,THOUGHT TO CAUSE,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
503,5-HT2A receptors,NEURAL,delayed in responding to positive cues,OUTCOME,THOUGHT TO CAUSE,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
504,psilocybin,DRUG,sustained adaptations,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
505,psilocybin,DRUG,depressed subjects,HEALTH,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
506,psilocybin,DRUG,increased P300 component,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
507,psilocybin,DRUG,shift dysfunctional emotional biases,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
508,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
509,psilocybin,DRUG,sustained adaptations,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
510,psilocybin,DRUG,emotional biases,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
511,psilocybin,DRUG,negative emotional biases,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
512,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
513,psilocybin,DRUG,negative mood states,SUBJECTIVE,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
514,psilocybin,DRUG,dysfunctional emotional biases,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
515,psilocybin,DRUG,depressed patients,HEALTH,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
516,psilocybin,DRUG,dysfunctional emotional biases,OUTCOME,POSITIVELY IMPACTS,6cc23b09fa92f4cb146e4331836d768828cde4c7dfb338f687823040ba941ab7
517,ketamine,DRUG,treatment-resistant depression,HEALTH,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
518,ketamine,DRUG,treatment-resistant depression,HEALTH,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
519,ayahuasca,DRUG,treatment-resistant depression,HEALTH,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
520,ayahuasca,DRUG,mood disorders,HEALTH,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
521,ayahuasca,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
522,ayahuasca,DRUG,depressive symptoms,OUTCOME,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
523,ayahuasca,DRUG,enhanced mindfulness-related capacities,OUTCOME,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
524,ayahuasca,DRUG,mood disorders,HEALTH,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
525,ayahuasca,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
526,ayahuasca,DRUG,depressive symptoms,OUTCOME,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
527,ayahuasca,DRUG,enhanced mindfulness-related capacities,OUTCOME,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
528,ayahuasca,DRUG,Brain circuits,NEURAL,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
529,ayahuasca,DRUG,mood disorders,HEALTH,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
530,ayahuasca,DRUG,brain regions,NEURAL,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
531,ayahuasca,DRUG,left subgenual area,NEURAL,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
532,ayahuasca,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
533,ayahuasca,DRUG,depressive symptoms,OUTCOME,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
534,ayahuasca,DRUG,enhanced mindfulness-related capacities,OUTCOME,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
535,ayahuasca,DRUG,meditation practices,OUTCOME,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
536,ayahuasca,DRUG,mood disorders,HEALTH,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
537,ayahuasca,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
538,ayahuasca,DRUG,depressive symptoms,OUTCOME,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
539,ayahuasca,DRUG,enhanced mindfulness-related capacities,OUTCOME,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
540,ayahuasca,DRUG,depressive symptoms,OUTCOME,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
541,ayahuasca,DRUG,enhanced mindfulness-related capacities,OUTCOME,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
542,psychedelic,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
543,psychedelic,DRUG,depressive symptoms,OUTCOME,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
544,psychedelic,DRUG,enhanced mindfulness-related capacities,OUTCOME,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
545,ayahuasca,DRUG,treatment-resistant depression,HEALTH,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
546,psychedelics,DRUG,treatment-resistant depression,HEALTH,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
547,psychedelics,DRUG,depression,HEALTH,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
548,psychedelics,DRUG,double blindness,OUTCOME,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
549,psychedelics,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
550,ayahuasca,DRUG,double blindness,OUTCOME,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
551,ayahuasca,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
552,ayahuasca,DRUG,D7,NEURAL,THOUGHT TO CAUSE,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
553,ayahuasca,DRUG,alcohol dependence,HEALTH,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
554,psychedelics,DRUG,alcohol dependence,HEALTH,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
555,psychedelics,DRUG,alcohol dependence,HEALTH,POSITIVELY IMPACTS,fbd3ef10acc4590cbe7a47d0cd12ccfe9738ab297696c8e8ccf5eea4a5e042df
556,LSD,DRUG,antiaddictive,OUTCOME,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
557,psilocybin,DRUG,antiaddictive,OUTCOME,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
558,LSD,DRUG,antiaddictive,OUTCOME,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
559,ayahuasca,DRUG,antiaddictive,OUTCOME,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
560,psilocybin,DRUG,therapeutic potentials,OUTCOME,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
561,LSD,DRUG,therapeutic potentials,OUTCOME,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
562,DMT,DRUG,therapeutic potentials,OUTCOME,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
563,psilocybin,DRUG,therapeutic potentials,OUTCOME,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
564,LSD,DRUG,therapeutic potentials,OUTCOME,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
565,LSD,DRUG,depressed patients,HEALTH,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
566,serotonin 5-HT1A/2A/2C receptors,NEURAL,therapeutic potentials,OUTCOME,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
567,5-HT1A/2A/2C receptor,NEURAL,depression,HEALTH,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
568,5-HT2A receptor agonists,NEURAL,depression,HEALTH,THOUGHT TO CAUSE,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
569,GDNF,NEURAL,hippocampus,NEURAL,NEEDS MORE RESEARCH BETWEEN,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
570,GDNF,NEURAL,neurogenesis,OUTCOME,NEEDS MORE RESEARCH BETWEEN,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
571,psilocybin,DRUG,hippocampus,NEURAL,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
572,psilocybin,DRUG,neurogenesis,OUTCOME,NEEDS MORE RESEARCH BETWEEN,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
573,5-HT2A receptor,NEURAL,GDNF,NEURAL,THOUGHT TO CAUSE,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
574,5-HT2A receptor,NEURAL,increased neurogenesis,OUTCOME,THOUGHT TO CAUSE,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
575,DMT,DRUG,"chemokine (Mcp-1, Cx3cl1) genes",NEURAL,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
576,DMT,DRUG,Th1/Th17 responses,NEURAL,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
577,THH,DRUG,Th1/Th17 responses,NEURAL,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
578,harmine,DRUG,depression,HEALTH,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
579,harmine,DRUG,antioxidant and neuroprotective effects,OUTCOME,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
580,psilocybin,DRUG,antiaddictive potentials,OUTCOME,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
581,ayahuasca,DRUG,default mode network,NEURAL,THOUGHT TO CAUSE,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
582,compounds,DRUG,intensification of the self-reference process of rumination,OUTCOME,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
583,ayahuasca,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
584,ayahuasca,DRUG,mood disorders,HEALTH,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
585,ayahuasca,DRUG,drug dependence,OUTCOME,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
586,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
587,psilocybin,DRUG,mood disorders,HEALTH,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
588,psilocybin,DRUG,drug dependence,OUTCOME,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
589,altered state of consciousness,SUBJECTIVE,anxiety,HEALTH,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
590,altered state of consciousness,SUBJECTIVE,mood disorders,HEALTH,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
591,altered state of consciousness,SUBJECTIVE,drug dependence,OUTCOME,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
592,classical hallucinogens,DRUG,mood disorders,HEALTH,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
593,psilocybin,DRUG,induces highly meaningful and spiritually significant experiences,OUTCOME,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
594,psilocybin,DRUG,induces highly meaningful and spiritually significant experiences,OUTCOME,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
595,psilocybin,DRUG,smoking cessation,OUTCOME,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
596,psilocybin,DRUG,induces highly meaningful and spiritually significant experiences,OUTCOME,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
597,psilocybin,DRUG,induces highly meaningful and spiritually significant experiences,OUTCOME,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
598,psilocybin,DRUG,smoking cessation,OUTCOME,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
599,LSD,DRUG,tobacco dependence,OUTCOME,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
600,LSD,DRUG,spiritual significance,OUTCOME,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
601,LSD,DRUG,impact on well-being,OUTCOME,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
602,LSD,DRUG,smoking cessation,OUTCOME,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
603,LSD,DRUG,"long-term beneficial changes in perspectives, attitudes, values, and quality of life",OUTCOME,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
604,hallucinogens,DRUG,antiaddictive,OUTCOME,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
605,hallucinogens,DRUG,lasting beneficial changes,OUTCOME,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
606,hallucinogens,DRUG,lasting beneficial changes,OUTCOME,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
607,ayahuasca,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
608,ayahuasca,DRUG,drug dependence,HEALTH,POSITIVELY IMPACTS,a8eabad724ab6dbfeb3f551372cc5a9bf1a39401b1534b009f787b2b0125418d
609,LSD,DRUG,dying cancer patients.2,HEALTH,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
610,LSD,DRUG,mood,OUTCOME,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
611,LSD,DRUG,reduced anxiety,OUTCOME,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
612,LSD,DRUG,fear of death,OUTCOME,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
613,LSD,DRUG,advanced-stage cancer,HEALTH,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
614,LSD,DRUG,advanced-stage cancer cancer,HEALTH,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
615,psilocybin,DRUG,mood,OUTCOME,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
616,psilocybin,DRUG,reduced anxiety,OUTCOME,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
617,psilocybin,DRUG,fear of death,OUTCOME,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
618,Psilocybin,DRUG,mood,OUTCOME,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
619,Psilocybin,DRUG,reduced anxiety,OUTCOME,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
620,Psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
621,Psilocybe,DRUG,mood,OUTCOME,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
622,psilocybin,DRUG,mood,OUTCOME,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
623,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
624,Psilocybe,DRUG,mood,OUTCOME,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
625,psilocybin,DRUG,cancer-related psychosocial distress,HEALTH,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
626,psilocybin,DRUG,cancer-related psychosocial distress,HEALTH,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
627,psilocybin,DRUG,Anxiety,HEALTH,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
628,mystical experience,SUBJECTIVE,mood,OUTCOME,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
629,mystical experience,SUBJECTIVE,depression,HEALTH,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
630,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
631,psilocybin,DRUG,cancer diagnosis,HEALTH,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
632,psilocybin,DRUG,improved attitudes toward disease progression and death,OUTCOME,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
633,psilocybin,DRUG,improved quality of life,OUTCOME,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
634,LSD,DRUG,cancer,HEALTH,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
635,LSD,DRUG,anxiolytic and antidepressant effects,OUTCOME,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
636,LSD,DRUG,improved attitudes toward disease progression and death,OUTCOME,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
637,LSD,DRUG,improved quality of life,OUTCOME,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
638,LSD,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
639,LSD,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
640,LSD,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
641,LSD,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
642,LSD,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
643,subjective experiences,SUBJECTIVE,anxiety,HEALTH,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
644,LSD,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
645,LSD,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
646,LSD,DRUG,marked improvement in depressive symptoms,OUTCOME,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
647,ayahuasca,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,1162aa9a126228c73bcb716fcaa7218221a3a6d9dc5789c17e1fe42c2ce8d2cd
648,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
649,psilocybin,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
650,psilocybin,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
651,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
652,psilocybin,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
653,psilocybin,DRUG,normalize limbic hyperactivity,OUTCOME,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
654,psilocybin,DRUG,depressed mood state,HEALTH,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
655,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
656,psilocybin,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
657,psilocybin,DRUG,normalize limbic hyperactivity,OUTCOME,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
658,psilocybin,DRUG,depressed mood state,HEALTH,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
659,psilocybin,DRUG,amygdala,NEURAL,THOUGHT TO CAUSE,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
660,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
661,psilocybin,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
662,psilocybin,DRUG,normalize limbic hyperactivity,OUTCOME,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
663,psilocybin,DRUG,depressed mood state,HEALTH,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
664,psilocybin,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
665,psilocybin,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
666,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
667,psilocybin,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
668,psilocybin,DRUG,normalize limbic hyperactivity,OUTCOME,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
669,psilocybin,DRUG,depressed mood state,HEALTH,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
670,psilocybin,DRUG,reduction of amygdala reactivity,OUTCOME,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
671,psilocybin,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
672,psilocybin,DRUG,emotion processing,OUTCOME,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
673,psilocybin,DRUG,depressed mood state,HEALTH,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
674,psilocybin,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
675,SSRIs,ANTIDEPRESSANT_DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
676,serotonin transporters,NEURAL,amygdala,NEURAL,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
677,psilocybin,DRUG,decreased activation in the visual cortex,OUTCOME,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
678,psilocybin,DRUG,decrease of activation in the visual cortex,OUTCOME,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
679,psilocybin,DRUG,decrease of activation in the visual cortex,OUTCOME,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
680,psilocybin,DRUG,processing of threat-related signals,OUTCOME,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
681,psilocybin,DRUG,attenuation of amygdala activation,OUTCOME,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
682,psilocybin,DRUG,processing of threat-related signals,OUTCOME,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
683,psilocybin,DRUG,attenuation of amygdala activation,OUTCOME,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
684,psilocybin,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
685,psilocybin,DRUG,emotion,SUBJECTIVE,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
686,psilocybin,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
687,psilocybin,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
688,ketanserin,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
689,psilocybin,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
690,psilocybin,DRUG,emotion,SUBJECTIVE,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
691,psilocybin,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
692,psilocybin,DRUG,mood state,OUTCOME,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
693,Psilocybin,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
694,Psilocybin,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
695,Psilocybin,DRUG,increased positive mood state,OUTCOME,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
696,Psilocybin,DRUG,effect on negative mood state,OUTCOME,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
697,Psilocybin,DRUG,psychotropic effects,OUTCOME,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
698,Psilocybin,DRUG,mood state,OUTCOME,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
699,Psilocybin,DRUG,mood state,SUBJECTIVE,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
700,psilocybin,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
701,psilocybin,DRUG,mood state,OUTCOME,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
702,psilocybin,DRUG,mood state,SUBJECTIVE,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
703,activation of 5-HT2A receptors,NEURAL,psychotropic effects,OUTCOME,THOUGHT TO CAUSE,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
704,psilocybin,DRUG,mood state,OUTCOME,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
705,psilocybin,DRUG,mood state,SUBJECTIVE,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
706,ketanserin,ANTIDEPRESSANT_DRUG,mood state,SUBJECTIVE,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
707,psilocybin,DRUG,mood state,OUTCOME,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
708,psilocybin,DRUG,mood state,SUBJECTIVE,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
709,psilocybin,DRUG,mood state,OUTCOME,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
710,psilocybin,DRUG,mood state,SUBJECTIVE,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
711,psilocybin,DRUG,mood state,OUTCOME,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
712,psilocybin,DRUG,mood state,SUBJECTIVE,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
713,5-HT2A receptors,NEURAL,psychotropic effects,OUTCOME,THOUGHT TO CAUSE,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
714,5-HT2A receptors,NEURAL,mood state,OUTCOME,THOUGHT TO CAUSE,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
715,5-HT2A receptors,NEURAL,inhibition of the amygdala,OUTCOME,THOUGHT TO CAUSE,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
716,5-HT2A receptor stimulation,NEURAL,mood state,OUTCOME,THOUGHT TO CAUSE,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
717,5-HT2A receptor stimulation,NEURAL,inhibition of the amygdala,OUTCOME,THOUGHT TO CAUSE,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
718,psilocybin,DRUG,5-HT2C blockade,NEURAL,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
719,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
720,psilocybin,DRUG,emotion,SUBJECTIVE,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
721,psilocybin,DRUG,mood,OUTCOME,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
722,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
723,psilocybin,DRUG,mood state,SUBJECTIVE,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
724,psilocybin,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
725,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
726,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
727,psilocybin,DRUG,mood,OUTCOME,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
728,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
729,psilocybin,DRUG,mood state,SUBJECTIVE,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
730,psilocybin,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
731,psilocybin,DRUG,mood,OUTCOME,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
732,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
733,psilocybin,DRUG,mood state,SUBJECTIVE,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
734,psilocybin,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
735,psilocybin,DRUG,mood,OUTCOME,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
736,psilocybin,DRUG,mood state,SUBJECTIVE,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
737,psilocybin,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,f5a9232f729a7d319b774fb18f79f09f42b31664c4b8ff8c74271cdc7a512666
738,psilocybin,DRUG,feeling some discernable benefits,OUTCOME,POSITIVELY IMPACTS,8e826e5edbf979990faf0068270602d75fde468da9faaf0a084d16bef6aaa344
739,Psychedelics,DRUG,depression,HEALTH,POSITIVELY IMPACTS,8e826e5edbf979990faf0068270602d75fde468da9faaf0a084d16bef6aaa344
740,Psychedelics,DRUG,drug experiences,OUTCOME,POSITIVELY IMPACTS,8e826e5edbf979990faf0068270602d75fde468da9faaf0a084d16bef6aaa344
741,serotonin receptors,NEURAL,drug experiences,OUTCOME,POSITIVELY IMPACTS,8e826e5edbf979990faf0068270602d75fde468da9faaf0a084d16bef6aaa344
742,serotonin receptors,NEURAL,brain,NEURAL,NEEDS MORE RESEARCH BETWEEN,8e826e5edbf979990faf0068270602d75fde468da9faaf0a084d16bef6aaa344
743,psychedelic,DRUG,therapeutic outcomes,OUTCOME,POSITIVELY IMPACTS,8e826e5edbf979990faf0068270602d75fde468da9faaf0a084d16bef6aaa344
744,psychedelic,DRUG,psychological flexibility,OUTCOME,POSITIVELY IMPACTS,8e826e5edbf979990faf0068270602d75fde468da9faaf0a084d16bef6aaa344
745,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
746,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
747,peyote,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
748,LSD,DRUG,more understanding and acceptance of they and,OUTCOME,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
749,LSD,DRUG,more understanding and acceptance of they and,OUTCOME,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
750,LSD,DRUG,life satisfaction,OUTCOME,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
751,LSD,DRUG,life satisfaction,OUTCOME,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
752,psilocybin,DRUG,improved well-being,OUTCOME,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
753,psilocybin,DRUG,life satisfaction,OUTCOME,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
754,psychedelics,DRUG,life satisfaction,OUTCOME,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
755,psychedelics,DRUG,mescaline,DRUG,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
756,psychedelics,DRUG,depression,HEALTH,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
757,psychedelics,DRUG,suicide attempt,OUTCOME,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
758,psychedelics,DRUG,depression,HEALTH,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
759,LSD,DRUG,depression,HEALTH,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
760,LSD,DRUG,depression,HEALTH,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
761,peyote,DRUG,depression,HEALTH,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
762,peyote,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
763,peyote,DRUG,suicide attempts,OUTCOME,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
764,peyote,DRUG,depression,HEALTH,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
765,peyote,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
766,peyote,DRUG,suicide attempts,OUTCOME,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
767,peyote,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
768,peyote,DRUG,suicide attempts,OUTCOME,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
769,peyote,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
770,peyote,DRUG,suicide attempts,OUTCOME,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
771,LSD,DRUG,suicide attempts,OUTCOME,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
772,psychedelics,DRUG,adverse events,OUTCOME,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
773,psychedelics,DRUG,acceptable safety for clinical use,OUTCOME,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
774,psychedelics,DRUG,death,HEALTH,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
775,psychedelics,DRUG,cultural biases,OUTCOME,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
776,LSD,DRUG,death,HEALTH,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
777,LSD,DRUG,cultural biases,OUTCOME,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
778,LSD,DRUG,beatnik,DRUG,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
779,high abuse potential,OUTCOME,mental disorders,HEALTH,NEEDS MORE RESEARCH BETWEEN,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
780,LSD,DRUG,…,DRUG,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
781,psychedelics,DRUG,mescaline,DRUG,POSITIVELY IMPACTS,a6b14e8399b2dda89e44f081ddf209960a0c6561bb695c0ada6fe1b58fdf1d9f
782,psilocybin,DRUG,"minimal adverse event profile,22,23",OUTCOME,POSITIVELY IMPACTS,d47a810c853a4b2f2aa5514f4dcea3c2167033980f911ca863b0389c863a9c5a
783,psilocybin,DRUG,therapeutic advantages,OUTCOME,POSITIVELY IMPACTS,d47a810c853a4b2f2aa5514f4dcea3c2167033980f911ca863b0389c863a9c5a
784,psilocybin,DRUG,treatment-resistant depression,HEALTH,POSITIVELY IMPACTS,d47a810c853a4b2f2aa5514f4dcea3c2167033980f911ca863b0389c863a9c5a
785,psilocybin,DRUG,treatment-resistant depression,HEALTH,NEEDS MORE RESEARCH BETWEEN,d47a810c853a4b2f2aa5514f4dcea3c2167033980f911ca863b0389c863a9c5a
786,psilocybin,DRUG,alcohol use disorder49,HEALTH,NEEDS MORE RESEARCH BETWEEN,d47a810c853a4b2f2aa5514f4dcea3c2167033980f911ca863b0389c863a9c5a
787,psilocybin,DRUG,alcohol use disorder49,HEALTH,POSITIVELY IMPACTS,d47a810c853a4b2f2aa5514f4dcea3c2167033980f911ca863b0389c863a9c5a
788,psilocybin,DRUG,personally meaningful,OUTCOME,POSITIVELY IMPACTS,d47a810c853a4b2f2aa5514f4dcea3c2167033980f911ca863b0389c863a9c5a
789,psilocybin,DRUG,insightful experiences,OUTCOME,POSITIVELY IMPACTS,d47a810c853a4b2f2aa5514f4dcea3c2167033980f911ca863b0389c863a9c5a
790,psilocybin,DRUG,"large, rapid, and sustained antidepressant effects",OUTCOME,POSITIVELY IMPACTS,d47a810c853a4b2f2aa5514f4dcea3c2167033980f911ca863b0389c863a9c5a
791,psilocybin,DRUG,personally meaningful,OUTCOME,POSITIVELY IMPACTS,d47a810c853a4b2f2aa5514f4dcea3c2167033980f911ca863b0389c863a9c5a
792,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,d47a810c853a4b2f2aa5514f4dcea3c2167033980f911ca863b0389c863a9c5a
793,psilocybin,DRUG,problematic effects,OUTCOME,POSITIVELY IMPACTS,d47a810c853a4b2f2aa5514f4dcea3c2167033980f911ca863b0389c863a9c5a
794,psilocybin,DRUG,emergence of psychosis,OUTCOME,POSITIVELY IMPACTS,d47a810c853a4b2f2aa5514f4dcea3c2167033980f911ca863b0389c863a9c5a
795,efficacy,OUTCOME,treatment-resistant depression,HEALTH,NEEDS MORE RESEARCH BETWEEN,9aa987ae030e031dde4a25c62338fc878f6044db9ca6270c4859c4cec77dcdbd
796,psilocybin,DRUG,treatment-resistant depression,HEALTH,NEEDS MORE RESEARCH BETWEEN,9aa987ae030e031dde4a25c62338fc878f6044db9ca6270c4859c4cec77dcdbd
797,LSD,DRUG,addiction,HEALTH,POSITIVELY IMPACTS,9aa987ae030e031dde4a25c62338fc878f6044db9ca6270c4859c4cec77dcdbd
798,ayahuasca,DRUG,mindfulness capacities,OUTCOME,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
799,ayahuasca,DRUG,increase in several mindfulness-related parameters,OUTCOME,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
800,ayahuasca,DRUG,addiction,HEALTH,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
801,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
802,ayahuasca,DRUG,mindfulness capacities,OUTCOME,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
803,ayahuasca,DRUG,increase in several mindfulness-related parameters,OUTCOME,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
804,ayahuasca,DRUG,addiction,HEALTH,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
805,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
806,ayahuasca,DRUG,mindfulness capacities,OUTCOME,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
807,ayahuasca,DRUG,increase in several mindfulness-related parameters,OUTCOME,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
808,ayahuasca,DRUG,addiction,HEALTH,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
809,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
810,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
811,ayahuasca,DRUG,mindfulness capacities,OUTCOME,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
812,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
813,ayahuasca,DRUG,mindfulness capacities,OUTCOME,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
814,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
815,ayahuasca,DRUG,mindfulness capacities,OUTCOME,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
816,ayahuasca,DRUG,addiction,HEALTH,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
817,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
818,ayahuasca,DRUG,mindfulness capacities,OUTCOME,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
819,ayahuasca,DRUG,acceptance,OUTCOME,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
820,ayahuasca,DRUG,increased self-acceptance,OUTCOME,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
821,ayahuasca,DRUG,acceptance,OUTCOME,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
822,ayahuasca,DRUG,increased self-acceptance,OUTCOME,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
823,ayahuasca,DRUG,increased self-acceptance,OUTCOME,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
824,ayahuasca,DRUG,increased self-acceptance,OUTCOME,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
825,ayahuasca,DRUG,decentering,OUTCOME,THOUGHT TO CAUSE,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
826,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
827,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
828,ayahuasca,DRUG,advanced-stage cancer patients,HEALTH,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
829,psychedelic 5-HT2A agonists,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
830,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
831,psilocybin,DRUG,depressive symptoms,HEALTH,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
832,LSD,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
833,ayahuasca,DRUG,default mode network,NEURAL,THOUGHT TO CAUSE,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
834,ayahuasca,DRUG,default mode network,NEURAL,THOUGHT TO CAUSE,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
835,spirituality,SUBJECTIVE,default mode network,NEURAL,THOUGHT TO CAUSE,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
836,ayahuasca,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
837,ayahuasca,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
838,default mode network deactivation,NEURAL,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
839,ayahuasca,DRUG,transpersonal feelings,SUBJECTIVE,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
840,ayahuasca,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
841,psychedelics,DRUG,transpersonal feelings,SUBJECTIVE,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
842,psychedelics,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
843,psilocybin,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
844,ayahuasca,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
845,ayahuasca,DRUG,increases in mindfulness-related capacities,OUTCOME,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
846,ayahuasca,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
847,ayahuasca,DRUG,increases in mindfulness-related capacities,OUTCOME,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
848,ayahuasca,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
849,ayahuasca,DRUG,increases in mindfulness-related capacities,OUTCOME,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
850,ayahuasca,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
851,ayahuasca,DRUG,increases in mindfulness-related capacities,OUTCOME,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
852,ayahuasca,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
853,ayahuasca,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,fb1b2e1c6b1e6012f85d04a14faaf0c1b0c02c4681b6fa0d6794f4bb0f52ae2a
854,psychedelics,DRUG,decreased brain entropy,OUTCOME,POSITIVELY IMPACTS,393d8f4178b861f4bdabc23f86a05ef2eb7290d8bed915832bb81c002ef27740
855,psychedelics,DRUG,entropy,OUTCOME,POSITIVELY IMPACTS,393d8f4178b861f4bdabc23f86a05ef2eb7290d8bed915832bb81c002ef27740
856,psychedelics,DRUG,complexity,OUTCOME,POSITIVELY IMPACTS,393d8f4178b861f4bdabc23f86a05ef2eb7290d8bed915832bb81c002ef27740
857,psychedelics,DRUG,stimulant,DRUG,POSITIVELY IMPACTS,393d8f4178b861f4bdabc23f86a05ef2eb7290d8bed915832bb81c002ef27740
858,psychedelics,DRUG,subjective uncertainty,SUBJECTIVE,POSITIVELY IMPACTS,393d8f4178b861f4bdabc23f86a05ef2eb7290d8bed915832bb81c002ef27740
859,altered states of consciousness,SUBJECTIVE,subjective uncertainty,SUBJECTIVE,POSITIVELY IMPACTS,393d8f4178b861f4bdabc23f86a05ef2eb7290d8bed915832bb81c002ef27740
860,altered states of consciousness,SUBJECTIVE,sense of uncertainty,SUBJECTIVE,POSITIVELY IMPACTS,393d8f4178b861f4bdabc23f86a05ef2eb7290d8bed915832bb81c002ef27740
861,psychedelics,DRUG,sense of uncertainty,SUBJECTIVE,POSITIVELY IMPACTS,393d8f4178b861f4bdabc23f86a05ef2eb7290d8bed915832bb81c002ef27740
862,serotonergic psychedelics,DRUG,sense of uncertainty,SUBJECTIVE,POSITIVELY IMPACTS,393d8f4178b861f4bdabc23f86a05ef2eb7290d8bed915832bb81c002ef27740
863,psychedelics,DRUG,compressibility of signals,OUTCOME,POSITIVELY IMPACTS,393d8f4178b861f4bdabc23f86a05ef2eb7290d8bed915832bb81c002ef27740
864,psychedelics,DRUG,brain entropy,NEURAL,POSITIVELY IMPACTS,393d8f4178b861f4bdabc23f86a05ef2eb7290d8bed915832bb81c002ef27740
865,psychedelics,DRUG,neurobiology of consciousness,NEURAL,POSITIVELY IMPACTS,393d8f4178b861f4bdabc23f86a05ef2eb7290d8bed915832bb81c002ef27740
866,psychedelic,DRUG,neurobiology of consciousness,NEURAL,POSITIVELY IMPACTS,393d8f4178b861f4bdabc23f86a05ef2eb7290d8bed915832bb81c002ef27740
867,psychedelic,DRUG,neurobiology of consciousness,NEURAL,POSITIVELY IMPACTS,393d8f4178b861f4bdabc23f86a05ef2eb7290d8bed915832bb81c002ef27740
868,psychedelics,DRUG,entropy,OUTCOME,POSITIVELY IMPACTS,393d8f4178b861f4bdabc23f86a05ef2eb7290d8bed915832bb81c002ef27740
869,consciousness,SUBJECTIVE,integrated-information theory,SUBJECTIVE,POSITIVELY IMPACTS,393d8f4178b861f4bdabc23f86a05ef2eb7290d8bed915832bb81c002ef27740
870,consciousness,SUBJECTIVE,brain entropy,NEURAL,POSITIVELY IMPACTS,393d8f4178b861f4bdabc23f86a05ef2eb7290d8bed915832bb81c002ef27740
871,consciousness,SUBJECTIVE,complexity,OUTCOME,POSITIVELY IMPACTS,393d8f4178b861f4bdabc23f86a05ef2eb7290d8bed915832bb81c002ef27740
872,consciousness,SUBJECTIVE,brain,NEURAL,POSITIVELY IMPACTS,393d8f4178b861f4bdabc23f86a05ef2eb7290d8bed915832bb81c002ef27740
873,consciousness,SUBJECTIVE,complexity,OUTCOME,POSITIVELY IMPACTS,393d8f4178b861f4bdabc23f86a05ef2eb7290d8bed915832bb81c002ef27740
874,consciousness,SUBJECTIVE,complexity,SUBJECTIVE,POSITIVELY IMPACTS,393d8f4178b861f4bdabc23f86a05ef2eb7290d8bed915832bb81c002ef27740
875,consciousness,SUBJECTIVE,entropy,OUTCOME,POSITIVELY IMPACTS,393d8f4178b861f4bdabc23f86a05ef2eb7290d8bed915832bb81c002ef27740
876,integration,SUBJECTIVE,entropy,OUTCOME,POSITIVELY IMPACTS,393d8f4178b861f4bdabc23f86a05ef2eb7290d8bed915832bb81c002ef27740
877,psilocybin,DRUG,attract emotive and often polarised opinions,OUTCOME,POSITIVELY IMPACTS,99e1f6252ff5413505d6174e8bf9c69471abb56cebd60c294a7011612dc47f1b
878,psilocybin,DRUG,depressive disorder,HEALTH,POSITIVELY IMPACTS,99e1f6252ff5413505d6174e8bf9c69471abb56cebd60c294a7011612dc47f1b
879,psilocybin,DRUG,deliverability and cost-effectiveness,OUTCOME,POSITIVELY IMPACTS,99e1f6252ff5413505d6174e8bf9c69471abb56cebd60c294a7011612dc47f1b
880,safety and efficacy,OUTCOME,treatment resistant depression,HEALTH,NEEDS MORE RESEARCH BETWEEN,99e1f6252ff5413505d6174e8bf9c69471abb56cebd60c294a7011612dc47f1b
881,psychedelics,DRUG,deliverability and cost-effectiveness,OUTCOME,POSITIVELY IMPACTS,99e1f6252ff5413505d6174e8bf9c69471abb56cebd60c294a7011612dc47f1b
882,efficacy,OUTCOME,alcohol dependence,HEALTH,POSITIVELY IMPACTS,dc5abf8945bfdae99bcdc1352242d6c85be08fc868b991ecbb47564a385839b7
883,ayahuasca,DRUG,transient modified state of awareness,OUTCOME,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
884,ayahuasca,DRUG,introspection,OUTCOME,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
885,ayahuasca,DRUG,visions,OUTCOME,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
886,ayahuasca,DRUG,autobiographic and emotional memories,OUTCOME,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
887,ayahuasca,DRUG,positive and valuable,OUTCOME,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
888,ayahuasca,DRUG,substance use disorders,HEALTH,NEEDS MORE RESEARCH BETWEEN,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
889,ayahuasca,DRUG,psychiatric conditions,HEALTH,NEEDS MORE RESEARCH BETWEEN,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
890,ayahuasca,DRUG,receptor,NEURAL,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
891,therapeutic potential,OUTCOME,substance use disorders,HEALTH,NEEDS MORE RESEARCH BETWEEN,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
892,therapeutic potential,OUTCOME,psychiatric conditions,HEALTH,NEEDS MORE RESEARCH BETWEEN,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
893,therapeutic potential,OUTCOME,substance use disorders,HEALTH,NEEDS MORE RESEARCH BETWEEN,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
894,ayahuasca,DRUG,psychotropic effects,OUTCOME,THOUGHT TO CAUSE,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
895,ayahuasca,DRUG,beneficial effects,OUTCOME,THOUGHT TO CAUSE,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
896,ayahuasca,DRUG,receptor,NEURAL,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
897,ayahuasca,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
898,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
899,receptor,NEURAL,psychotropic effects,OUTCOME,THOUGHT TO CAUSE,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
900,receptor,NEURAL,beneficial effects,OUTCOME,THOUGHT TO CAUSE,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
901,ayahuasca,DRUG,receptor,NEURAL,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
902,ayahuasca,DRUG,psychotropic effects,OUTCOME,THOUGHT TO CAUSE,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
903,ayahuasca,DRUG,beneficial effects,OUTCOME,THOUGHT TO CAUSE,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
904,ayahuasca,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
905,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
906,5-HT2A receptor,NEURAL,receptor,NEURAL,THOUGHT TO CAUSE,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
907,5-HT2A receptor,NEURAL,glutamatergic transmission,NEURAL,THOUGHT TO CAUSE,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
908,ayahuasca,DRUG,receptor,NEURAL,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
909,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
910,ayahuasca,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
911,SR1,NEURAL,receptor,NEURAL,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
912,SR1,NEURAL,depression,HEALTH,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
913,SR1,NEURAL,anxiety,HEALTH,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
914,ayahuasca,DRUG,receptor,NEURAL,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
915,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
916,ayahuasca,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
917,serotonin reuptake inhibitor,ANTIDEPRESSANT_DRUG,receptor,NEURAL,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
918,serotonin reuptake inhibitor,ANTIDEPRESSANT_DRUG,depression,HEALTH,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
919,serotonin reuptake inhibitor,ANTIDEPRESSANT_DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
920,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
921,ayahuasca,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
922,ayahuasca,DRUG,improvements in mindfulness,OUTCOME,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
923,ayahuasca,DRUG,empowerment,OUTCOME,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
924,ayahuasca,DRUG,hopefulness,OUTCOME,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
925,ayahuasca,DRUG,quality of life-outlook,OUTCOME,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
926,ayahuasca,DRUG,quality of life-meaning,OUTCOME,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
927,ayahuasca,DRUG,improvements in mindfulness,OUTCOME,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
928,ayahuasca,DRUG,empowerment,OUTCOME,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
929,ayahuasca,DRUG,hopefulness,OUTCOME,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
930,ayahuasca,DRUG,quality of life-outlook,OUTCOME,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
931,ayahuasca,DRUG,quality of life-meaning,OUTCOME,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
932,ayahuasca,DRUG,"remission of alcohol, depressive, or anxiety disorders",OUTCOME,THOUGHT TO CAUSE,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
933,ayahuasca,DRUG,improvement in alcohol use,OUTCOME,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
934,ayahuasca,DRUG,cessation of drug use,OUTCOME,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
935,ayahuasca,DRUG,improvement in alcohol use,OUTCOME,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
936,ayahuasca,DRUG,cessation of drug use,OUTCOME,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
937,ayahuasca,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
938,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
939,ayahuasca,DRUG,reductions in associated symptomatology,OUTCOME,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
940,ayahuasca,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
941,ayahuasca,DRUG,panic- and hopelessness-related states,OUTCOME,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
942,ayahuasca,DRUG,Depression,HEALTH,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
943,ayahuasca,DRUG,Depression,HEALTH,POSITIVELY IMPACTS,ba1d40d2a7bad95ea9e52bb86d0c726de7cc8b54b0d1147331eacfdc1da0caa1
944,somatomotor network,NEURAL,psychedelic,DRUG,THOUGHT TO CAUSE,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
945,5-HT2A receptor,NEURAL,psychedelic,DRUG,THOUGHT TO CAUSE,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
946,superior temporal gyrus,NEURAL,subjective effects,OUTCOME,THOUGHT TO CAUSE,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
947,superior temporal gyrus,NEURAL,effects on GBC,OUTCOME,THOUGHT TO CAUSE,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
948,superior temporal gyrus,NEURAL,cortical areas,NEURAL,THOUGHT TO CAUSE,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
949,LSD,DRUG,elevated brain-wide shared signal,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
950,LSD,DRUG,brain-wide hyper-connectivity,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
951,ayahuasca,DRUG,elevated brain-wide shared signal,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
952,ayahuasca,DRUG,hypo-connectivity,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
953,ayahuasca,DRUG,brain-wide hyper-connectivity,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
954,5-HT2A receptor,NEURAL,decreases of connectivity within the DMN,OUTCOME,THOUGHT TO CAUSE,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
955,5-HT2A receptor,NEURAL,desynchronization within the DMN,OUTCOME,THOUGHT TO CAUSE,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
956,5-HT2A receptor,NEURAL,Amygdala neurons,NEURAL,THOUGHT TO CAUSE,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
957,psilocybin,DRUG,hypo-connectivity,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
958,psilocybin,DRUG,brain-wide hyper-connectivity,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
959,5-HT2A receptors,NEURAL,decreases of connectivity within the DMN,OUTCOME,THOUGHT TO CAUSE,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
960,5-HT2A receptors,NEURAL,desynchronization within the DMN,OUTCOME,THOUGHT TO CAUSE,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
961,LSD,DRUG,hypo-connectivity,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
962,LSD,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
963,LSD,DRUG,brain-wide hyper-connectivity,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
964,LSD,DRUG,alterations in amygdala activity and connectivity,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
965,LSD,DRUG,beneficial clinical effects,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
966,LSD,DRUG,de-coupling in associative networks,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
967,LSD,DRUG,systems-level perturbations,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
968,LSD,DRUG,hyper-and hypo-connectivity,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
969,LSD,DRUG,altered state of consciousness,SUBJECTIVE,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
970,LSD,DRUG,hypo-connectivity,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
971,LSD,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
972,LSD,DRUG,brain-wide hyper-connectivity,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
973,LSD,DRUG,alterations in amygdala activity and connectivity,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
974,LSD,DRUG,beneficial clinical effects,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
975,LSD,DRUG,de-coupling in associative networks,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
976,LSD,DRUG,systems-level perturbations,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
977,LSD,DRUG,hyper-and hypo-connectivity,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
978,LSD,DRUG,altered state of consciousness,SUBJECTIVE,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
979,LSD,DRUG,hypo-connectivity,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
980,LSD,DRUG,brain-wide hyper-connectivity,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
981,LSD,DRUG,systems-level perturbations,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
982,LSD,DRUG,negligible changes,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
983,Pla,DRUG,negligible changes,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
984,Ketanserin,DRUG,negligible changes,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
985,Pla,DRUG,negligible changes,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
986,Pla,DRUG,brain-wide dysconnectivity,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
987,LSD,DRUG,altered state of consciousness,SUBJECTIVE,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
988,LSD,DRUG,sensory networks,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
989,LSD,DRUG,hypo-connectivity,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
990,LSD,DRUG,brain-wide net effect,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
991,LSD,DRUG,negligible changes,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
992,LSD,DRUG,brain-wide dysconnectivity,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
993,Ketanserin,DRUG,sensory networks,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
994,Ketanserin,DRUG,hypo-connectivity,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
995,Ketanserin,DRUG,brain-wide net effect,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
996,Ketanserin,DRUG,negligible changes,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
997,Ketanserin,DRUG,brain-wide dysconnectivity,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
998,LSD,DRUG,sensory networks,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
999,LSD,DRUG,hypo-connectivity,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1000,LSD,DRUG,brain-wide net effect,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1001,LSD,DRUG,negligible changes,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1002,LSD,DRUG,alterations in neural and behavioral effects,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1003,LSD,DRUG,brain-wide dysconnectivity,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1004,LSD,DRUG,brain-wide integration of sensory networks,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1005,LSD,DRUG,negligible changes,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1006,LSD,DRUG,brain-wide dysconnectivity,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1007,LSD,DRUG,neural and behavioral alterations,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1008,of the 5-HT2A receptor,NEURAL,default-mode,NEURAL,THOUGHT TO CAUSE,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1009,LSD,DRUG,brain-wide dysconnectivity,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1010,LSD,DRUG,brain-wide integration of sensory networks,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1011,LSD,DRUG,neural and behavioral alterations,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1012,LSD,DRUG,cortices,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1013,LSD,DRUG,brain-wide dysconnectivity,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1014,LSD,DRUG,neural and behavioral alterations,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1015,LSD,DRUG,cortices,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1016,LSD,DRUG,brain-wide dysconnectivity,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1017,LSD,DRUG,cortices,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1018,LSD,DRUG,hyper- and hypo-connectivity change scores,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1019,LSD,DRUG,hyper-connectivity,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1020,LSD,DRUG,functionally pre-defined networks,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1021,LSD,DRUG,hyper- and hypo-connectivity change scores,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1022,LSD,DRUG,hyper-connectivity,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1023,LSD,DRUG,functionally pre-defined networks,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1024,LSD,DRUG,bi-directional brain-wide shared signal,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1025,5-HT2A receptor stimulation,NEURAL,subjective effects,OUTCOME,THOUGHT TO CAUSE,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1026,5-HT2A,NEURAL,change in connectivity,OUTCOME,THOUGHT TO CAUSE,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1027,LSD,DRUG,Ket,DRUG,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1028,LSD,DRUG,subjective drug effects,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1029,LSD,DRUG,subjectively accessible,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1030,LSD,DRUG,blissful state,SUBJECTIVE,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1031,LSD,DRUG,higher subjective effects,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1032,LSD,DRUG,Ket,DRUG,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1033,LSD,DRUG,subjective drug effects,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1034,LSD,DRUG,subjectively accessible,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1035,LSD,DRUG,blissful state,SUBJECTIVE,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1036,LSD,DRUG,postcentral gyrus,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1037,somatomotor network,NEURAL,change in connectivity,OUTCOME,THOUGHT TO CAUSE,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1038,somatomotor network,NEURAL,change in connectivity,OUTCOME,THOUGHT TO CAUSE,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1039,somatomotor network,NEURAL,functional networks,NEURAL,THOUGHT TO CAUSE,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1040,LSD,DRUG,subjectively accessible,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1041,LSD,DRUG,blissful state,SUBJECTIVE,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1042,Pla,DRUG,subjectively accessible,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1043,Pla,DRUG,blissful state,SUBJECTIVE,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1044,Pla,DRUG,postcentral gyrus,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1045,somatomotor network,NEURAL,change in connectivity,OUTCOME,THOUGHT TO CAUSE,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1046,somatomotor network,NEURAL,increased connectivity,OUTCOME,THOUGHT TO CAUSE,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1047,somatomotor network,NEURAL,change in connectivity,OUTCOME,THOUGHT TO CAUSE,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1048,somatomotor network,NEURAL,Pla,DRUG,THOUGHT TO CAUSE,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1049,somatomotor network,NEURAL,functional networks,NEURAL,THOUGHT TO CAUSE,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1050,somatomotor network,NEURAL,supplementary motor area,NEURAL,THOUGHT TO CAUSE,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1051,GBC,NEURAL,blissful state,SUBJECTIVE,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1052,Connectivity changes,OUTCOME,functional networks,NEURAL,NEEDS MORE RESEARCH BETWEEN,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1053,psychedelic,DRUG,sense of self,SUBJECTIVE,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1054,LSD,DRUG,sense of self,SUBJECTIVE,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1055,consciousness,SUBJECTIVE,sense of self,SUBJECTIVE,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1056,sensorimotor system,NEURAL,sense of self,SUBJECTIVE,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1057,psychedelic,DRUG,sense of self,SUBJECTIVE,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1058,psychedelic,DRUG,delusions,HEALTH,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1059,psychedelic,DRUG,alterations in the sense of self,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1060,somatomotor network connectivity,NEURAL,changes in functional connectivity,OUTCOME,THOUGHT TO CAUSE,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1061,LSD,DRUG,delusions,HEALTH,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1062,LSD,DRUG,alterations in the sense of self,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1063,LSD,DRUG,alterations in the sense of self,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1064,5-HT2A receptor,NEURAL,changes in functional connectivity,OUTCOME,THOUGHT TO CAUSE,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1065,LSD,DRUG,neuronal and subjective effects,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1066,LSD,DRUG,neuronal and subjective effects,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1067,5-HT2A receptor,NEURAL,changes in functional connectivity,OUTCOME,THOUGHT TO CAUSE,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1068,5-HT2A receptor,NEURAL,changes in functional connectivity,OUTCOME,THOUGHT TO CAUSE,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1069,LSD,DRUG,neuronal and subjective effects,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1070,LSD,DRUG,neuronal and subjective effects,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1071,5-HT2A receptor,NEURAL,changes in functional connectivity,OUTCOME,THOUGHT TO CAUSE,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1072,LSD,DRUG,neuronal and subjective effects,OUTCOME,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1073,LSD,DRUG,HTR2C,NEURAL,NEEDS MORE RESEARCH BETWEEN,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1074,5-HT2A receptor,NEURAL,HTR2C,NEURAL,NEEDS MORE RESEARCH BETWEEN,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1075,LSD,DRUG,HTR2C,NEURAL,POSITIVELY IMPACTS,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1076,GBC,NEURAL,HTR2C,NEURAL,NEEDS MORE RESEARCH BETWEEN,4a3d5f2b7d6b40cb189f4adfd0520b6071294bd882a4ac8efb910e6b440a269e
1077,ayahuasca,DRUG,decrease in conventional convergent thinking,OUTCOME,THOUGHT TO CAUSE,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1078,ayahuasca,DRUG,creativity,OUTCOME,POSITIVELY IMPACTS,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1079,ayahuasca,DRUG,default mode network,NEURAL,THOUGHT TO CAUSE,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1080,ayahuasca,DRUG,creativity,OUTCOME,POSITIVELY IMPACTS,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1081,ayahuasca,DRUG,decrease in conventional convergent thinking,OUTCOME,THOUGHT TO CAUSE,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1082,ayahuasca,DRUG,default mode network,NEURAL,THOUGHT TO CAUSE,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1083,ayahuasca,DRUG,enhancement of divergent thinking,OUTCOME,POSITIVELY IMPACTS,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1084,ayahuasca,DRUG,brain,NEURAL,POSITIVELY IMPACTS,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1085,ayahuasca,DRUG,creativity,OUTCOME,POSITIVELY IMPACTS,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1086,ayahuasca,DRUG,creativity,OUTCOME,POSITIVELY IMPACTS,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1087,salience network,NEURAL,SN,NEURAL,THOUGHT TO CAUSE,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1088,SN,NEURAL,SN,NEURAL,THOUGHT TO CAUSE,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1089,ayahuasca,DRUG,increase in blood perfusion in the SN,OUTCOME,THOUGHT TO CAUSE,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1090,ayahuasca,DRUG,mescaline,DRUG,POSITIVELY IMPACTS,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1091,ayahuasca,DRUG,SN,NEURAL,THOUGHT TO CAUSE,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1092,ayahuasca,DRUG,reducing top-down control and increasing bottom-up information transfer,OUTCOME,THOUGHT TO CAUSE,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1093,ayahuasca,DRUG,reducing top-down control and increasing bottom-up information transfer,OUTCOME,THOUGHT TO CAUSE,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1094,ayahuasca,DRUG,decrement in the functional connectivity in parts of the DMN,OUTCOME,THOUGHT TO CAUSE,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1095,ayahuasca,DRUG,associations and insights,OUTCOME,POSITIVELY IMPACTS,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1096,ayahuasca,DRUG,decrement in the functional connectivity in parts of the DMN,OUTCOME,THOUGHT TO CAUSE,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1097,ayahuasca,DRUG,cognitive flexibility,OUTCOME,POSITIVELY IMPACTS,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1098,ayahuasca,DRUG,enhanced divergent thinking,OUTCOME,POSITIVELY IMPACTS,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1099,ayahuasca,DRUG,brain,NEURAL,POSITIVELY IMPACTS,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1100,ayahuasca,DRUG,placebo state,SUBJECTIVE,POSITIVELY IMPACTS,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1101,psilocybin,DRUG,cognitive flexibility,OUTCOME,POSITIVELY IMPACTS,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1102,increased integration,OUTCOME,increased influence of imagination on visual perception,OUTCOME,THOUGHT TO CAUSE,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1103,ayahuasca,DRUG,convergent thinking,OUTCOME,NEGATIVELY IMPACTS,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1104,psychedelics,DRUG,more novel thoughts,OUTCOME,POSITIVELY IMPACTS,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1105,psilocybin,DRUG,increase in functional connectivity,OUTCOME,THOUGHT TO CAUSE,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1106,ayahuasca,DRUG,order effect,OUTCOME,NO RELATIONSHIP FOUND BETWEEN,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1107,order effect could have influenced the results,OUTCOME,order effect,OUTCOME,NO RELATIONSHIP FOUND BETWEEN,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1108,order effects,OUTCOME,order effect,OUTCOME,NO RELATIONSHIP FOUND BETWEEN,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1109,improvement of divergent thinking and impairment of convergent thinking,OUTCOME,order effect,OUTCOME,NO RELATIONSHIP FOUND BETWEEN,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1110,mood,SUBJECTIVE,order effect,OUTCOME,NO RELATIONSHIP FOUND BETWEEN,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1111,mood,SUBJECTIVE,order effect,OUTCOME,NO RELATIONSHIP FOUND BETWEEN,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1112,openness to creative ideas,OUTCOME,order effect,OUTCOME,NO RELATIONSHIP FOUND BETWEEN,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1113,Mood,SUBJECTIVE,order effect,OUTCOME,NO RELATIONSHIP FOUND BETWEEN,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1114,ayahuasca,DRUG,order effect,OUTCOME,NO RELATIONSHIP FOUND BETWEEN,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1115,ayahuasca,DRUG,induces an intense modified state of consciousness,OUTCOME,THOUGHT TO CAUSE,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1116,ayahuasca,DRUG,divergent thinking was enhanced and convergent thinking distorted,OUTCOME,THOUGHT TO CAUSE,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1117,ayahuasca,DRUG,mindfulness-related capacities were enhanced,OUTCOME,POSITIVELY IMPACTS,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1118,ayahuasca,DRUG,mindfulness-related capacities were enhanced,OUTCOME,POSITIVELY IMPACTS,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1119,ayahuasca,DRUG,post-traumatic stress disorder,HEALTH,POSITIVELY IMPACTS,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1120,ayahuasca,DRUG,post-traumatic stress disorder,HEALTH,POSITIVELY IMPACTS,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1121,ayahuasca,DRUG,post-traumatic stress disorder,HEALTH,POSITIVELY IMPACTS,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1122,psychedelics,DRUG,therapeutic process,OUTCOME,POSITIVELY IMPACTS,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1123,ayahuasca,DRUG,therapeutic process,OUTCOME,POSITIVELY IMPACTS,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1124,ayahuasca,DRUG,convergent thinking,OUTCOME,NEGATIVELY IMPACTS,8752156c3e56c251c2ecd62153355635872064b93eac2ab05c84a93eedb251ae
1125,Psilocybin,DRUG,psychological distress,HEALTH,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1126,Psilocybin,DRUG,psychiatric conditions,HEALTH,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1127,psilocybin,DRUG,single mediating factor,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1128,psilocybin,DRUG,"relational, bodily, affective, and other aspects of participant experiences",SUBJECTIVE,NEEDS MORE RESEARCH BETWEEN,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1129,psilocybin,DRUG,deeply meaningful attachments to important family members and significant others,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1130,psilocybin,DRUG,forgiveness of others,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1131,psilocybin,DRUG,loved ones as spirit guides,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1132,psilocybin,DRUG,narrating one’s experience with loved ones,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1133,psilocybin,DRUG,improved relationships posttreatment,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1134,psilocybin,DRUG,deeply meaningful attachments to important family members and significant others,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1135,psilocybin,DRUG,forgiveness of others,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1136,psilocybin,DRUG,loved ones as spirit guides,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1137,psilocybin,DRUG,narrating one’s experience with loved ones,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1138,psilocybin,DRUG,improved relationships posttreatment,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1139,psilocybin,DRUG,somatic synesthetic experiences,OUTCOME,NEGATIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1140,psilocybin,DRUG,fear,OUTCOME,NEGATIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1141,psilocybin,DRUG,confusion,OUTCOME,NEGATIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1142,psilocybin,DRUG,panic,OUTCOME,NEGATIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1143,psilocybin,DRUG,paranoia,OUTCOME,NEGATIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1144,psilocybin,DRUG,panic,OUTCOME,NEGATIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1145,psilocybin,DRUG,paranoia,OUTCOME,NEGATIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1146,psilocybin,DRUG,"feelings of relief, wholeness, freedom, and affirmation",OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1147,fear,OUTCOME,"surrender or “let go,”",OUTCOME,THOUGHT TO CAUSE,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1148,dysphoria,OUTCOME,"surrender or “let go,”",OUTCOME,THOUGHT TO CAUSE,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1149,"surrender or “let go,”",OUTCOME,"feelings of relief, wholeness, freedom, and affirmation",OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1150,psilocybin,DRUG,experienced profound emotional depths,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1151,psilocybin,DRUG,expanded affective boundaries,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1152,psilocybin,DRUG,visions,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1153,psilocybin,DRUG,deeply coded with layers of meaning,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1154,psilocybin,DRUG,lasting impacts to study participants quality of life,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1155,psilocybin,DRUG,life priorities,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1156,psilocybin,DRUG,sense of identity,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1157,psilocybin,DRUG,recovered a sense of what is most important and vital,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1158,psilocybin,DRUG,being present in the moment,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1159,psilocybin,DRUG,kind to other people,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1160,psilocybin,DRUG,feeling “reborn,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1161,psilocybin,DRUG,more expansive,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1162,psilocybin,DRUG,more confident,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1163,psilocybin,DRUG,more connected,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1164,psilocybin,DRUG,more alive,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1165,psilocybin,DRUG,feeling of empowerment,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1166,psilocybin,DRUG,obesity,OUTCOME,NEEDS MORE RESEARCH BETWEEN,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1167,psilocybin,DRUG,eating disorders,OUTCOME,NEEDS MORE RESEARCH BETWEEN,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1168,psilocybin,DRUG,obesity,OUTCOME,NEEDS MORE RESEARCH BETWEEN,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1169,psilocybin,DRUG,obesity,OUTCOME,NEEDS MORE RESEARCH BETWEEN,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1170,psilocybin,DRUG,lasting impacts,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1171,psilocybin,DRUG,death,HEALTH,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1172,psilocybin,DRUG,spirituality,SUBJECTIVE,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1173,psilocybin,DRUG,cancer patients,HEALTH,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1174,psilocybin,DRUG,existential and psychological distress,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1175,psilocybin,DRUG,cancer diagnosis,HEALTH,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1176,psilocybin,DRUG,relationally embedded,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1177,psilocybin,DRUG,deeply meaningful,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1178,psilocybin,DRUG,biographically instantiated,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1179,psilocybin,DRUG,lasting impacts to Participants experience of Participants and the world,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1180,psilocybin,DRUG,cancer,HEALTH,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1181,psilocybin,DRUG,death,HEALTH,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1182,psilocybin,DRUG,spirituality,SUBJECTIVE,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1183,psilocybin,DRUG,cancer patients,HEALTH,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1184,psilocybin,DRUG,existential and psychological distress,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1185,psilocybin,DRUG,cancer diagnosis,HEALTH,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1186,psilocybin,DRUG,relationally embedded,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1187,psilocybin,DRUG,deeply meaningful,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1188,psilocybin,DRUG,biographically instantiated,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1189,psilocybin,DRUG,lasting impacts to Participants experience of Participants and the world,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1190,psilocybin,DRUG,maximize therapeutic benefit,OUTCOME,POSITIVELY IMPACTS,55826d4e0db7bf6424e3e17e0554460e1e79f70c0d60daf7330ba8807441ea4b
1191,abuse potential,OUTCOME,substance,DRUG,NEEDS MORE RESEARCH BETWEEN,4840771be2fe2887b5e654a8281b2b45676e7927f5c29239fb85a09beb940f9d
1192,psilocybin,DRUG,medical and public health significance,OUTCOME,POSITIVELY IMPACTS,4840771be2fe2887b5e654a8281b2b45676e7927f5c29239fb85a09beb940f9d
1193,psilocybin,DRUG,potential therapeutic benefits,OUTCOME,POSITIVELY IMPACTS,4840771be2fe2887b5e654a8281b2b45676e7927f5c29239fb85a09beb940f9d
1194,psilocybin,DRUG,medical and public health significance,OUTCOME,POSITIVELY IMPACTS,4840771be2fe2887b5e654a8281b2b45676e7927f5c29239fb85a09beb940f9d
1195,psilocybin,DRUG,rates of abuse,OUTCOME,NO RELATIONSHIP FOUND BETWEEN,4840771be2fe2887b5e654a8281b2b45676e7927f5c29239fb85a09beb940f9d
1196,psilocybin,DRUG,emergency department reports,OUTCOME,NO RELATIONSHIP FOUND BETWEEN,4840771be2fe2887b5e654a8281b2b45676e7927f5c29239fb85a09beb940f9d
1197,psilocybin,DRUG,treatment seeking in youth and adults,OUTCOME,NO RELATIONSHIP FOUND BETWEEN,4840771be2fe2887b5e654a8281b2b45676e7927f5c29239fb85a09beb940f9d
1198,psilocybin,DRUG,not mean no abuse or dependence risk,OUTCOME,NEGATIVELY IMPACTS,4840771be2fe2887b5e654a8281b2b45676e7927f5c29239fb85a09beb940f9d
1199,psilocybin,DRUG,science does not support scheduling more restrictive than IV,OUTCOME,POSITIVELY IMPACTS,4840771be2fe2887b5e654a8281b2b45676e7927f5c29239fb85a09beb940f9d
1200,psilocybin,DRUG,profound and very long lasting positive changes in mood and well-being,OUTCOME,POSITIVELY IMPACTS,4840771be2fe2887b5e654a8281b2b45676e7927f5c29239fb85a09beb940f9d
1201,psilocybin,DRUG,treatment resistant mental and behavioral disorders,HEALTH,POSITIVELY IMPACTS,4840771be2fe2887b5e654a8281b2b45676e7927f5c29239fb85a09beb940f9d
1202,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,4840771be2fe2887b5e654a8281b2b45676e7927f5c29239fb85a09beb940f9d
1203,psilocybin,DRUG,the need for such research is urgent,OUTCOME,POSITIVELY IMPACTS,4840771be2fe2887b5e654a8281b2b45676e7927f5c29239fb85a09beb940f9d
1204,psilocybin,DRUG,profound and very long lasting positive changes in mood and well-being,OUTCOME,POSITIVELY IMPACTS,4840771be2fe2887b5e654a8281b2b45676e7927f5c29239fb85a09beb940f9d
1205,psychedelics,DRUG,profound and very long lasting positive changes in mood and well-being,OUTCOME,POSITIVELY IMPACTS,4840771be2fe2887b5e654a8281b2b45676e7927f5c29239fb85a09beb940f9d
1206,drug abuse potential,OUTCOME,psilocybin,DRUG,NEEDS MORE RESEARCH BETWEEN,4840771be2fe2887b5e654a8281b2b45676e7927f5c29239fb85a09beb940f9d
1207,abuse potential,OUTCOME,psilocybin,DRUG,NEEDS MORE RESEARCH BETWEEN,4840771be2fe2887b5e654a8281b2b45676e7927f5c29239fb85a09beb940f9d
1208,abuse potential,OUTCOME,facilitate innovative therapeutic breakthroughs,OUTCOME,NEEDS MORE RESEARCH BETWEEN,4840771be2fe2887b5e654a8281b2b45676e7927f5c29239fb85a09beb940f9d
1209,LSD,DRUG,neuronal populations,NEURAL,POSITIVELY IMPACTS,e3b91b85684f073c98177f70ac4fc7c3c5616e5cf55ee11fca3233929509add3
1210,LSD,DRUG,highly interrelated processes,OUTCOME,POSITIVELY IMPACTS,e3b91b85684f073c98177f70ac4fc7c3c5616e5cf55ee11fca3233929509add3
1211,LSD,DRUG,disruption of established neural connectivity,OUTCOME,POSITIVELY IMPACTS,e3b91b85684f073c98177f70ac4fc7c3c5616e5cf55ee11fca3233929509add3
1212,LSD,DRUG,emergence of novel functional associations,OUTCOME,POSITIVELY IMPACTS,e3b91b85684f073c98177f70ac4fc7c3c5616e5cf55ee11fca3233929509add3
1213,psilocybin,DRUG,neuronal populations,NEURAL,POSITIVELY IMPACTS,e3b91b85684f073c98177f70ac4fc7c3c5616e5cf55ee11fca3233929509add3
1214,psilocybin,DRUG,highly interrelated processes,OUTCOME,POSITIVELY IMPACTS,e3b91b85684f073c98177f70ac4fc7c3c5616e5cf55ee11fca3233929509add3
1215,psilocybin,DRUG,disruption of established neural connectivity,OUTCOME,POSITIVELY IMPACTS,e3b91b85684f073c98177f70ac4fc7c3c5616e5cf55ee11fca3233929509add3
1216,psilocybin,DRUG,emergence of novel functional associations,OUTCOME,POSITIVELY IMPACTS,e3b91b85684f073c98177f70ac4fc7c3c5616e5cf55ee11fca3233929509add3
1217,interneurons,NEURAL,functional connectivity,NEURAL,NEEDS MORE RESEARCH BETWEEN,e3b91b85684f073c98177f70ac4fc7c3c5616e5cf55ee11fca3233929509add3
1218,interneurons,NEURAL,brain regions,NEURAL,NEEDS MORE RESEARCH BETWEEN,e3b91b85684f073c98177f70ac4fc7c3c5616e5cf55ee11fca3233929509add3
1219,interneurons,NEURAL,hallucinogenic behaviors,OUTCOME,NEEDS MORE RESEARCH BETWEEN,e3b91b85684f073c98177f70ac4fc7c3c5616e5cf55ee11fca3233929509add3
1220,interneurons,NEURAL,brain regions,NEURAL,NEEDS MORE RESEARCH BETWEEN,e3b91b85684f073c98177f70ac4fc7c3c5616e5cf55ee11fca3233929509add3
1221,interneurons,NEURAL,hippocampus,NEURAL,NEEDS MORE RESEARCH BETWEEN,e3b91b85684f073c98177f70ac4fc7c3c5616e5cf55ee11fca3233929509add3
1222,glia,NEURAL,functional connectivity,NEURAL,NEEDS MORE RESEARCH BETWEEN,e3b91b85684f073c98177f70ac4fc7c3c5616e5cf55ee11fca3233929509add3
1223,glia,NEURAL,brain regions,NEURAL,NEEDS MORE RESEARCH BETWEEN,e3b91b85684f073c98177f70ac4fc7c3c5616e5cf55ee11fca3233929509add3
1224,glia,NEURAL,same cell type,NEURAL,NEEDS MORE RESEARCH BETWEEN,e3b91b85684f073c98177f70ac4fc7c3c5616e5cf55ee11fca3233929509add3
1225,glia,NEURAL,hallucinogenic behaviors,OUTCOME,NEEDS MORE RESEARCH BETWEEN,e3b91b85684f073c98177f70ac4fc7c3c5616e5cf55ee11fca3233929509add3
1226,glia,NEURAL,brain regions,NEURAL,NEEDS MORE RESEARCH BETWEEN,e3b91b85684f073c98177f70ac4fc7c3c5616e5cf55ee11fca3233929509add3
1227,glia,NEURAL,hippocampus,NEURAL,NEEDS MORE RESEARCH BETWEEN,e3b91b85684f073c98177f70ac4fc7c3c5616e5cf55ee11fca3233929509add3
1228,psychedelic,DRUG,brain regions,NEURAL,POSITIVELY IMPACTS,e3b91b85684f073c98177f70ac4fc7c3c5616e5cf55ee11fca3233929509add3
1229,psychedelic,DRUG,different transcriptional responses,OUTCOME,POSITIVELY IMPACTS,e3b91b85684f073c98177f70ac4fc7c3c5616e5cf55ee11fca3233929509add3
1230,psychedelic,DRUG,brain regions,NEURAL,POSITIVELY IMPACTS,e3b91b85684f073c98177f70ac4fc7c3c5616e5cf55ee11fca3233929509add3
1231,broad network changes,OUTCOME,hallucinogenic behaviors,OUTCOME,NEEDS MORE RESEARCH BETWEEN,e3b91b85684f073c98177f70ac4fc7c3c5616e5cf55ee11fca3233929509add3
1232,compounds,DRUG,brain regions,NEURAL,POSITIVELY IMPACTS,e3b91b85684f073c98177f70ac4fc7c3c5616e5cf55ee11fca3233929509add3
1233,compounds,DRUG,brain regions,NEURAL,POSITIVELY IMPACTS,e3b91b85684f073c98177f70ac4fc7c3c5616e5cf55ee11fca3233929509add3
1234,compounds,DRUG,addiction,HEALTH,POSITIVELY IMPACTS,e3b91b85684f073c98177f70ac4fc7c3c5616e5cf55ee11fca3233929509add3
1235,compounds,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,e3b91b85684f073c98177f70ac4fc7c3c5616e5cf55ee11fca3233929509add3
1236,compounds,DRUG,brain regions,NEURAL,POSITIVELY IMPACTS,e3b91b85684f073c98177f70ac4fc7c3c5616e5cf55ee11fca3233929509add3
1237,compounds,DRUG,brain regions,NEURAL,POSITIVELY IMPACTS,e3b91b85684f073c98177f70ac4fc7c3c5616e5cf55ee11fca3233929509add3
1238,compounds,DRUG,addiction,HEALTH,POSITIVELY IMPACTS,e3b91b85684f073c98177f70ac4fc7c3c5616e5cf55ee11fca3233929509add3
1239,compounds,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,e3b91b85684f073c98177f70ac4fc7c3c5616e5cf55ee11fca3233929509add3
1240,psychedelic drugs,DRUG,addiction,HEALTH,POSITIVELY IMPACTS,e3b91b85684f073c98177f70ac4fc7c3c5616e5cf55ee11fca3233929509add3
1241,psychedelic drugs,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,e3b91b85684f073c98177f70ac4fc7c3c5616e5cf55ee11fca3233929509add3
1242,harmine,DRUG,neural stem cell activity,NEURAL,THOUGHT TO CAUSE,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1243,harmine,DRUG,stimulated the proliferation and migration of progenitor cells,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1244,harmine,DRUG,promoted progenitor cells differentiation,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1245,THH,DRUG,neural stem cell activity,NEURAL,THOUGHT TO CAUSE,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1246,THH,DRUG,stimulated the proliferation and migration of progenitor cells,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1247,THH,DRUG,promoted progenitor cells differentiation,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1248,harmaline,DRUG,neural stem cell activity,NEURAL,THOUGHT TO CAUSE,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1249,harmaline,DRUG,stimulated the proliferation and migration of progenitor cells,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1250,harmaline,DRUG,promoted progenitor cells differentiation,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1251,ayahuasca,DRUG,neural stem cell activity,NEURAL,THOUGHT TO CAUSE,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1252,ayahuasca,DRUG,stimulated the proliferation and migration of progenitor cells,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1253,ayahuasca,DRUG,promoted progenitor cells differentiation,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1254,harmol,DRUG,neural stem cell activity,NEURAL,THOUGHT TO CAUSE,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1255,SVZ,NEURAL,stimulated the proliferation and migration of progenitor cells,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1256,SVZ,NEURAL,promoted progenitor cells differentiation,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1257,SGZ,NEURAL,stimulated the proliferation and migration of progenitor cells,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1258,SGZ,NEURAL,promoted progenitor cells differentiation,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1259,harmaline,DRUG,neurogenesis,OUTCOME,NEEDS MORE RESEARCH BETWEEN,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1260,THH,DRUG,neurogenesis,OUTCOME,NEEDS MORE RESEARCH BETWEEN,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1261,THH,DRUG,neurogenesis,OUTCOME,NEEDS MORE RESEARCH BETWEEN,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1262,harmine,DRUG,stem cell,NEURAL,THOUGHT TO CAUSE,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1263,compound29,DRUG,stem cell,NEURAL,THOUGHT TO CAUSE,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1264,harmine,DRUG,stem cell,NEURAL,THOUGHT TO CAUSE,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1265,harmaline,DRUG,stem cell,NEURAL,THOUGHT TO CAUSE,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1266,brain injury,HEALTH,stem cell,NEURAL,THOUGHT TO CAUSE,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1267,compounds,DRUG,cellular differentiation,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1268,compounds,DRUG,Tuj-1,NEURAL,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1269,compounds,DRUG,equally expressed,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1270,compounds,DRUG,Tuj-1 levels,NEURAL,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1271,astrocytes,NEURAL,stem cell,NEURAL,THOUGHT TO CAUSE,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1272,equally expressed,OUTCOME,stem cell,NEURAL,THOUGHT TO CAUSE,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1273,Tuj-1 levels,NEURAL,stem cell,NEURAL,THOUGHT TO CAUSE,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1274,neurons,NEURAL,stem cell,NEURAL,THOUGHT TO CAUSE,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1275,MAP-2,NEURAL,stem cell,NEURAL,THOUGHT TO CAUSE,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1276,compounds,DRUG,stimulated migration,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1277,compounds,DRUG,promote the three processes involved in full adult neurogenesis,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1278,BDNF,NEURAL,bFGF43,NEURAL,NEEDS MORE RESEARCH BETWEEN,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1279,Lmx1a,NEURAL,promote the three processes involved in full adult neurogenesis,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1280,Lmx1b44,NEURAL,stimulated migration,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1281,Lmx1b44,NEURAL,promote the three processes involved in full adult neurogenesis,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1282,compounds,DRUG,promote the three processes involved in full adult neurogenesis,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1283,compounds,DRUG,stimulated migration,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1284,compounds,DRUG,promote the three processes involved in full adult neurogenesis,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1285,compounds,DRUG,promote the three processes involved in full adult neurogenesis,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1286,THH,DRUG,promote the three processes involved in full adult neurogenesis,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1287,monoamines,NEURAL,neurogenesis,OUTCOME,NEEDS MORE RESEARCH BETWEEN,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1288,serotonin depletion,NEURAL,harmol,DRUG,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1289,serotonin depletion,NEURAL,fluoxetine,ANTIDEPRESSANT_DRUG,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1290,serotonin depletion,NEURAL,imipramine,ANTIDEPRESSANT_DRUG,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1291,serotonin depletion,NEURAL,hippocampal neurogenesis,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1292,serotonin depletion,NEURAL,human neural progenitor cells,NEURAL,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1293,molecules,NEURAL,hippocampal neurogenesis,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1294,molecules,NEURAL,human neural progenitor cells,NEURAL,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1295,molecules,NEURAL,endothelial growth,NEURAL,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1296,molecules,NEURAL,relevant therapeutic implications,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1297,serotonin reuptake inhibitor fluoxetine,ANTIDEPRESSANT_DRUG,endothelial growth,NEURAL,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1298,serotonin reuptake inhibitor fluoxetine,ANTIDEPRESSANT_DRUG,increases neurogenesis,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1299,serotonin reuptake inhibitor fluoxetine,ANTIDEPRESSANT_DRUG,imipramine,ANTIDEPRESSANT_DRUG,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1300,selective MAO-A inhibitor pirlindole53,ANTIDEPRESSANT_DRUG,increases neurogenesis,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1301,selective MAO-A inhibitor pirlindole53,ANTIDEPRESSANT_DRUG,imipramine,ANTIDEPRESSANT_DRUG,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1302,SGZ,NEURAL,increases neurogenesis,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1303,SGZ,NEURAL,imipramine,ANTIDEPRESSANT_DRUG,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1304,fluoxetine,ANTIDEPRESSANT_DRUG,imipramine,ANTIDEPRESSANT_DRUG,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1305,therapeutic potential,OUTCOME,ayahuasca,DRUG,NEEDS MORE RESEARCH BETWEEN,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1306,therapeutic potential,OUTCOME,substance use disorders,HEALTH,NEEDS MORE RESEARCH BETWEEN,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1307,ayahuasca,DRUG,imipramine,ANTIDEPRESSANT_DRUG,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1308,ayahuasca,DRUG,"neuropsychiatric disorders60,61,62",HEALTH,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1309,ayahuasca,DRUG,decreases in problematic alcohol,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1310,ayahuasca,DRUG,cocaine and opiate consumption,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1311,ayahuasca,DRUG,anti-addiction properties,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1312,ayahuasca,DRUG,substance use disorders,HEALTH,NEEDS MORE RESEARCH BETWEEN,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1313,ayahuasca,DRUG,neurogenesis model,OUTCOME,NEEDS MORE RESEARCH BETWEEN,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1314,ayahuasca,DRUG,neurogenesis model,OUTCOME,NEEDS MORE RESEARCH BETWEEN,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1315,5-HT2A receptor,NEURAL,serotonergic psychedelic9,DRUG,THOUGHT TO CAUSE,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1316,5-HT2A receptor,NEURAL,profound psychological experiences,OUTCOME,THOUGHT TO CAUSE,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1317,5-HT2A receptor,NEURAL,neurogenesis model,OUTCOME,NEEDS MORE RESEARCH BETWEEN,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1318,profound psychological experiences,OUTCOME,improves behavioral measures of depression17,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1319,profound psychological experiences,OUTCOME,behavioral improvement,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1320,psilocybin,DRUG,neurogenesis model,OUTCOME,NEEDS MORE RESEARCH BETWEEN,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1321,psilocybin,DRUG,neurogenesis model,OUTCOME,NEEDS MORE RESEARCH BETWEEN,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1322,LSD,DRUG,neurogenesis model,OUTCOME,NEEDS MORE RESEARCH BETWEEN,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1323,LSD,DRUG,neurogenesis model,OUTCOME,NEEDS MORE RESEARCH BETWEEN,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1324,harmine,DRUG,improves behavioral measures of depression17,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1325,harmine,DRUG,neurogenesis,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1326,harmine,DRUG,behavioral improvement,OUTCOME,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1327,MAO inhibitors,ANTIDEPRESSANT_DRUG,brain plasticity,NEURAL,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1328,ayahuasca,DRUG,brain plasticity,NEURAL,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1329,ayahuasca,DRUG,neurologic disorders,HEALTH,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1330,ayahuasca,DRUG,brain plasticity,NEURAL,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1331,ayahuasca,DRUG,neurologic disorders,HEALTH,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1332,compounds,DRUG,brain plasticity,NEURAL,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1333,compounds,DRUG,neurologic disorders,HEALTH,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1334,compounds,DRUG,brain plasticity,NEURAL,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1335,compounds,DRUG,neurologic disorders,HEALTH,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1336,compounds,DRUG,brain plasticity,NEURAL,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1337,compounds,DRUG,neurologic disorders,HEALTH,POSITIVELY IMPACTS,7bfbd5f04346d6ab9e75fe5bac153cb393d6da7782e34236417aef2762b8fecc
1338,MEQ30,NEURAL,changes in perception,OUTCOME,THOUGHT TO CAUSE,4502e87d7287ecf607c4dd6ef08dc96cc3079a0302a613b308d045b807564ce9
1339,psychedelic,DRUG,stimulation of mood,OUTCOME,POSITIVELY IMPACTS,4502e87d7287ecf607c4dd6ef08dc96cc3079a0302a613b308d045b807564ce9
1340,5-HT2A and 2C receptors,NEURAL,changes in perception,OUTCOME,THOUGHT TO CAUSE,4502e87d7287ecf607c4dd6ef08dc96cc3079a0302a613b308d045b807564ce9
1341,psilocybin,DRUG,psilocin,DRUG,POSITIVELY IMPACTS,4502e87d7287ecf607c4dd6ef08dc96cc3079a0302a613b308d045b807564ce9
1342,psychedelic “,DRUG,mood,SUBJECTIVE,POSITIVELY IMPACTS,4502e87d7287ecf607c4dd6ef08dc96cc3079a0302a613b308d045b807564ce9
1343,psilocybin,DRUG,enhanced creativity,OUTCOME,POSITIVELY IMPACTS,4502e87d7287ecf607c4dd6ef08dc96cc3079a0302a613b308d045b807564ce9
1344,psilocybin,DRUG,mood,SUBJECTIVE,POSITIVELY IMPACTS,4502e87d7287ecf607c4dd6ef08dc96cc3079a0302a613b308d045b807564ce9
1345,psilocybin,DRUG,mood,SUBJECTIVE,POSITIVELY IMPACTS,4502e87d7287ecf607c4dd6ef08dc96cc3079a0302a613b308d045b807564ce9
1346,psilocybin,DRUG,decrease in cerebral 5-HT levels,OUTCOME,POSITIVELY IMPACTS,4502e87d7287ecf607c4dd6ef08dc96cc3079a0302a613b308d045b807564ce9
1347,psilocybin,DRUG,underestimation of occupancy,OUTCOME,POSITIVELY IMPACTS,4502e87d7287ecf607c4dd6ef08dc96cc3079a0302a613b308d045b807564ce9
1348,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,4502e87d7287ecf607c4dd6ef08dc96cc3079a0302a613b308d045b807564ce9
1349,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,4502e87d7287ecf607c4dd6ef08dc96cc3079a0302a613b308d045b807564ce9
1350,ayahuasca,DRUG,anxiolytic and antidepressive properties,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1351,ayahuasca,DRUG,reduced psychopathology,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1352,ayahuasca,DRUG,anxiolytic and antidepressive effects,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1353,ayahuasca,DRUG,anxiolytic and antidepressive properties,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1354,ayahuasca,DRUG,reduced psychopathology,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1355,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1356,these compounds,DRUG,anxiolytic and antidepressive properties,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1357,these compounds,DRUG,reduced psychopathology,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1358,these compounds,DRUG,depression,HEALTH,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1359,ayahuasca,DRUG,anxiolytic and antidepressive effects,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1360,ayahuasca,DRUG,anxiolytic and antidepressive properties,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1361,ayahuasca,DRUG,do not exhibit symptoms of psychiatric disorders or neurocognitive problems,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1362,ayahuasca,DRUG,better cognitive function,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1363,ayahuasca,DRUG,increased well-being and spirituality,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1364,ayahuasca,DRUG,reduced psychopathology,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1365,ayahuasca,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1366,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1367,ayahuasca,DRUG,"MAO-A inhibitor,3,5",NEURAL,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1368,harmine,DRUG,anxiolytic or antidepressive effects,OUTCOME,THOUGHT TO CAUSE,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1369,harmine,DRUG,harmaline,DRUG,THOUGHT TO CAUSE,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1370,harmine,DRUG,anxiolytic effects,OUTCOME,THOUGHT TO CAUSE,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1371,harmine,DRUG,antidepressive effects,OUTCOME,THOUGHT TO CAUSE,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1372,harmine,DRUG,antidepressive effects,OUTCOME,THOUGHT TO CAUSE,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1373,harmaline,DRUG,anxiolytic or antidepressive effects,OUTCOME,THOUGHT TO CAUSE,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1374,ayahuasca,DRUG,anxiolytic or antidepressive effects,OUTCOME,THOUGHT TO CAUSE,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1375,ayahuasca,DRUG,antidepressive effects,OUTCOME,THOUGHT TO CAUSE,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1376,harmaline,DRUG,reduced psychopathology,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1377,harmaline,DRUG,depression,HEALTH,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1378,hallucinogens,DRUG,emotional processing,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1379,5-HT2A receptors,NEURAL,antidepressive effects,OUTCOME,THOUGHT TO CAUSE,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1380,5-HT2A receptors,NEURAL,antidepressive effects,OUTCOME,THOUGHT TO CAUSE,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1381,5-HT2A receptors,NEURAL,increase cortical glutamate levels,OUTCOME,THOUGHT TO CAUSE,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1382,5-HT2A receptors,NEURAL,antidepressive effects,OUTCOME,THOUGHT TO CAUSE,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1383,harmine,DRUG,emotional processing,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1384,serotonergic receptor,NEURAL,antidepressive effects,OUTCOME,THOUGHT TO CAUSE,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1385,serotonergic receptor,NEURAL,antidepressive effects,OUTCOME,THOUGHT TO CAUSE,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1386,GABAA receptor,NEURAL,increase cortical glutamate levels,OUTCOME,THOUGHT TO CAUSE,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1387,GABAA receptor,NEURAL,antidepressive effects,OUTCOME,THOUGHT TO CAUSE,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1388,THH,DRUG,emotional processing,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1389,THH,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1390,THH,DRUG,depressive symptoms,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1391,THH,DRUG,mood,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1392,5-HT1A/2A/2C receptor agonists,NEURAL,emotional processing,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1393,5-HT1A/2A/2C receptor agonists,NEURAL,anxiety,HEALTH,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1394,5-HT1A/2A/2C receptor agonists,NEURAL,depressive symptoms,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1395,5-HT1A/2A/2C receptor agonists,NEURAL,mood,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1396,5-HT1A/2A/2C receptor,NEURAL,depressive symptoms,HEALTH,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1397,5-HT1A/2A/2C receptor agonists,NEURAL,depressive symptoms,HEALTH,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1398,5-HT1A/2A/2C receptor agonists,NEURAL,mood,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1399,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1400,psilocybin,DRUG,depressive symptoms,HEALTH,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1401,psilocybin,DRUG,mood,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1402,LSD,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1403,LSD,DRUG,depressive symptoms,HEALTH,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1404,LSD,DRUG,mood,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1405,psilocybin,DRUG,depressive symptoms,HEALTH,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1406,LSD,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1407,LSD,DRUG,depressive symptoms,HEALTH,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1408,LSD,DRUG,mood,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1409,OCDs,HEALTH,anxiety,HEALTH,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1410,OCDs,HEALTH,depressive symptoms,HEALTH,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1411,OCDs,HEALTH,mood,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1412,psilocybin,DRUG,neurosis,HEALTH,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1413,psilocybin,DRUG,OCDs,HEALTH,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1414,psilocybin,DRUG,anxiolytic effects,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1415,psilocybin-,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1416,psilocybin-,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1417,psilocybin-,DRUG,depression,HEALTH,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1418,psilocybin-,DRUG,cancer,HEALTH,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1419,LSD,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1420,LSD,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1421,LSD,DRUG,depression,HEALTH,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1422,LSD,DRUG,cancer,HEALTH,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1423,ayahuasca,DRUG,significantly reduced DMN activation.73,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1424,Depressive states,SUBJECTIVE,rumination,OUTCOME,NEGATIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1425,ayahuasca,DRUG,significantly reduced DMN activation.73,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1426,serotonergic hallucinogens,DRUG,significantly reduced DMN activation.73,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1427,serotonergic hallucinogens,DRUG,increased functional connectivity of the DMN,NEURAL,THOUGHT TO CAUSE,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1428,psilocybin,DRUG,increased functional connectivity of the DMN,NEURAL,THOUGHT TO CAUSE,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1429,PCC,NEURAL,significantly reduced DMN activation.73,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1430,hallucinogens,DRUG,increased functional connectivity of the DMN,NEURAL,THOUGHT TO CAUSE,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1431,hallucinogens,DRUG,anxiolytic and antidepressive effects,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1432,psychotic,HEALTH,increased functional connectivity of the DMN,NEURAL,THOUGHT TO CAUSE,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1433,ayahuasca,DRUG,meditative states,SUBJECTIVE,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1434,ayahuasca,DRUG,anxiolytic and antidepressive effects,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1435,ayahuasca,DRUG,anxiolytic and antidepressive properties,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1436,ayahuasca,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1437,ayahuasca,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1438,ayahuasca,DRUG,depressive disorders,HEALTH,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1439,ayahuasca,DRUG,anxiolytic and antidepressive properties,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1440,ayahuasca,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1441,ayahuasca,DRUG,anxiolytic and antidepressive effects,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1442,ayahuasca,DRUG,anxiolytic and antidepressive effects,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1443,ayahuasca,DRUG,anxiolytic and antidepressive effects,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1444,ayahuasca,DRUG,depressed patients,HEALTH,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1445,ayahuasca,DRUG,anxiolytic or antidepressive effect,OUTCOME,THOUGHT TO CAUSE,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1446,ayahuasca,DRUG,anxiolytic and antidepressive effects,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1447,ayahuasca,DRUG,anxiolytic and antidepressive effects,OUTCOME,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1448,ayahuasca,DRUG,depressed patients,HEALTH,POSITIVELY IMPACTS,037e504d3d1039b55dee95537c9b9c7bf65a8140502a3e859cc2a75219bff3ba
1449,5-HT2A serotonin receptor,NEURAL,actions of classical psychedelics,OUTCOME,THOUGHT TO CAUSE,42e51bcb326f0364fe6481b545dca69a3adad932f9e9fde5bcc1e09314a8beaf
1450,HT2A receptor,NEURAL,actions of classical psychedelics,OUTCOME,THOUGHT TO CAUSE,42e51bcb326f0364fe6481b545dca69a3adad932f9e9fde5bcc1e09314a8beaf
1451,5-HT2A receptor,NEURAL,actions of classical psychedelics,OUTCOME,THOUGHT TO CAUSE,42e51bcb326f0364fe6481b545dca69a3adad932f9e9fde5bcc1e09314a8beaf
1452,5-HT2A receptor,NEURAL,actions of classical psychedelics,OUTCOME,THOUGHT TO CAUSE,42e51bcb326f0364fe6481b545dca69a3adad932f9e9fde5bcc1e09314a8beaf
1453,5-HT2A receptor,NEURAL,HTR2A,NEURAL,THOUGHT TO CAUSE,42e51bcb326f0364fe6481b545dca69a3adad932f9e9fde5bcc1e09314a8beaf
1454,5-HT2A receptor,NEURAL,actions of classical psychedelics,OUTCOME,THOUGHT TO CAUSE,42e51bcb326f0364fe6481b545dca69a3adad932f9e9fde5bcc1e09314a8beaf
1455,5-HT2A receptor,NEURAL,HTR2A,NEURAL,THOUGHT TO CAUSE,42e51bcb326f0364fe6481b545dca69a3adad932f9e9fde5bcc1e09314a8beaf
1456,LSD,DRUG,depression,HEALTH,POSITIVELY IMPACTS,42e51bcb326f0364fe6481b545dca69a3adad932f9e9fde5bcc1e09314a8beaf
1457,LSD,DRUG,cluster headaches,HEALTH,POSITIVELY IMPACTS,42e51bcb326f0364fe6481b545dca69a3adad932f9e9fde5bcc1e09314a8beaf
1458,psilocybin,DRUG,HTR2A,NEURAL,NEEDS MORE RESEARCH BETWEEN,42e51bcb326f0364fe6481b545dca69a3adad932f9e9fde5bcc1e09314a8beaf
1459,psilocybin,DRUG,GPCR-Gq,NEURAL,NEEDS MORE RESEARCH BETWEEN,42e51bcb326f0364fe6481b545dca69a3adad932f9e9fde5bcc1e09314a8beaf
1460,psilocybin,DRUG,depression,HEALTH,NEEDS MORE RESEARCH BETWEEN,42e51bcb326f0364fe6481b545dca69a3adad932f9e9fde5bcc1e09314a8beaf
1461,psilocybin,DRUG,substance abuse,HEALTH,NEEDS MORE RESEARCH BETWEEN,42e51bcb326f0364fe6481b545dca69a3adad932f9e9fde5bcc1e09314a8beaf
1462,psilocybin,DRUG,cluster headaches,HEALTH,POSITIVELY IMPACTS,42e51bcb326f0364fe6481b545dca69a3adad932f9e9fde5bcc1e09314a8beaf
1463,psilocybin,DRUG,HTR2A ligand recognition,NEURAL,NEEDS MORE RESEARCH BETWEEN,42e51bcb326f0364fe6481b545dca69a3adad932f9e9fde5bcc1e09314a8beaf
1464,psilocybin,DRUG,HTR2A-effector coupling,NEURAL,NEEDS MORE RESEARCH BETWEEN,42e51bcb326f0364fe6481b545dca69a3adad932f9e9fde5bcc1e09314a8beaf
1465,psilocybin,DRUG,HTR2A agonists,NEURAL,NEEDS MORE RESEARCH BETWEEN,42e51bcb326f0364fe6481b545dca69a3adad932f9e9fde5bcc1e09314a8beaf
1466,psilocybin,DRUG,GPCRs,NEURAL,NEEDS MORE RESEARCH BETWEEN,42e51bcb326f0364fe6481b545dca69a3adad932f9e9fde5bcc1e09314a8beaf
1467,microdosing,DRUG,decreased depression,OUTCOME,POSITIVELY IMPACTS,9cc87db7435b0c1f639c32711e66c83132b05a0104fd310c9be07512fa24095b
1468,microdosing,DRUG,stress,HEALTH,POSITIVELY IMPACTS,9cc87db7435b0c1f639c32711e66c83132b05a0104fd310c9be07512fa24095b
1469,microdosing,DRUG,immediate boost,OUTCOME,POSITIVELY IMPACTS,9cc87db7435b0c1f639c32711e66c83132b05a0104fd310c9be07512fa24095b
1470,microdosing,DRUG,increased absorption,OUTCOME,POSITIVELY IMPACTS,9cc87db7435b0c1f639c32711e66c83132b05a0104fd310c9be07512fa24095b
1471,microdosing,DRUG,decreased depression,OUTCOME,POSITIVELY IMPACTS,9cc87db7435b0c1f639c32711e66c83132b05a0104fd310c9be07512fa24095b
1472,microdosing,DRUG,stress,HEALTH,POSITIVELY IMPACTS,9cc87db7435b0c1f639c32711e66c83132b05a0104fd310c9be07512fa24095b
1473,microdosing,DRUG,decreased depression,OUTCOME,POSITIVELY IMPACTS,9cc87db7435b0c1f639c32711e66c83132b05a0104fd310c9be07512fa24095b
1474,microdosing,DRUG,stress,HEALTH,POSITIVELY IMPACTS,9cc87db7435b0c1f639c32711e66c83132b05a0104fd310c9be07512fa24095b
1475,psilocybin,DRUG,Extraversion and Openness scores significantly increased,OUTCOME,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1476,psilocybin,DRUG,Extraversion and Openness scores significantly increased,OUTCOME,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1477,psilocybin,DRUG,changes of personality traits,OUTCOME,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1478,psilocybin,DRUG,Conscientiousness only at trend-level,OUTCOME,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1479,psychedelic,DRUG,depressed individuals,HEALTH,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1480,moclobemide,ANTIDEPRESSANT_DRUG,Conscientiousness,OUTCOME,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1481,SSRIs,ANTIDEPRESSANT_DRUG,personality,SUBJECTIVE,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1482,psychedelics,DRUG,personality,SUBJECTIVE,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1483,psychedelics,DRUG,long-lasting increases in trait Openness,OUTCOME,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1484,LSD,DRUG,brain,NEURAL,NEEDS MORE RESEARCH BETWEEN,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1485,LSD,DRUG,long-lasting increases in trait Openness,OUTCOME,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1486,LSD,DRUG,post-traumatic stress disorder,HEALTH,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1487,ayahuasca,DRUG,post-traumatic stress disorder,HEALTH,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1488,ayahuasca,DRUG,post-traumatic stress disorder,HEALTH,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1489,psychedelic,DRUG,post-traumatic stress disorder,HEALTH,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1490,Neuroticism,NEURAL,Extraversion,OUTCOME,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1491,Neuroticism,NEURAL,Openness,OUTCOME,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1492,psychedelic,DRUG,Openness,OUTCOME,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1493,psychedelic,DRUG,higher Openness,OUTCOME,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1494,psychedelic,DRUG,lasting changes in personality,OUTCOME,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1495,psychedelic,DRUG,subtle drop in Openness and Extraversion scores,OUTCOME,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1496,religious conversion,SUBJECTIVE,outlook,SUBJECTIVE,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1497,spiritual experience,OUTCOME,outlook,SUBJECTIVE,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1498,spiritual experience,OUTCOME,long-lasting impact,OUTCOME,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1499,mystical experience,SUBJECTIVE,blissful state,SUBJECTIVE,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1500,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1501,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1502,psilocybin,DRUG,self-consciousness,SUBJECTIVE,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1503,psilocybin,DRUG,depressed patients,HEALTH,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1504,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1505,2A receptor,NEURAL,changes in Openness,OUTCOME,THOUGHT TO CAUSE,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1506,DMT,DRUG,elevated Openness,OUTCOME,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1507,LSD,DRUG,elevated Openness,OUTCOME,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1508,LSD,DRUG,changes in Openness,OUTCOME,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1509,LSD,DRUG,changes in personality measures,OUTCOME,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1510,serotonin 2A receptor stimulation,NEURAL,changes in Openness,OUTCOME,THOUGHT TO CAUSE,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1511,psychedelic,DRUG,increases in Conscientiousness,OUTCOME,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1512,psilocybin,DRUG,increases in Conscientiousness,OUTCOME,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1513,psilocybin,DRUG,pronounced increases in Extraversion,OUTCOME,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1514,psilocybin,DRUG,Insight,SUBJECTIVE,POSITIVELY IMPACTS,72889081a3aecf1337f8cd6dd4945d62436220f87435a8aaf43c7ece24261afd
1515,psychedelic,DRUG,enhanced mindfulness capacities,OUTCOME,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1516,psychedelic,DRUG,decreased judgmental and reactive attitudes,OUTCOME,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1517,ayahuasca,DRUG,enhanced mindfulness capacities,OUTCOME,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1518,ayahuasca,DRUG,decreased judgmental and reactive attitudes,OUTCOME,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1519,ayahuasca,DRUG,Mindsens,NEURAL,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1520,Ayahuasca,DRUG,enhanced mindfulness capacities,OUTCOME,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1521,Ayahuasca,DRUG,decreased judgmental and reactive attitudes,OUTCOME,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1522,NAAG,NEURAL,decrease of alpha oscillations,OUTCOME,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1523,ayahuasca,DRUG,Glx,NEURAL,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1524,ayahuasca,DRUG,clinical improvement,OUTCOME,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1525,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1526,Psychedelics,DRUG,clinical improvement,OUTCOME,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1527,Psychedelics,DRUG,depression,HEALTH,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1528,Psychedelics,DRUG,personal sense of “self,SUBJECTIVE,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1529,Psychedelics,DRUG,increase in coupling,OUTCOME,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1530,psilocybin,DRUG,enhanced mindfulness capacities,OUTCOME,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1531,LSD,DRUG,increase in coupling,OUTCOME,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1532,LSD,DRUG,enhanced mindfulness capacities,OUTCOME,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1533,LSD,DRUG,reduced judgmental processing,OUTCOME,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1534,LSD,DRUG,increased self-kindness,OUTCOME,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1535,psilocybin,DRUG,limbic structures,NEURAL,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1536,psilocybin,DRUG,depressed patients,HEALTH,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1537,ayahuasca,DRUG,limbic structures,NEURAL,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1538,modification induced by psychedelics,OUTCOME,limbic structures,NEURAL,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1539,psychedelic,DRUG,depression,HEALTH,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1540,psychedelic,DRUG,brain plasticity,NEURAL,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1541,psychedelic,DRUG,increases in trait openness,OUTCOME,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1542,ayahuasca,DRUG,increases in trait openness,OUTCOME,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1543,ayahuasca,DRUG,increased self-transcendence,OUTCOME,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1544,ayahuasca,DRUG,brain dynamics,NEURAL,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1545,ayahuasca,DRUG,addiction disorders,HEALTH,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1546,ayahuasca,DRUG,self-centeredness,SUBJECTIVE,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1547,ayahuasca,DRUG,increased self-transcendence,OUTCOME,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1548,ayahuasca,DRUG,brain dynamics,NEURAL,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1549,ayahuasca,DRUG,addiction disorders,HEALTH,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1550,ayahuasca,DRUG,self-centeredness,SUBJECTIVE,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1551,ayahuasca,DRUG,brain function,NEURAL,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1552,ayahuasca,DRUG,increased self-transcendence,OUTCOME,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1553,ayahuasca,DRUG,brain dynamics,NEURAL,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1554,ayahuasca,DRUG,addiction disorders,HEALTH,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1555,ayahuasca,DRUG,self-centeredness,SUBJECTIVE,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1556,ayahuasca,DRUG,brain function,NEURAL,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1557,ayahuasca,DRUG,increased self-transcendence,OUTCOME,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1558,ayahuasca,DRUG,brain dynamics,NEURAL,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1559,ayahuasca,DRUG,addiction disorders,HEALTH,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1560,ayahuasca,DRUG,self-centeredness,SUBJECTIVE,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1561,ayahuasca,DRUG,brain function,NEURAL,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1562,ayahuasca,DRUG,addiction disorders,HEALTH,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1563,ayahuasca,DRUG,addiction disorders,HEALTH,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1564,ayahuasca,DRUG,self-centeredness,SUBJECTIVE,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1565,ayahuasca,DRUG,brain function,NEURAL,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1566,ayahuasca,DRUG,enhanced mindfulness facets,OUTCOME,POSITIVELY IMPACTS,c048fdacb16ddba0cb14b792af1c47b82cb03091eca1b8fc664cae948dcea7c4
1567,psilocybin,DRUG,a sense of grounding,OUTCOME,POSITIVELY IMPACTS,2f3bf25995a3ad67c97aea9e88fc52bb787d858eb86acd8826c84417a18b30b2
1568,LSD,DRUG,treatment-resistant depression,HEALTH,NEEDS MORE RESEARCH BETWEEN,2f3bf25995a3ad67c97aea9e88fc52bb787d858eb86acd8826c84417a18b30b2
1569,psilocybin,DRUG,…,DRUG,POSITIVELY IMPACTS,2f3bf25995a3ad67c97aea9e88fc52bb787d858eb86acd8826c84417a18b30b2
1570,…,DRUG,…,DRUG,POSITIVELY IMPACTS,2f3bf25995a3ad67c97aea9e88fc52bb787d858eb86acd8826c84417a18b30b2
1571,misguidance,DRUG,dissonance,DRUG,POSITIVELY IMPACTS,2f3bf25995a3ad67c97aea9e88fc52bb787d858eb86acd8826c84417a18b30b2
1572,psilocybin,DRUG,"liking, resonance, and openness",OUTCOME,POSITIVELY IMPACTS,2f3bf25995a3ad67c97aea9e88fc52bb787d858eb86acd8826c84417a18b30b2
1573,psilocybin,DRUG,reported insightfulness,OUTCOME,POSITIVELY IMPACTS,2f3bf25995a3ad67c97aea9e88fc52bb787d858eb86acd8826c84417a18b30b2
1574,psilocybin,DRUG,insightfulness,SUBJECTIVE,POSITIVELY IMPACTS,2f3bf25995a3ad67c97aea9e88fc52bb787d858eb86acd8826c84417a18b30b2
1575,psilocybin,DRUG,promote the occurrence of therapeutically meaningful experiences,OUTCOME,POSITIVELY IMPACTS,2f3bf25995a3ad67c97aea9e88fc52bb787d858eb86acd8826c84417a18b30b2
1576,psilocybin,DRUG,sustained positive changes in behaviour and personality,OUTCOME,POSITIVELY IMPACTS,2f3bf25995a3ad67c97aea9e88fc52bb787d858eb86acd8826c84417a18b30b2
1577,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,2f3bf25995a3ad67c97aea9e88fc52bb787d858eb86acd8826c84417a18b30b2
1578,psilocybin,DRUG,sustained positive changes in behaviour and personality,OUTCOME,POSITIVELY IMPACTS,2f3bf25995a3ad67c97aea9e88fc52bb787d858eb86acd8826c84417a18b30b2
1579,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,2f3bf25995a3ad67c97aea9e88fc52bb787d858eb86acd8826c84417a18b30b2
1580,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,2f3bf25995a3ad67c97aea9e88fc52bb787d858eb86acd8826c84417a18b30b2
1581,drug effect,OUTCOME,depression,HEALTH,POSITIVELY IMPACTS,2f3bf25995a3ad67c97aea9e88fc52bb787d858eb86acd8826c84417a18b30b2
1582,psychedelics,DRUG,deeply felt and personally meaningful emotionality,OUTCOME,POSITIVELY IMPACTS,2f3bf25995a3ad67c97aea9e88fc52bb787d858eb86acd8826c84417a18b30b2
1583,music,DRUG,deeply felt and personally meaningful emotionality,OUTCOME,POSITIVELY IMPACTS,2f3bf25995a3ad67c97aea9e88fc52bb787d858eb86acd8826c84417a18b30b2
1584,intense emotional experiences,OUTCOME,deeply felt and personally meaningful emotionality,OUTCOME,POSITIVELY IMPACTS,2f3bf25995a3ad67c97aea9e88fc52bb787d858eb86acd8826c84417a18b30b2
1585,dislike,OUTCOME,sense of being on a journey,SUBJECTIVE,POSITIVELY IMPACTS,2f3bf25995a3ad67c97aea9e88fc52bb787d858eb86acd8826c84417a18b30b2
1586,psilocybin,DRUG,paranoia,OUTCOME,POSITIVELY IMPACTS,0456ad5a08777d868b9a735a8a9c82f441626770aef9762de361efc6f18f883d
1587,psilocybin,DRUG,meaningful and spiritually significant experiences,OUTCOME,POSITIVELY IMPACTS,0456ad5a08777d868b9a735a8a9c82f441626770aef9762de361efc6f18f883d
1588,psilocybin,DRUG,meaningful and spiritually significant experiences,OUTCOME,POSITIVELY IMPACTS,0456ad5a08777d868b9a735a8a9c82f441626770aef9762de361efc6f18f883d
1589,psilocybin,DRUG,egodissolution,SUBJECTIVE,POSITIVELY IMPACTS,0456ad5a08777d868b9a735a8a9c82f441626770aef9762de361efc6f18f883d
1590,psilocybin,DRUG,addiction treatment,HEALTH,POSITIVELY IMPACTS,0456ad5a08777d868b9a735a8a9c82f441626770aef9762de361efc6f18f883d
1591,unity experience,SUBJECTIVE,sense of sanity,SUBJECTIVE,POSITIVELY IMPACTS,0456ad5a08777d868b9a735a8a9c82f441626770aef9762de361efc6f18f883d
1592,serotonergic hallucinogens,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1593,serotonergic hallucinogens,DRUG,mood,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1594,serotonergic hallucinogens,DRUG,anxiolytic,OUTCOME,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1595,serotonergic hallucinogens,DRUG,antidepressive,OUTCOME,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1596,serotonergic hallucinogens,DRUG,antiaddictive,OUTCOME,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1597,psychedelics,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1598,psychedelics,DRUG,mood,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1599,psychedelics,DRUG,anxiolytic,OUTCOME,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1600,psychedelics,DRUG,antiaddictive,OUTCOME,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1601,LSD,DRUG,substance-use disorders,HEALTH,NEEDS MORE RESEARCH BETWEEN,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1602,LSD,DRUG,antiaddictive,OUTCOME,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1603,LSD,DRUG,alcoholic patients,HEALTH,NEEDS MORE RESEARCH BETWEEN,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1604,LSD,DRUG,ayahuasca,DRUG,NEEDS MORE RESEARCH BETWEEN,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1605,ayahuasca,DRUG,antiaddictive,OUTCOME,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1606,ayahuasca,DRUG,antiaddictive,OUTCOME,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1607,LSD,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1608,LSD,DRUG,mood,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1609,LSD,DRUG,anxiolytic,OUTCOME,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1610,LSD,DRUG,antiaddictive,OUTCOME,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1611,LSD,DRUG,alcohol dependence,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1612,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1613,psilocybin,DRUG,mood,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1614,psilocybin,DRUG,anxiolytic,OUTCOME,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1615,psilocybin,DRUG,antidepressive,OUTCOME,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1616,psilocybin,DRUG,antiaddictive,OUTCOME,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1617,psilocybin,DRUG,alcohol dependence,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1618,psilocybin,DRUG,anxiolytic and antidepressive effects,OUTCOME,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1619,psilocybin,DRUG,advanced-stage cancer,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1620,LSD,DRUG,ayahuasca,DRUG,NEEDS MORE RESEARCH BETWEEN,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1621,LSD,DRUG,alcohol dependence,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1622,LSD,DRUG,advanced-stage cancer,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1623,LSD,DRUG,advanced-stage cancer,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1624,LSD,DRUG,existential anxiety,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1625,LSD,DRUG,depression,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1626,psilocybin,DRUG,alcohol dependence,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1627,psilocybin,DRUG,anxiolytic and antidepressive effects,OUTCOME,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1628,psilocybin,DRUG,advanced-stage cancer,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1629,psilocybin,DRUG,advanced-stage cancer,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1630,psilocybin,DRUG,existential anxiety,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1631,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1632,LSD,DRUG,alcohol dependence,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1633,LSD,DRUG,existential anxiety,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1634,LSD,DRUG,depression,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1635,LSD,DRUG,depression,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1636,alcoholism,DRUG,depression,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1637,psilocybin,DRUG,existential anxiety,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1638,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1639,LSD,DRUG,alcohol dependence,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1640,LSD,DRUG,advanced-stage cancer,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1641,LSD,DRUG,advanced-stage cancer,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1642,LSD,DRUG,existential anxiety,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1643,LSD,DRUG,depression,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1644,LSD,DRUG,existential anxiety,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1645,LSD,DRUG,depression,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1646,LSD,DRUG,existential anxiety,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1647,LSD,DRUG,depression,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1648,LSD,DRUG,depression,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1649,LSD,DRUG,existential anxiety,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1650,LSD,DRUG,depression,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1651,LSD,DRUG,existential anxiety,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1652,LSD,DRUG,depression,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1653,psilocybin,DRUG,existential anxiety,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1654,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1655,psilocybin,DRUG,existential anxiety,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1656,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1657,psilocybin,DRUG,existential anxiety,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1658,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1659,psilocybin,DRUG,rapid (24 h),OUTCOME,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1660,psilocybin,DRUG,therapeutic effects,OUTCOME,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1661,psilocybin,DRUG,antiaddictive effects,OUTCOME,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1662,psilocybin,DRUG,rapid (24 h),OUTCOME,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1663,psilocybin,DRUG,therapeutic effects,OUTCOME,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1664,psilocybin,DRUG,antiaddictive effects,OUTCOME,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1665,ayahuasca,DRUG,rapid (24 h),OUTCOME,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1666,ayahuasca,DRUG,therapeutic effects,OUTCOME,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1667,ayahuasca,DRUG,antiaddictive effects,OUTCOME,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1668,psilocybin,DRUG,antiaddictive effects,OUTCOME,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1669,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1670,psilocybin,DRUG,depressive symptoms,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1671,LSD,DRUG,antiaddictive effects,OUTCOME,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1672,LSD,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1673,LSD,DRUG,depressive symptoms,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1674,LSD,DRUG,reduced impulsivity,OUTCOME,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1675,LSD,DRUG,novelty seeking,OUTCOME,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1676,LSD,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1677,LSD,DRUG,depressive symptoms,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1678,ayahuasca,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1679,ayahuasca,DRUG,depressive symptoms,HEALTH,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1680,ayahuasca,DRUG,antiaddictive,OUTCOME,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1681,ayahuasca,DRUG,anxiolytic,OUTCOME,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1682,ayahuasca,DRUG,antiaddictive,OUTCOME,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1683,ayahuasca,DRUG,psychotic episodes,HEALTH,THOUGHT TO CAUSE,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1684,ayahuasca,DRUG,psychotic episodes,HEALTH,THOUGHT TO CAUSE,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1685,ayahuasca,DRUG,antiaddictive,OUTCOME,POSITIVELY IMPACTS,5d60ce3d186e70de00b9ba548ac4e9ba84fd40ec9aadd14a107701bfd3123fe2
1686,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1687,ayahuasca,DRUG,stress,OUTCOME,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1688,ayahuasca,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1689,convergent thinking,OUTCOME,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1690,ayahuasca,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1691,ayahuasca,DRUG,stress,OUTCOME,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1692,ayahuasca,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1693,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1694,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1695,ayahuasca,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1696,ayahuasca,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1697,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1698,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1699,Antidepressant properties,OUTCOME,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1700,ayahuasca,DRUG,satisfaction with life,OUTCOME,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1701,ayahuasca,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1702,ayahuasca,DRUG,stress,OUTCOME,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1703,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1704,ayahuasca,DRUG,stress,OUTCOME,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1705,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1706,ayahuasca,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1707,MAO-A inhibitors,NEURAL,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1708,harmaline,DRUG,depression,HEALTH,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1709,harmaline,DRUG,hippocampal progenitor cells,NEURAL,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1710,harmaline,DRUG,Neurogenesis,OUTCOME,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1711,psychedelic compounds,DRUG,hippocampal progenitor cells,NEURAL,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1712,psychedelic compounds,DRUG,synaptic plasticity,NEURAL,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1713,psychedelic compounds,DRUG,Neurogenesis,OUTCOME,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1714,ayahuasca,DRUG,mindfulness,OUTCOME,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1715,ayahuasca,DRUG,satisfaction with life,OUTCOME,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1716,ayahuasca,DRUG,mindfulness,OUTCOME,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1717,ayahuasca,DRUG,changes in mindfulness,OUTCOME,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1718,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1719,ayahuasca,DRUG,stress,HEALTH,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1720,ayahuasca,DRUG,changes in mindfulness,OUTCOME,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1721,ayahuasca,DRUG,stress,HEALTH,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1722,ayahuasca,DRUG,modified state of consciousness,SUBJECTIVE,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1723,PCT performance,OUTCOME,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1724,ayahuasca,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1725,psychedelic,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1726,ayahuasca,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1727,ayahuasca,DRUG,changes in affect and thinking style,OUTCOME,THOUGHT TO CAUSE,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1728,ayahuasca,DRUG,stress levels,OUTCOME,THOUGHT TO CAUSE,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1729,ayahuasca,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1730,ayahuasca,DRUG,stronger reductions in symptoms of depression,OUTCOME,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1731,ayahuasca,DRUG,stress,HEALTH,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1732,ayahuasca,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1733,ayahuasca,DRUG,satisfaction with life,OUTCOME,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1734,ayahuasca,DRUG,stronger reductions in symptoms of depression,OUTCOME,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1735,ayahuasca,DRUG,stress,HEALTH,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1736,ayahuasca,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1737,ayahuasca,DRUG,satisfaction with life,OUTCOME,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1738,ayahuasca,DRUG,stronger reductions in symptoms of depression,OUTCOME,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1739,ayahuasca,DRUG,stress,HEALTH,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1740,ayahuasca,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1741,ayahuasca,DRUG,satisfaction with life,OUTCOME,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1742,ayahuasca,DRUG,changes in mood and thinking,OUTCOME,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1743,ayahuasca,DRUG,affect and cognition,OUTCOME,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1744,ayahuasca,DRUG,stronger reductions in symptoms of depression,OUTCOME,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1745,ayahuasca,DRUG,stress,HEALTH,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1746,ayahuasca,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1747,ayahuasca,DRUG,satisfaction with life,OUTCOME,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1748,ayahuasca,DRUG,affect,SUBJECTIVE,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1749,ayahuasca,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1750,ayahuasca,DRUG,stronger reductions in symptoms of depression,OUTCOME,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1751,ayahuasca,DRUG,stress,HEALTH,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1752,ayahuasca,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1753,ayahuasca,DRUG,satisfaction with life,OUTCOME,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1754,ayahuasca,DRUG,changes in mood and thinking,OUTCOME,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1755,ayahuasca,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1756,ayahuasca,DRUG,affect and cognition,OUTCOME,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1757,ayahuasca,DRUG,affect,SUBJECTIVE,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1758,ayahuasca,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1759,ayahuasca,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1760,ayahuasca,DRUG,satisfaction with life,OUTCOME,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1761,ayahuasca,DRUG,changes in mood and thinking,OUTCOME,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1762,ayahuasca,DRUG,affect and cognition,OUTCOME,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1763,ayahuasca,DRUG,affect,SUBJECTIVE,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1764,ayahuasca,DRUG,mindfulness,SUBJECTIVE,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1765,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1766,therapeutic potential,OUTCOME,mental health disorders,HEALTH,NEEDS MORE RESEARCH BETWEEN,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1767,ayahuasca,DRUG,mental health disorders,HEALTH,NEEDS MORE RESEARCH BETWEEN,55155261638d1906840631c9cba615cf9f56f4375eeb21937a1e8d30d8919c13
1768,ayahuasca,DRUG,depressed patients,HEALTH,POSITIVELY IMPACTS,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1769,ayahuasca,DRUG,prolonged psychotic reactions,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1770,manic episodes,HEALTH,ayahuasca,DRUG,NEEDS MORE RESEARCH BETWEEN,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1771,increased psychopathology,OUTCOME,manic episodes,HEALTH,NO RELATIONSHIP FOUND BETWEEN,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1772,increased psychopathology,OUTCOME,ayahuasca,DRUG,NO RELATIONSHIP FOUND BETWEEN,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1773,increased psychopathology,OUTCOME,adverse reactions,OUTCOME,NO RELATIONSHIP FOUND BETWEEN,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1774,ayahuasca,DRUG,psychotic depression,HEALTH,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1775,ayahuasca,DRUG,psychotic episode,HEALTH,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1776,other hallucinogens,DRUG,psychotic episode,HEALTH,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1777,schizophrenia,HEALTH,psychotic episode,HEALTH,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1778,cortical 5-HT2A receptors,NEURAL,MDMA,DRUG,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1779,5-HT2A receptor,NEURAL,MDMA,DRUG,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1780,5-HT2A receptor,NEURAL,dopaminergic system,NEURAL,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1781,5-HT2A receptor,NEURAL,psychotic effects,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1782,5-HT2A receptor,NEURAL,psychotic crisis,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1783,5-HT2A receptor,NEURAL,psychotic crisis,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1784,5-HT2A receptor,NEURAL,psychotic crisis,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1785,ayahuasca,DRUG,psychotic effects,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1786,ayahuasca,DRUG,psychotic crisis,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1787,ayahuasca,DRUG,psychotic crisis,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1788,ayahuasca,DRUG,psychotic crisis,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1789,ayahuasca,DRUG,psychotic,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1790,serotonergic hallucinogens,DRUG,psychotic crisis,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1791,serotonergic hallucinogens,DRUG,psychotic crisis,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1792,serotonergic hallucinogens,DRUG,psychotic crisis,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1793,ayahuasca,DRUG,psychotic effects,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1794,ayahuasca,DRUG,psychotic crisis,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1795,ayahuasca,DRUG,psychotic crisis,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1796,ayahuasca,DRUG,psychotic crisis,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1797,ayahuasca,DRUG,psychotic,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1798,ayahuasca,DRUG,psychotic effects,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1799,ayahuasca,DRUG,psychotic crisis,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1800,ayahuasca,DRUG,psychotic crisis,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1801,ayahuasca,DRUG,psychotic crisis,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1802,ayahuasca,DRUG,psychotic,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1803,5-HT2A receptors,NEURAL,psychotic effects,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1804,5-HT2A receptors,NEURAL,psychotic crisis,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1805,5-HT2A receptors,NEURAL,psychotic crisis,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1806,5-HT2A receptors,NEURAL,psychotic crisis,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1807,5-HT2A receptors,NEURAL,psychotic,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1808,cannabis,DRUG,psychotic crisis,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1809,cannabis,DRUG,psychotic crisis,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1810,5-HT2A agonists,NEURAL,psychotic crisis,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1811,5-HT2A agonists,NEURAL,psychotic crisis,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1812,5-HT2A agonists,NEURAL,psychotic,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1813,5-HT2A antagonists,NEURAL,psychotic,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1814,5-HT2A antagonists,NEURAL,reduced the effects,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1815,5-HT2A antagonists,NEURAL,psychotic reactions,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1816,hallucinogens,DRUG,alcohol,DRUG,POSITIVELY IMPACTS,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1817,psilocybin,DRUG,alcohol,DRUG,POSITIVELY IMPACTS,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1818,DMT,DRUG,alcohol,DRUG,POSITIVELY IMPACTS,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1819,ayahuasca,DRUG,psychotic effects,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1820,ayahuasca,DRUG,biochemical reactions,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1821,biochemical reactions,OUTCOME,psychotic state,OUTCOME,POSITIVELY IMPACTS,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1822,hallucinogens,DRUG,psychotic state,OUTCOME,POSITIVELY IMPACTS,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1823,5-HT2A receptors,NEURAL,biochemical reactions,OUTCOME,THOUGHT TO CAUSE,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1824,ayahuasca,DRUG,psychotic state,OUTCOME,POSITIVELY IMPACTS,a82ef49c6e5ca3db24ffee8bdd79c3f15aaef337946c6c662ecabeef7efa0bff
1825,serotonergic hallucinogens,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1826,ayahuasca,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1827,psilocybin,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1828,LSD,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1829,serotonergic hallucinogens,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1830,psilocybin,DRUG,medial prefrontal cortex,NEURAL,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1831,psilocybin,DRUG,lingual gyrus,NEURAL,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1832,psilocybin,DRUG,attenuated right amygdala activation,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1833,psilocybin,DRUG,increases in positive mood,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1834,psilocybin,DRUG,decreased the threat-induced modulation of top-down connectivity,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1835,psilocybin,DRUG,increased parahippocampal cortex/visual cortex functional connectivity,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1836,psilocybin,DRUG,parahippocampal cortex to visual cortex information flow,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1837,precuneus,NEURAL,self-transcendence”/spirituality,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1838,superior frontal gyrus,NEURAL,decreased the threat-induced modulation of top-down connectivity,OUTCOME,THOUGHT TO CAUSE,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1839,superior frontal gyrus,NEURAL,increased parahippocampal cortex/visual cortex functional connectivity,OUTCOME,THOUGHT TO CAUSE,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1840,superior frontal gyrus,NEURAL,increased thickening in precentral gyrus and,OUTCOME,THOUGHT TO CAUSE,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1841,superior frontal gyrus,NEURAL,increased psychopathology,OUTCOME,THOUGHT TO CAUSE,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1842,superior frontal gyrus,NEURAL,self-transcendence”/spirituality,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1843,increased psychopathology,OUTCOME,increased parahippocampal cortex/visual cortex functional connectivity,OUTCOME,NO RELATIONSHIP FOUND BETWEEN,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1844,increased psychopathology,OUTCOME,parahippocampal cortex to visual cortex information flow,OUTCOME,NO RELATIONSHIP FOUND BETWEEN,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1845,increased psychopathology,OUTCOME,cortical thinning in mesotemporal and inferior frontal gyri,OUTCOME,NO RELATIONSHIP FOUND BETWEEN,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1846,increased psychopathology,OUTCOME,superior frontal gyrus,NEURAL,NO RELATIONSHIP FOUND BETWEEN,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1847,increased psychopathology,OUTCOME,posterior cingulate cortex,NEURAL,NO RELATIONSHIP FOUND BETWEEN,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1848,increased psychopathology,OUTCOME,superior occipital gyrus,NEURAL,NO RELATIONSHIP FOUND BETWEEN,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1849,increased psychopathology,OUTCOME,increased thickening in precentral gyrus and,OUTCOME,NO RELATIONSHIP FOUND BETWEEN,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1850,increased psychopathology,OUTCOME,anterior cingulate cortex,NEURAL,NO RELATIONSHIP FOUND BETWEEN,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1851,increased psychopathology,OUTCOME,ayahuasca,DRUG,NO RELATIONSHIP FOUND BETWEEN,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1852,increased psychopathology,OUTCOME,structural alterations,OUTCOME,NO RELATIONSHIP FOUND BETWEEN,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1853,increased psychopathology,OUTCOME,ayahuasca,DRUG,NO RELATIONSHIP FOUND BETWEEN,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1854,increased psychopathology,OUTCOME,ayahuasca,DRUG,NO RELATIONSHIP FOUND BETWEEN,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1855,increased psychopathology,OUTCOME,self-transcendence”/spirituality,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1856,increased psychopathology,OUTCOME,SERT and 5-HT2A receptor binding,OUTCOME,NO RELATIONSHIP FOUND BETWEEN,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1857,increased psychopathology,OUTCOME,effects regarding SERT values,OUTCOME,NO RELATIONSHIP FOUND BETWEEN,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1858,increased psychopathology,OUTCOME,slight reduction on 5-HT2A receptor densities,OUTCOME,NO RELATIONSHIP FOUND BETWEEN,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1859,ayahuasca,DRUG,self-transcendence”/spirituality,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1860,hallucinogens,DRUG,self-transcendence”/spirituality,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1861,serotonergic hallucinogens,DRUG,self-transcendence”/spirituality,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1862,serotonergic hallucinogens,DRUG,neocortex,NEURAL,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1863,serotonergic hallucinogens,DRUG,"genetic, neurochemical, and behavioral alterations",OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1864,serotonergic hallucinogens,DRUG,brain regions,NEURAL,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1865,serotonergic hallucinogens,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1866,serotonergic hallucinogens,DRUG,γ-aminobutyric acid,DRUG,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1867,ayahuasca,DRUG,"genetic, neurochemical, and behavioral alterations",OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1868,ayahuasca,DRUG,brain regions,NEURAL,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1869,ayahuasca,DRUG,γ-aminobutyric acid,DRUG,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1870,ayahuasca,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1871,ayahuasca,DRUG,γ-aminobutyric acid,DRUG,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1872,ayahuasca,DRUG,interfered with emotional memory,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1873,ayahuasca,DRUG,patterns of neuronal activation,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1874,ayahuasca,DRUG,higher neuronal activation,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1875,ayahuasca,DRUG,higher neuronal activation,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1876,DMN,NEURAL,decrease the power of lower frequency oscillations,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1877,serotonergic hallucinogens,DRUG,decrease the power of lower frequency oscillations,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1878,serotonergic hallucinogens,DRUG,alpha oscillations,NEURAL,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1879,DMN,NEURAL,decrease the power of lower frequency oscillations,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1880,parahippocampal region,NEURAL,decrease the power of lower frequency oscillations,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1881,altered information flow,OUTCOME,expanded awareness,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1882,altered information flow,OUTCOME,unconstrained cognition,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1883,glutamatergic neurotransmission,NEURAL,GDNF,NEURAL,THOUGHT TO CAUSE,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1884,compounds,DRUG,antidepressive,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1885,compounds,DRUG,anxiolytic,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1886,compounds,DRUG,antiaddictive,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1887,ayahuasca,DRUG,antidepressive,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1888,ayahuasca,DRUG,anxiolytic,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1889,ayahuasca,DRUG,antiaddictive,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1890,psilocybin,DRUG,antidepressive,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1891,psilocybin,DRUG,anxiolytic,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1892,psilocybin,DRUG,antiaddictive,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1893,LSD,DRUG,antidepressive,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1894,LSD,DRUG,anxiolytic,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1895,LSD,DRUG,antiaddictive,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1896,ayahuasca,DRUG,increases in positive mood,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1897,psilocybin,DRUG,therapeutic potentials,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1898,LSD,DRUG,therapeutic potentials,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1899,ayahuasca,DRUG,therapeutic potentials,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1900,ayahuasca,DRUG,self-transcendence,SUBJECTIVE,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1901,ayahuasca,DRUG,self-transcendence,SUBJECTIVE,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1902,serotonergic hallucinogens,DRUG,self-transcendence,SUBJECTIVE,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1903,serotonergic hallucinogens,DRUG,Self-transcendence,SUBJECTIVE,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1904,serotonergic hallucinogens,DRUG,self-transcendence,SUBJECTIVE,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1905,serotonergic hallucinogens,DRUG,Self-transcendence,SUBJECTIVE,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1906,religious/mystical experiences,OUTCOME,self-transcendence,SUBJECTIVE,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1907,psilocybin,DRUG,attitudes,SUBJECTIVE,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1908,psilocybin,DRUG,mood,SUBJECTIVE,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1909,psilocybin,DRUG,alcohol (,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1910,religious-like experiences,OUTCOME,mood,SUBJECTIVE,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1911,psilocybin,DRUG,attitudes,SUBJECTIVE,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1912,psilocybin,DRUG,mood,SUBJECTIVE,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1913,psilocybin,DRUG,alcohol (,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1914,LSD,DRUG,attitudes,SUBJECTIVE,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1915,LSD,DRUG,mood,SUBJECTIVE,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1916,serotonergic hallucinogens,DRUG,decreased DMN activity,OUTCOME,THOUGHT TO CAUSE,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1917,serotonergic hallucinogens,DRUG,decreased DMN-TPN inverse coupling,OUTCOME,THOUGHT TO CAUSE,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1918,serotonergic hallucinogens,DRUG,meditation,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1919,serotonergic hallucinogens,DRUG,prefrontal and limbic areas,NEURAL,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1920,serotonergic hallucinogens,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1921,compounds,DRUG,meditation,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1922,compounds,DRUG,prefrontal and limbic areas,NEURAL,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1923,compounds,DRUG,decreases in reactivity of brain structures,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1924,compounds,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1925,compounds,DRUG,reduced brain activity in key regions of the DMN,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1926,amygdala,NEURAL,prefrontal and limbic areas,NEURAL,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1927,amygdala,NEURAL,anxiety,HEALTH,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1928,amygdala,NEURAL,mood disorders,HEALTH,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1929,amygdala,NEURAL,cortical thickness alterations,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1930,altered state of consciousness,SUBJECTIVE,anxiety,HEALTH,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1931,altered state of consciousness,SUBJECTIVE,mood disorders,HEALTH,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1932,serotonergic hallucinogens,DRUG,prefrontal and limbic areas,NEURAL,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1933,serotonergic hallucinogens,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1934,serotonergic hallucinogens,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1935,serotonergic hallucinogens,DRUG,mood disorders,HEALTH,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1936,serotonergic hallucinogens,DRUG,cortical thickness alterations,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1937,drugs,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1938,drugs,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1939,drugs,DRUG,mood disorders,HEALTH,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1940,drugs,DRUG,cortical thickness alterations,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1941,DMN,NEURAL,mood disorders,HEALTH,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1942,posterior,NEURAL,anxiety,HEALTH,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1943,posterior,NEURAL,mood disorders,HEALTH,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1944,serotonergic hallucinogens,DRUG,psychiatric disorders,HEALTH,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1945,serotonergic hallucinogens,DRUG,therapeutic uses,OUTCOME,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1946,serotonergic hallucinogens,DRUG,treatment-resistant patients,HEALTH,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1947,serotonergic hallucinogens,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1948,serotonergic hallucinogens,DRUG,mood disorders,HEALTH,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1949,drugs,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1950,drugs,DRUG,mood disorders,HEALTH,POSITIVELY IMPACTS,a0e9fea56512607428583ebe1fcab9aaa7614066936c4d316fba3c2b3956149e
1951,psilocybin,DRUG,"deeply meaningful, mystical experiences",OUTCOME,POSITIVELY IMPACTS,eead851e26b9fad19722f3ef44b32815392c533ebcae810210f53de27eae054e
1952,psilocybin,DRUG,"deeply meaningful, mystical experiences",OUTCOME,POSITIVELY IMPACTS,eead851e26b9fad19722f3ef44b32815392c533ebcae810210f53de27eae054e
1953,Indocybin,DRUG,mood disorder,HEALTH,POSITIVELY IMPACTS,eead851e26b9fad19722f3ef44b32815392c533ebcae810210f53de27eae054e
1954,psychedelic drugs,DRUG,toxicity ratio,OUTCOME,POSITIVELY IMPACTS,eead851e26b9fad19722f3ef44b32815392c533ebcae810210f53de27eae054e
1955,psychedelic drugs,DRUG,fluoxetine,ANTIDEPRESSANT_DRUG,POSITIVELY IMPACTS,eead851e26b9fad19722f3ef44b32815392c533ebcae810210f53de27eae054e
1956,psilocybin,DRUG,toxicity ratio,OUTCOME,POSITIVELY IMPACTS,eead851e26b9fad19722f3ef44b32815392c533ebcae810210f53de27eae054e
1957,psilocybin,DRUG,fluoxetine,ANTIDEPRESSANT_DRUG,POSITIVELY IMPACTS,eead851e26b9fad19722f3ef44b32815392c533ebcae810210f53de27eae054e
1958,LSD,DRUG,brain damage,OUTCOME,POSITIVELY IMPACTS,eead851e26b9fad19722f3ef44b32815392c533ebcae810210f53de27eae054e
1959,LSD,DRUG,brain damage,OUTCOME,POSITIVELY IMPACTS,eead851e26b9fad19722f3ef44b32815392c533ebcae810210f53de27eae054e
1960,LSD,DRUG,long-lasting personality change,OUTCOME,POSITIVELY IMPACTS,eead851e26b9fad19722f3ef44b32815392c533ebcae810210f53de27eae054e
1961,LSD,DRUG,brain damage,HEALTH,POSITIVELY IMPACTS,eead851e26b9fad19722f3ef44b32815392c533ebcae810210f53de27eae054e
1962,LSD,DRUG,long-lasting personality change,OUTCOME,POSITIVELY IMPACTS,eead851e26b9fad19722f3ef44b32815392c533ebcae810210f53de27eae054e
1963,LSD,DRUG,brain damage,OUTCOME,POSITIVELY IMPACTS,eead851e26b9fad19722f3ef44b32815392c533ebcae810210f53de27eae054e
1964,LSD,DRUG,long-lasting personality change,OUTCOME,POSITIVELY IMPACTS,eead851e26b9fad19722f3ef44b32815392c533ebcae810210f53de27eae054e
1965,LSD,DRUG,brain damage,HEALTH,POSITIVELY IMPACTS,eead851e26b9fad19722f3ef44b32815392c533ebcae810210f53de27eae054e
1966,LSD,DRUG,long-lasting personality change,OUTCOME,POSITIVELY IMPACTS,eead851e26b9fad19722f3ef44b32815392c533ebcae810210f53de27eae054e
1967,LSD,DRUG,brain damage,OUTCOME,POSITIVELY IMPACTS,eead851e26b9fad19722f3ef44b32815392c533ebcae810210f53de27eae054e
1968,LSD,DRUG,long-lasting personality change,OUTCOME,POSITIVELY IMPACTS,eead851e26b9fad19722f3ef44b32815392c533ebcae810210f53de27eae054e
1969,LSD,DRUG,brain damage,HEALTH,POSITIVELY IMPACTS,eead851e26b9fad19722f3ef44b32815392c533ebcae810210f53de27eae054e
1970,LSD,DRUG,long-lasting personality change,OUTCOME,POSITIVELY IMPACTS,eead851e26b9fad19722f3ef44b32815392c533ebcae810210f53de27eae054e
1971,psychedelic drugs,DRUG,brain damage,OUTCOME,POSITIVELY IMPACTS,eead851e26b9fad19722f3ef44b32815392c533ebcae810210f53de27eae054e
1972,psychedelic drugs,DRUG,long-lasting personality change,OUTCOME,POSITIVELY IMPACTS,eead851e26b9fad19722f3ef44b32815392c533ebcae810210f53de27eae054e
1973,psychedelic drugs,DRUG,brain damage,HEALTH,POSITIVELY IMPACTS,eead851e26b9fad19722f3ef44b32815392c533ebcae810210f53de27eae054e
1974,psychedelic drugs,DRUG,long-lasting personality change,OUTCOME,POSITIVELY IMPACTS,eead851e26b9fad19722f3ef44b32815392c533ebcae810210f53de27eae054e
1975,serotonergic psychedelics,DRUG,opiate overdoses(National,ANTIDEPRESSANT_DRUG,POSITIVELY IMPACTS,eead851e26b9fad19722f3ef44b32815392c533ebcae810210f53de27eae054e
1976,psilocybin,DRUG,opiate overdoses(National,ANTIDEPRESSANT_DRUG,POSITIVELY IMPACTS,eead851e26b9fad19722f3ef44b32815392c533ebcae810210f53de27eae054e
1977,escitalopram,ANTIDEPRESSANT_DRUG,depression,HEALTH,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
1978,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
1979,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
1980,escitalopram,ANTIDEPRESSANT_DRUG,depression,HEALTH,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
1981,escitalopram,ANTIDEPRESSANT_DRUG,depression,HEALTH,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
1982,escitalopram,ANTIDEPRESSANT_DRUG,anxiety,HEALTH,NEGATIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
1983,escitalopram,ANTIDEPRESSANT_DRUG,dry mouth,OUTCOME,NEGATIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
1984,escitalopram,ANTIDEPRESSANT_DRUG,sexual dysfunction,OUTCOME,NEGATIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
1985,escitalopram,ANTIDEPRESSANT_DRUG,reduced emotional responsiveness,OUTCOME,NEGATIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
1986,escitalopram,ANTIDEPRESSANT_DRUG,adverse event,OUTCOME,NEGATIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
1987,psilocybin,DRUG,mediating influence on positive outcomes.21,OUTCOME,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
1988,psilocybin,DRUG,psychiatric conditions,HEALTH,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
1989,psilocybin,DRUG,mediating influence on positive outcomes.21,OUTCOME,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
1990,psilocybin,DRUG,psychiatric conditions,HEALTH,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
1991,psychological support,OUTCOME,improved outcomes,OUTCOME,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
1992,psychological support,OUTCOME,subjective effects,SUBJECTIVE,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
1993,escitalopram,ANTIDEPRESSANT_DRUG,delayed therapeutic action on depression.22,OUTCOME,THOUGHT TO CAUSE,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
1994,psilocybin,DRUG,improved outcomes,OUTCOME,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
1995,psilocybin,DRUG,psilocybin,DRUG,NEEDS MORE RESEARCH BETWEEN,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
1996,biased expectations,OUTCOME,psilocybin,DRUG,NEEDS MORE RESEARCH BETWEEN,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
1997,psilocybin,DRUG,psilocybin,DRUG,NEEDS MORE RESEARCH BETWEEN,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
1998,Psychedelic agents,DRUG,depression,HEALTH,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
1999,Psychedelic agents,DRUG,depression,HEALTH,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
2000,Psychedelic agents,DRUG,treatment-resistant depression,HEALTH,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
2001,Psychedelic agents,DRUG,"enhance suggestibility,23",OUTCOME,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
2002,Psychedelic agents,DRUG,treatment-resistant depression,OUTCOME,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
2003,Psychedelic agents,DRUG,increase dendritic arbor complexity,OUTCOME,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
2004,Psychedelic agents,DRUG,depression,HEALTH,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
2005,Psychedelic agents,DRUG,depression,HEALTH,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
2006,Psychedelic agents,DRUG,"enhance suggestibility,23",OUTCOME,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
2007,Psychedelic agents,DRUG,treatment-resistant depression,OUTCOME,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
2008,Psychedelic agents,DRUG,increase dendritic arbor complexity,OUTCOME,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
2009,psychological effects,OUTCOME,neuronal plasticity,OUTCOME,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
2010,memories,SUBJECTIVE,subjective quality of the psychedelic experience,SUBJECTIVE,THOUGHT TO CAUSE,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
2011,perceptions,SUBJECTIVE,subjective quality of the psychedelic experience,SUBJECTIVE,THOUGHT TO CAUSE,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
2012,degree to which the environment is supportive,SUBJECTIVE,subjective quality of the psychedelic experience,SUBJECTIVE,THOUGHT TO CAUSE,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
2013,psychedelic compounds,DRUG,depression,HEALTH,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
2014,psychedelic compounds,DRUG,increase dendritic arbor complexity,OUTCOME,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
2015,psychedelic compounds,DRUG,neuronal plasticity,OUTCOME,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
2016,compounds,DRUG,neuronal plasticity,OUTCOME,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
2017,5-HT2A receptor,NEURAL,subjective quality of the psychedelic experience,SUBJECTIVE,THOUGHT TO CAUSE,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
2018,5-HT2A receptor,NEURAL,stimulate synapse formation,OUTCOME,THOUGHT TO CAUSE,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
2019,5-HT2A receptor,NEURAL,neuronal plasticity,OUTCOME,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
2020,psychedelics,DRUG,neuronal plasticity,OUTCOME,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
2021,escitalopram,ANTIDEPRESSANT_DRUG,neuronal plasticity,OUTCOME,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
2022,psilocybin,DRUG,increase dendritic arbor complexity,OUTCOME,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
2023,psilocybin,DRUG,neuronal plasticity,OUTCOME,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
2024,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
2025,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
2026,escitalopram,ANTIDEPRESSANT_DRUG,increase dendritic arbor complexity,OUTCOME,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
2027,escitalopram,ANTIDEPRESSANT_DRUG,neuronal plasticity,OUTCOME,POSITIVELY IMPACTS,0a3ed1209b84ff06d1c7690004f1a409edd4cea23ebd7aa2c1cd8820d00a45fc
2028,psilocybin,DRUG,microdoses,DRUG,POSITIVELY IMPACTS,dc7d2730eb98b05cee69223fb18165aa98fdf369d714e774bd442b5d414c8e16
2029,psilocybin,DRUG,microdosed,DRUG,POSITIVELY IMPACTS,dc7d2730eb98b05cee69223fb18165aa98fdf369d714e774bd442b5d414c8e16
2030,psilocybin,DRUG,mood and cognitive enhancers,OUTCOME,POSITIVELY IMPACTS,dc7d2730eb98b05cee69223fb18165aa98fdf369d714e774bd442b5d414c8e16
2031,psychedelic microdosing,DRUG,depression,HEALTH,POSITIVELY IMPACTS,dc7d2730eb98b05cee69223fb18165aa98fdf369d714e774bd442b5d414c8e16
2032,performance improvements,OUTCOME,anxiety,HEALTH,POSITIVELY IMPACTS,dc7d2730eb98b05cee69223fb18165aa98fdf369d714e774bd442b5d414c8e16
2033,psychedelic drugs,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,dc7d2730eb98b05cee69223fb18165aa98fdf369d714e774bd442b5d414c8e16
2034,OCD,HEALTH,anxiety,HEALTH,POSITIVELY IMPACTS,dc7d2730eb98b05cee69223fb18165aa98fdf369d714e774bd442b5d414c8e16
2035,psychedelics,DRUG,depression,HEALTH,POSITIVELY IMPACTS,dc7d2730eb98b05cee69223fb18165aa98fdf369d714e774bd442b5d414c8e16
2036,psychedelics,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,dc7d2730eb98b05cee69223fb18165aa98fdf369d714e774bd442b5d414c8e16
2037,LSD,DRUG,functional drug use,OUTCOME,POSITIVELY IMPACTS,dc7d2730eb98b05cee69223fb18165aa98fdf369d714e774bd442b5d414c8e16
2038,psychedelic drugs,DRUG,functional drug use,OUTCOME,POSITIVELY IMPACTS,dc7d2730eb98b05cee69223fb18165aa98fdf369d714e774bd442b5d414c8e16
2039,Psychedelics,DRUG,functional drug use,OUTCOME,POSITIVELY IMPACTS,dc7d2730eb98b05cee69223fb18165aa98fdf369d714e774bd442b5d414c8e16
2040,Psychedelics,DRUG,avoiding the problems,OUTCOME,POSITIVELY IMPACTS,dc7d2730eb98b05cee69223fb18165aa98fdf369d714e774bd442b5d414c8e16
2041,microdosing,DRUG,less constructive and self-reflective approach,OUTCOME,POSITIVELY IMPACTS,dc7d2730eb98b05cee69223fb18165aa98fdf369d714e774bd442b5d414c8e16
2042,psychedelics,DRUG,improved disease coping strategies and attitudes,OUTCOME,POSITIVELY IMPACTS,feab93a665b9cfaf7d483256723f990d63ae6eb0d0cb58ea8d950e2590b08bd1
2043,LSD,DRUG,self-reflection,SUBJECTIVE,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2044,DMN,NEURAL,self-reflection,SUBJECTIVE,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2045,DMN,NEURAL,spontaneous cognition,SUBJECTIVE,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2046,DMN,NEURAL,cognition,SUBJECTIVE,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2047,DMN,NEURAL,self-reflection,SUBJECTIVE,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2048,DMN,NEURAL,spontaneous cognition,SUBJECTIVE,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2049,DMN,NEURAL,self-reflection,SUBJECTIVE,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2050,DMN,NEURAL,spontaneous cognition,SUBJECTIVE,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2051,DMN,NEURAL,spontaneous cognition,SUBJECTIVE,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2052,psilocybin,DRUG,autobiographical memory,OUTCOME,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2053,psilocybin,DRUG,preservation of the sense of self,OUTCOME,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2054,psilocybin,DRUG,maintenance of one’s sense of self,OUTCOME,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2055,LSD,DRUG,maintenance of one’s sense of self,OUTCOME,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2056,psychedelic,DRUG,maintenance of one’s sense of self,OUTCOME,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2057,psychedelic,DRUG,self-loss,SUBJECTIVE,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2058,autobiographical information,OUTCOME,secure sense of self,OUTCOME,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2059,LSD,DRUG,autobiographical memory,SUBJECTIVE,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2060,LSD,DRUG,self,SUBJECTIVE,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2061,psychedelic,DRUG,highly salient and/or traumatic events,OUTCOME,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2062,altered) states of consciousness,SUBJECTIVE,spontaneous cognition,OUTCOME,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2063,altered) states of consciousness,SUBJECTIVE,spontaneous cognition,OUTCOME,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2064,LSD,DRUG,cognition,SUBJECTIVE,NEEDS MORE RESEARCH BETWEEN,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2065,LSD,DRUG,cognition,SUBJECTIVE,NEEDS MORE RESEARCH BETWEEN,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2066,LSD,DRUG,alcohol,DRUG,NEEDS MORE RESEARCH BETWEEN,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2067,LSD,DRUG,intoxicant,DRUG,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2068,LSD,DRUG,mentation about the future,OUTCOME,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2069,LSD,DRUG,alcohol,DRUG,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2070,LSD,DRUG,alcohol,DRUG,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2071,exhilarating,DRUG,alcohol,DRUG,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2072,exhilarating,DRUG,past-focused mentation,SUBJECTIVE,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2073,exhilarating,DRUG,past-focused reflection,SUBJECTIVE,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2074,exhilarating experiences,HEALTH,alcohol,DRUG,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2075,exhilarating experiences,HEALTH,past-focused reflection,SUBJECTIVE,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2076,LSD,DRUG,alcohol,DRUG,NEEDS MORE RESEARCH BETWEEN,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2077,LSD,DRUG,exhilarating,DRUG,NEEDS MORE RESEARCH BETWEEN,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2078,psychedelics,DRUG,alcohol,DRUG,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2079,therapeutic potential,OUTCOME,treatment-resistant depression,HEALTH,NEEDS MORE RESEARCH BETWEEN,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2080,psilocybin,DRUG,past-focused reflection,SUBJECTIVE,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2081,psilocybin,DRUG,treatment-resistant depression,HEALTH,NEEDS MORE RESEARCH BETWEEN,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2082,psychedelics,DRUG,promoting a mental state,OUTCOME,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2083,psychedelics,DRUG,mindfulness-promoting effects,OUTCOME,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2084,LSD,DRUG,promoting a mental state,OUTCOME,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2085,LSD,DRUG,mindfulness-promoting effects,OUTCOME,POSITIVELY IMPACTS,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2086,LSD,DRUG,enduring effects,OUTCOME,NEEDS MORE RESEARCH BETWEEN,b0aa5905e7d2d260557ae3e3a143edf2a90f0e8a52b44ae21894d62cf784d673
2087,psychedelic compounds,DRUG,sustained changes in attitudes and beliefs,OUTCOME,POSITIVELY IMPACTS,6ea378fc491373dc310f7763508e703bb67164b722f165d563d21c2dfb1244a2
2088,psychedelic compounds,DRUG,trait openness,OUTCOME,POSITIVELY IMPACTS,6ea378fc491373dc310f7763508e703bb67164b722f165d563d21c2dfb1244a2
2089,psychedelic compounds,DRUG,optimism,OUTCOME,POSITIVELY IMPACTS,6ea378fc491373dc310f7763508e703bb67164b722f165d563d21c2dfb1244a2
2090,psychedelic compounds,DRUG,depression,HEALTH,POSITIVELY IMPACTS,6ea378fc491373dc310f7763508e703bb67164b722f165d563d21c2dfb1244a2
2091,psilocybin,DRUG,reduction of depressive symptoms,OUTCOME,POSITIVELY IMPACTS,6ea378fc491373dc310f7763508e703bb67164b722f165d563d21c2dfb1244a2
2092,psilocybin,DRUG,trait openness,OUTCOME,POSITIVELY IMPACTS,6ea378fc491373dc310f7763508e703bb67164b722f165d563d21c2dfb1244a2
2093,psilocybin,DRUG,optimism,OUTCOME,POSITIVELY IMPACTS,6ea378fc491373dc310f7763508e703bb67164b722f165d563d21c2dfb1244a2
2094,psilocybin,DRUG,enduring reductions in anxiety,OUTCOME,POSITIVELY IMPACTS,6ea378fc491373dc310f7763508e703bb67164b722f165d563d21c2dfb1244a2
2095,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,6ea378fc491373dc310f7763508e703bb67164b722f165d563d21c2dfb1244a2
2096,psilocybin,DRUG,"life meaning, and optimism",OUTCOME,POSITIVELY IMPACTS,6ea378fc491373dc310f7763508e703bb67164b722f165d563d21c2dfb1244a2
2097,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,6ea378fc491373dc310f7763508e703bb67164b722f165d563d21c2dfb1244a2
2098,psilocybin,DRUG,advanced-stage cancer,HEALTH,POSITIVELY IMPACTS,6ea378fc491373dc310f7763508e703bb67164b722f165d563d21c2dfb1244a2
2099,psilocybin,DRUG,rapid and sustained antidepressant effects,OUTCOME,POSITIVELY IMPACTS,6ea378fc491373dc310f7763508e703bb67164b722f165d563d21c2dfb1244a2
2100,psilocybin,DRUG,MDD,HEALTH,POSITIVELY IMPACTS,6ea378fc491373dc310f7763508e703bb67164b722f165d563d21c2dfb1244a2
2101,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,6ea378fc491373dc310f7763508e703bb67164b722f165d563d21c2dfb1244a2
2102,greater nature relatedness,OUTCOME,depression,HEALTH,POSITIVELY IMPACTS,6ea378fc491373dc310f7763508e703bb67164b722f165d563d21c2dfb1244a2
2103,psychedelic,DRUG,nature-inspiring experiences of awe,OUTCOME,POSITIVELY IMPACTS,6ea378fc491373dc310f7763508e703bb67164b722f165d563d21c2dfb1244a2
2104,psychedelic,DRUG,cognitive and affective benefits,OUTCOME,POSITIVELY IMPACTS,6ea378fc491373dc310f7763508e703bb67164b722f165d563d21c2dfb1244a2
2105,psychedelic,DRUG,depression,HEALTH,POSITIVELY IMPACTS,6ea378fc491373dc310f7763508e703bb67164b722f165d563d21c2dfb1244a2
2106,psilocybin,DRUG,sense of ‘connectedness,SUBJECTIVE,POSITIVELY IMPACTS,6ea378fc491373dc310f7763508e703bb67164b722f165d563d21c2dfb1244a2
2107,Psychedelic drug,DRUG,higher on attitudes of,OUTCOME,POSITIVELY IMPACTS,6ea378fc491373dc310f7763508e703bb67164b722f165d563d21c2dfb1244a2
2108,psychedelic,DRUG,higher on attitudes of,OUTCOME,POSITIVELY IMPACTS,6ea378fc491373dc310f7763508e703bb67164b722f165d563d21c2dfb1244a2
2109,psychedelics,DRUG,higher on attitudes of,OUTCOME,POSITIVELY IMPACTS,6ea378fc491373dc310f7763508e703bb67164b722f165d563d21c2dfb1244a2
2110,psychedelics,DRUG,lower value on ‘financial prosperity,OUTCOME,POSITIVELY IMPACTS,6ea378fc491373dc310f7763508e703bb67164b722f165d563d21c2dfb1244a2
2111,serotonin 2A receptor,NEURAL,quantum change,SUBJECTIVE,THOUGHT TO CAUSE,6ea378fc491373dc310f7763508e703bb67164b722f165d563d21c2dfb1244a2
2112,psychedelics,DRUG,increase trait openness,OUTCOME,POSITIVELY IMPACTS,6ea378fc491373dc310f7763508e703bb67164b722f165d563d21c2dfb1244a2
2113,psychedelics,DRUG,positive association between openness and liberalism,OUTCOME,POSITIVELY IMPACTS,6ea378fc491373dc310f7763508e703bb67164b722f165d563d21c2dfb1244a2
2114,selective serotonin reuptake inhibitors,ANTIDEPRESSANT_DRUG,alcohol,DRUG,POSITIVELY IMPACTS,6ea378fc491373dc310f7763508e703bb67164b722f165d563d21c2dfb1244a2
2115,selective serotonin reuptake inhibitors,ANTIDEPRESSANT_DRUG,profound implications,OUTCOME,POSITIVELY IMPACTS,6ea378fc491373dc310f7763508e703bb67164b722f165d563d21c2dfb1244a2
2116,selective serotonin reuptake inhibitors,ANTIDEPRESSANT_DRUG,promote a generalised sense of connectedness,OUTCOME,POSITIVELY IMPACTS,6ea378fc491373dc310f7763508e703bb67164b722f165d563d21c2dfb1244a2
2117,psychedelic,DRUG,profound implications,OUTCOME,POSITIVELY IMPACTS,6ea378fc491373dc310f7763508e703bb67164b722f165d563d21c2dfb1244a2
2118,psychedelic,DRUG,promote a generalised sense of connectedness,OUTCOME,POSITIVELY IMPACTS,6ea378fc491373dc310f7763508e703bb67164b722f165d563d21c2dfb1244a2
2119,psilocybin,DRUG,authoritarian attitudes,OUTCOME,POSITIVELY IMPACTS,6ea378fc491373dc310f7763508e703bb67164b722f165d563d21c2dfb1244a2
2120,psilocybin,DRUG,antiaddictive,OUTCOME,POSITIVELY IMPACTS,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2121,AYA,DRUG,antiaddictive,OUTCOME,POSITIVELY IMPACTS,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2122,AYA,DRUG,antiaddictive,OUTCOME,POSITIVELY IMPACTS,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2123,psychedelic substances,DRUG,antiaddictive,OUTCOME,POSITIVELY IMPACTS,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2124,AYA,DRUG,antiaddictive,OUTCOME,POSITIVELY IMPACTS,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2125,AYA,DRUG,antidepressive,OUTCOME,POSITIVELY IMPACTS,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2126,AYA,DRUG,antiaddictive,OUTCOME,POSITIVELY IMPACTS,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2127,AYA,DRUG,antidepressive,OUTCOME,POSITIVELY IMPACTS,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2128,AYA,DRUG,sense of “self,SUBJECTIVE,POSITIVELY IMPACTS,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2129,hallucinogens,DRUG,antiaddictive,OUTCOME,POSITIVELY IMPACTS,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2130,hallucinogens,DRUG,antidepressive,OUTCOME,POSITIVELY IMPACTS,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2131,psilocybin,DRUG,antiaddictive,OUTCOME,POSITIVELY IMPACTS,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2132,LSD,DRUG,antiaddictive,OUTCOME,POSITIVELY IMPACTS,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2133,psilocybin,DRUG,reduced amygdala reactivity,OUTCOME,POSITIVELY IMPACTS,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2134,psilocybin,DRUG,mood,OUTCOME,POSITIVELY IMPACTS,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2135,AYA,DRUG,insula,NEURAL,NEGATIVELY IMPACTS,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2136,AYA,DRUG,brain,NEURAL,POSITIVELY IMPACTS,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2137,AYA,DRUG,attentional processes,OUTCOME,POSITIVELY IMPACTS,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2138,increased psychopathology,OUTCOME,spirituality,SUBJECTIVE,NO RELATIONSHIP FOUND BETWEEN,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2139,increased psychopathology,OUTCOME,worse neuropsychological functioning,OUTCOME,NO RELATIONSHIP FOUND BETWEEN,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2140,5-HT2A receptor,NEURAL,sense of “self,SUBJECTIVE,THOUGHT TO CAUSE,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2141,5-HT2A receptor,NEURAL,enhanced expression of transcription,OUTCOME,THOUGHT TO CAUSE,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2142,AYA,DRUG,psychotic episodes,HEALTH,NEGATIVELY IMPACTS,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2143,AYA,DRUG,psychotic episodes,HEALTH,NEGATIVELY IMPACTS,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2144,AYA,DRUG,Psychotic symptoms,HEALTH,NEGATIVELY IMPACTS,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2145,AYA,DRUG,adverse reactions,OUTCOME,NEGATIVELY IMPACTS,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2146,hypomania,OUTCOME,bipolar disorders,HEALTH,POSITIVELY IMPACTS,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2147,scopolamine,DRUG,psychotic outcomes,OUTCOME,THOUGHT TO CAUSE,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2148,optimism,OUTCOME,life attitudes and views,OUTCOME,POSITIVELY IMPACTS,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2149,AYA,DRUG,changes in personality traits,OUTCOME,POSITIVELY IMPACTS,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2150,AYA,DRUG,life attitudes and views,OUTCOME,POSITIVELY IMPACTS,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2151,AYA,DRUG,shyness,OUTCOME,POSITIVELY IMPACTS,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2152,AYA,DRUG,transpersonal feelings and spirituality,OUTCOME,POSITIVELY IMPACTS,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2153,peyote,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2154,AYA,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,86a9e304905c85b51ab20e0e0312f5265066c3087fa434160ff88286684e288f
2155,psilocybin,DRUG,modulated effective connectivity,OUTCOME,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2156,psilocybin,DRUG,threat-processing,OUTCOME,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2157,AMG,NEURAL,visual threat processing,NEURAL,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2158,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2159,psilocybin,DRUG,attenuation of top-down threat signaling,OUTCOME,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2160,psilocybin,DRUG,decreased threat sensitivity in the visual cortex,OUTCOME,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2161,psilocybin,DRUG,emotion processing,OUTCOME,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2162,psilocybin,DRUG,attenuation of top-down threat signaling,OUTCOME,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2163,psilocybin,DRUG,attenuation of top-down connectivity,OUTCOME,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2164,psilocybin,DRUG,attenuation of top-down threat signaling,OUTCOME,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2165,psilocybin,DRUG,decreased threat sensitivity in the visual cortex,OUTCOME,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2166,psilocybin,DRUG,decrease of behavioral and electrophysiological responses in the visual cortex to threat stimuli,OUTCOME,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2167,psilocybin,DRUG,emotion processing,OUTCOME,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2168,psilocybin,DRUG,threat processing,OUTCOME,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2169,psilocybin,DRUG,attenuation of top-down connectivity,OUTCOME,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2170,psilocybin,DRUG,visual cortex,NEURAL,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2171,psilocybin,DRUG,threat processing,OUTCOME,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2172,LPFC,NEURAL,psilocybin,DRUG,NEEDS MORE RESEARCH BETWEEN,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2173,psilocybin,DRUG,visual cortex,NEURAL,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2174,psilocybin,DRUG,threat processing,OUTCOME,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2175,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2176,psilocybin,DRUG,inhibitory top-down connectivity,OUTCOME,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2177,psilocybin,DRUG,increased LPFC → AMG top-down connectivity,OUTCOME,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2178,psilocybin,DRUG,increase top-down connectivity,OUTCOME,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2179,psilocybin,DRUG,reduction of AMG activity,OUTCOME,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2180,psilocybin,DRUG,increased top-down effect,OUTCOME,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2181,psilocybin,DRUG,visual cortex,NEURAL,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2182,psilocybin,DRUG,threat processing,OUTCOME,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2183,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2184,psilocybin,DRUG,inhibitory top-down connectivity,OUTCOME,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2185,psilocybin,DRUG,increase top-down connectivity,OUTCOME,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2186,psilocybin,DRUG,reduced top-down connectivity,OUTCOME,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2187,psilocybin,DRUG,reduced top-down modulation,OUTCOME,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2188,psilocybin,DRUG,inhibitory top-down connectivity,OUTCOME,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2189,psilocybin,DRUG,increase top-down connectivity,OUTCOME,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2190,psilocybin,DRUG,reduced top-down connectivity,OUTCOME,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2191,psilocybin,DRUG,reduced top-down modulation,OUTCOME,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2192,psilocybin,DRUG,amygdala neurons,NEURAL,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2193,DOI,NEURAL,reduced top-down connectivity,OUTCOME,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2194,DOI,NEURAL,amygdala neurons,NEURAL,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2195,AMG,NEURAL,reduced top-down connectivity,OUTCOME,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2196,AMG,NEURAL,reduced top-down modulation,OUTCOME,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2197,AMG,NEURAL,amygdala neurons,NEURAL,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2198,selective serotonin reuptake inhibitor,ANTIDEPRESSANT_DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2199,PFC,NEURAL,prefrontal regions,NEURAL,NEEDS MORE RESEARCH BETWEEN,9a974fb41ab5618ae56fc09d8a1e7aff797f891a0572c45a863e311308f04f00
2200,psychedelic,DRUG,emotional breakthrough,OUTCOME,POSITIVELY IMPACTS,22cfb48af08d43db7742dfcfe0b9b0a6799c3d12f105e3389236740634474551
2201,EBI,NEURAL,emotional breakthrough,OUTCOME,POSITIVELY IMPACTS,22cfb48af08d43db7742dfcfe0b9b0a6799c3d12f105e3389236740634474551
2202,psychedelic,DRUG,therapeutic setting,OUTCOME,POSITIVELY IMPACTS,22cfb48af08d43db7742dfcfe0b9b0a6799c3d12f105e3389236740634474551
2203,psychedelic,DRUG,therapeutic setting,OUTCOME,POSITIVELY IMPACTS,22cfb48af08d43db7742dfcfe0b9b0a6799c3d12f105e3389236740634474551
2204,psychedelic,DRUG,state,SUBJECTIVE,POSITIVELY IMPACTS,22cfb48af08d43db7742dfcfe0b9b0a6799c3d12f105e3389236740634474551
2205,long-term changes,OUTCOME,brain,NEURAL,NEEDS MORE RESEARCH BETWEEN,22cfb48af08d43db7742dfcfe0b9b0a6799c3d12f105e3389236740634474551
2206,psychedelic,DRUG,state,SUBJECTIVE,POSITIVELY IMPACTS,22cfb48af08d43db7742dfcfe0b9b0a6799c3d12f105e3389236740634474551
2207,psychedelic,DRUG,increased brain entropy,OUTCOME,POSITIVELY IMPACTS,22cfb48af08d43db7742dfcfe0b9b0a6799c3d12f105e3389236740634474551
2208,psychedelic,DRUG,increased brain entropy,OUTCOME,POSITIVELY IMPACTS,22cfb48af08d43db7742dfcfe0b9b0a6799c3d12f105e3389236740634474551
2209,psychedelic,DRUG,increased trait ‘openness,OUTCOME,POSITIVELY IMPACTS,22cfb48af08d43db7742dfcfe0b9b0a6799c3d12f105e3389236740634474551
2210,psychedelic,DRUG,depressive symptoms,HEALTH,POSITIVELY IMPACTS,22cfb48af08d43db7742dfcfe0b9b0a6799c3d12f105e3389236740634474551
2211,psychedelic,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,22cfb48af08d43db7742dfcfe0b9b0a6799c3d12f105e3389236740634474551
2212,Psychedelics,DRUG,depressive symptoms,HEALTH,POSITIVELY IMPACTS,22cfb48af08d43db7742dfcfe0b9b0a6799c3d12f105e3389236740634474551
2213,DMT,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2214,DMT,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2215,DMT,DRUG,shorter total distance,OUTCOME,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2216,DMT,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2217,DMT,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2218,DMT,DRUG,spatial memory,OUTCOME,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2219,decreased rearing,OUTCOME,anxiety,HEALTH,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2220,compounds,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2221,DMT,DRUG,ayahuasca,DRUG,NEEDS MORE RESEARCH BETWEEN,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2222,compounds,DRUG,lasting impact on fear memory,OUTCOME,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2223,DMT,DRUG,stronger extinction memory,OUTCOME,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2224,DMT,DRUG,increases swimming behavior,OUTCOME,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2225,selective serotonin reuptake inhibitors,ANTIDEPRESSANT_DRUG,fluoxetine,ANTIDEPRESSANT_DRUG,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2226,ayahuasca,DRUG,fluoxetine,ANTIDEPRESSANT_DRUG,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2227,ayahuasca,DRUG,fluoxetine,ANTIDEPRESSANT_DRUG,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2228,ayahuasca,DRUG,treatment-resistant populations,HEALTH,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2229,ketamine,DRUG,fluoxetine,ANTIDEPRESSANT_DRUG,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2230,ketamine,DRUG,long-lasting,OUTCOME,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2231,ketamine,DRUG,fluoxetine,ANTIDEPRESSANT_DRUG,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2232,ketamine,DRUG,fluoxetine,ANTIDEPRESSANT_DRUG,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2233,ketamine,DRUG,treatment-resistant populations,HEALTH,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2234,ketamine,DRUG,long-lasting,OUTCOME,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2235,ketamine,DRUG,brain,NEURAL,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2236,ketamine,DRUG,long-lasting,OUTCOME,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2237,ketamine,DRUG,brain,NEURAL,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2238,ketamine,DRUG,long-lasting changes,OUTCOME,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2239,DMT,DRUG,long-lasting changes,OUTCOME,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2240,NMDA,NEURAL,long-lasting changes,OUTCOME,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2241,ketamine,DRUG,long-lasting changes,OUTCOME,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2242,ketamine,DRUG,long-lasting changes,OUTCOME,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2243,ayahausca,DRUG,long-lasting changes,OUTCOME,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2244,ayahausca,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2245,DMT,DRUG,depression,HEALTH,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2246,DMT,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2247,DMT,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2248,DMT,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2249,DMT,DRUG,depression,HEALTH,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2250,DMT,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2251,DMT,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2252,DMT,DRUG,depression,HEALTH,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2253,DMT,DRUG,depression,HEALTH,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2254,ayahuasca,DRUG,serotonergic psychedelic,DRUG,THOUGHT TO CAUSE,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2255,ayahuasca,DRUG,fear extinction,OUTCOME,THOUGHT TO CAUSE,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2256,serotonergic psychedelic,DRUG,depression,HEALTH,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2257,DMT,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2258,DMT,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2259,DMT,DRUG,depression,HEALTH,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2260,DMT,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2261,DMT,DRUG,depression,HEALTH,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2262,DMT,DRUG,antidepressants,ANTIDEPRESSANT_DRUG,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2263,ayahuasca,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2264,ayahuasca,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2265,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2266,ayahuasca,DRUG,serotonergic psychedelic,DRUG,THOUGHT TO CAUSE,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2267,ayahuasca,DRUG,fear extinction,OUTCOME,THOUGHT TO CAUSE,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2268,ayahuasca,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2269,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2270,ayahuasca,DRUG,antidepressants,ANTIDEPRESSANT_DRUG,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2271,serotonergic psychedelics,DRUG,depression,HEALTH,POSITIVELY IMPACTS,73447b1e30bddcccda0c1662a8ae83ab8ff1c1c76fecf77e39c315e073260423
2272,LSD,DRUG,mood,SUBJECTIVE,NEEDS MORE RESEARCH BETWEEN,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2273,LSD,DRUG,cognition,SUBJECTIVE,NEEDS MORE RESEARCH BETWEEN,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2274,LSD,DRUG,mood,SUBJECTIVE,POSITIVELY IMPACTS,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2275,LSD,DRUG,behavior,SUBJECTIVE,POSITIVELY IMPACTS,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2276,LSD,DRUG,detectable subjective effects,OUTCOME,POSITIVELY IMPACTS,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2277,LSD,DRUG,increases in ratings of drug effects scales,OUTCOME,POSITIVELY IMPACTS,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2278,LSD,DRUG,subjective and behavioral effects,OUTCOME,POSITIVELY IMPACTS,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2279,LSD,DRUG,microdoses,DRUG,POSITIVELY IMPACTS,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2280,LSD,DRUG,microdoses,DRUG,POSITIVELY IMPACTS,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2281,LSD,DRUG,mood,SUBJECTIVE,POSITIVELY IMPACTS,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2282,LSD,DRUG,behavior,SUBJECTIVE,POSITIVELY IMPACTS,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2283,LSD,DRUG,detectable subjective effects,OUTCOME,POSITIVELY IMPACTS,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2284,LSD,DRUG,increases in ratings of drug effects scales,OUTCOME,POSITIVELY IMPACTS,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2285,LSD,DRUG,subjective and behavioral effects,OUTCOME,POSITIVELY IMPACTS,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2286,LSD,DRUG,microdoses,DRUG,POSITIVELY IMPACTS,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2287,LSD,DRUG,feel drug,OUTCOME,POSITIVELY IMPACTS,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2288,LSD,DRUG,drug,OUTCOME,POSITIVELY IMPACTS,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2289,LSD,DRUG,feel drug,OUTCOME,POSITIVELY IMPACTS,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2290,LSD,DRUG,drug,OUTCOME,POSITIVELY IMPACTS,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2291,LSD,DRUG,increase heart rate,OUTCOME,NEGATIVELY IMPACTS,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2292,LSD,DRUG,blood pressure,OUTCOME,NEGATIVELY IMPACTS,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2293,LSD,DRUG,body temperature,OUTCOME,NEGATIVELY IMPACTS,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2294,LSD,DRUG,effects on mood,OUTCOME,POSITIVELY IMPACTS,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2295,LSD,DRUG,effects on mood,OUTCOME,POSITIVELY IMPACTS,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2296,LSD,DRUG,mood disturbances,HEALTH,POSITIVELY IMPACTS,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2297,drug,DRUG,depression,HEALTH,POSITIVELY IMPACTS,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2298,drug,DRUG,stress,OUTCOME,POSITIVELY IMPACTS,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2299,drug,DRUG,lower distractibility,OUTCOME,POSITIVELY IMPACTS,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2300,LSD,DRUG,psychological functioning,OUTCOME,NEEDS MORE RESEARCH BETWEEN,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2301,LSD,DRUG,mood,SUBJECTIVE,NEEDS MORE RESEARCH BETWEEN,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2302,LSD,DRUG,depression,HEALTH,NEEDS MORE RESEARCH BETWEEN,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2303,LSD,DRUG,cognition,OUTCOME,NEEDS MORE RESEARCH BETWEEN,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2304,microdosing psilocybin,DRUG,improved convergent and divergent thinking,OUTCOME,POSITIVELY IMPACTS,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2305,psilocybin,DRUG,reduced feelings of social rejection,OUTCOME,POSITIVELY IMPACTS,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2306,enhances global connectivity,OUTCOME,ego dissolution,SUBJECTIVE,THOUGHT TO CAUSE,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2307,enhances global connectivity,OUTCOME,weakening of the boundary between the self and the universe,OUTCOME,THOUGHT TO CAUSE,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2308,drugs,DRUG,therapeutic affects,OUTCOME,POSITIVELY IMPACTS,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2309,drugs,DRUG,the drug,DRUG,POSITIVELY IMPACTS,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2310,LSD,DRUG,the drug,DRUG,NEEDS MORE RESEARCH BETWEEN,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2311,LSD,DRUG,negative affect,OUTCOME,NEEDS MORE RESEARCH BETWEEN,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2312,drug,DRUG,the drug,DRUG,POSITIVELY IMPACTS,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2313,drug,DRUG,improves mood and cognition,OUTCOME,POSITIVELY IMPACTS,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2314,drug,DRUG,understanding of the neural and behavioral processes,OUTCOME,POSITIVELY IMPACTS,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2315,drug,DRUG,depressed mood,HEALTH,POSITIVELY IMPACTS,7317005d50b64fe7d312be18e2318e77dd492d20366b585451060e5ab5f4ee4a
2316,psychedelic microdosing,DRUG,lower dysfunctional attitudes and negative emotionality,OUTCOME,POSITIVELY IMPACTS,91ece9e7953299780e1d88d93be4a8d02bdcf6c6db5de75ab0d5b9c799f1eaec
2317,psychedelic microdosing,DRUG,"higher wisdom, open-mindedness, and creativity",OUTCOME,POSITIVELY IMPACTS,91ece9e7953299780e1d88d93be4a8d02bdcf6c6db5de75ab0d5b9c799f1eaec
2318,microdosing,DRUG,lower dysfunctional attitudes and negative emotionality,OUTCOME,POSITIVELY IMPACTS,91ece9e7953299780e1d88d93be4a8d02bdcf6c6db5de75ab0d5b9c799f1eaec
2319,microdosing,DRUG,"higher wisdom, open-mindedness, and creativity",OUTCOME,POSITIVELY IMPACTS,91ece9e7953299780e1d88d93be4a8d02bdcf6c6db5de75ab0d5b9c799f1eaec
2320,microdosing,DRUG,lower dysfunctional attitudes and negative emotionality,OUTCOME,POSITIVELY IMPACTS,91ece9e7953299780e1d88d93be4a8d02bdcf6c6db5de75ab0d5b9c799f1eaec
2321,microdosing,DRUG,"higher wisdom, open-mindedness, and creativity",OUTCOME,POSITIVELY IMPACTS,91ece9e7953299780e1d88d93be4a8d02bdcf6c6db5de75ab0d5b9c799f1eaec
2322,LSD,DRUG,lower dysfunctional attitudes and negative emotionality,OUTCOME,POSITIVELY IMPACTS,91ece9e7953299780e1d88d93be4a8d02bdcf6c6db5de75ab0d5b9c799f1eaec
2323,LSD,DRUG,"higher wisdom, open-mindedness, and creativity",OUTCOME,POSITIVELY IMPACTS,91ece9e7953299780e1d88d93be4a8d02bdcf6c6db5de75ab0d5b9c799f1eaec
2324,psilocybin,DRUG,lower dysfunctional attitudes and negative emotionality,OUTCOME,POSITIVELY IMPACTS,91ece9e7953299780e1d88d93be4a8d02bdcf6c6db5de75ab0d5b9c799f1eaec
2325,psilocybin,DRUG,"higher wisdom, open-mindedness, and creativity",OUTCOME,POSITIVELY IMPACTS,91ece9e7953299780e1d88d93be4a8d02bdcf6c6db5de75ab0d5b9c799f1eaec
2326,psilocybin,DRUG,meaningfully lower levels of dysfunctional attitudes,OUTCOME,POSITIVELY IMPACTS,91ece9e7953299780e1d88d93be4a8d02bdcf6c6db5de75ab0d5b9c799f1eaec
2327,microdosing,DRUG,mental health,HEALTH,NEEDS MORE RESEARCH BETWEEN,91ece9e7953299780e1d88d93be4a8d02bdcf6c6db5de75ab0d5b9c799f1eaec
2328,microdosing,DRUG,optimal dose scheduling,OUTCOME,NEEDS MORE RESEARCH BETWEEN,91ece9e7953299780e1d88d93be4a8d02bdcf6c6db5de75ab0d5b9c799f1eaec
2329,microdosing,DRUG,meaningfully lower levels of dysfunctional attitudes,OUTCOME,POSITIVELY IMPACTS,91ece9e7953299780e1d88d93be4a8d02bdcf6c6db5de75ab0d5b9c799f1eaec
2330,microdosing,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,91ece9e7953299780e1d88d93be4a8d02bdcf6c6db5de75ab0d5b9c799f1eaec
2331,microdosing,DRUG,depression,HEALTH,POSITIVELY IMPACTS,91ece9e7953299780e1d88d93be4a8d02bdcf6c6db5de75ab0d5b9c799f1eaec
2332,microdosers,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,91ece9e7953299780e1d88d93be4a8d02bdcf6c6db5de75ab0d5b9c799f1eaec
2333,microdosers,DRUG,depression,HEALTH,POSITIVELY IMPACTS,91ece9e7953299780e1d88d93be4a8d02bdcf6c6db5de75ab0d5b9c799f1eaec
2334,microdosers,DRUG,positive emotional valence,OUTCOME,POSITIVELY IMPACTS,91ece9e7953299780e1d88d93be4a8d02bdcf6c6db5de75ab0d5b9c799f1eaec
2335,microdosing,DRUG,mental health,HEALTH,NEEDS MORE RESEARCH BETWEEN,91ece9e7953299780e1d88d93be4a8d02bdcf6c6db5de75ab0d5b9c799f1eaec
2336,microdosers,DRUG,enhanced capacity for perspective taking,OUTCOME,POSITIVELY IMPACTS,91ece9e7953299780e1d88d93be4a8d02bdcf6c6db5de75ab0d5b9c799f1eaec
2337,microdosers,DRUG,resilience in the face of the vicissitudes of life,OUTCOME,POSITIVELY IMPACTS,91ece9e7953299780e1d88d93be4a8d02bdcf6c6db5de75ab0d5b9c799f1eaec
2338,microdosers,DRUG,increased feelings of engagement and connection,OUTCOME,POSITIVELY IMPACTS,91ece9e7953299780e1d88d93be4a8d02bdcf6c6db5de75ab0d5b9c799f1eaec
2339,microdosers,DRUG,increases in openness,OUTCOME,POSITIVELY IMPACTS,91ece9e7953299780e1d88d93be4a8d02bdcf6c6db5de75ab0d5b9c799f1eaec
2340,microdosing,DRUG,creativity,DRUG,POSITIVELY IMPACTS,91ece9e7953299780e1d88d93be4a8d02bdcf6c6db5de75ab0d5b9c799f1eaec
2341,microdosing,DRUG,mood,DRUG,POSITIVELY IMPACTS,91ece9e7953299780e1d88d93be4a8d02bdcf6c6db5de75ab0d5b9c799f1eaec
2342,psychedelics,DRUG,benefits lasting at least a month,OUTCOME,THOUGHT TO CAUSE,91ece9e7953299780e1d88d93be4a8d02bdcf6c6db5de75ab0d5b9c799f1eaec
2343,psychedelics,DRUG,benefits lasting at least a month,OUTCOME,THOUGHT TO CAUSE,91ece9e7953299780e1d88d93be4a8d02bdcf6c6db5de75ab0d5b9c799f1eaec
2344,psychedelics,DRUG,benefits lasting at least a month,OUTCOME,THOUGHT TO CAUSE,91ece9e7953299780e1d88d93be4a8d02bdcf6c6db5de75ab0d5b9c799f1eaec
2345,psilocybin,DRUG,Increased amygdala responses,OUTCOME,THOUGHT TO CAUSE,166915e3d62065201e5352533cb4ea88d3675eba8079444e3272ec3cc6437593
2346,decreased amygdala responsiveness,OUTCOME,therapeutic action,OUTCOME,POSITIVELY IMPACTS,166915e3d62065201e5352533cb4ea88d3675eba8079444e3272ec3cc6437593
2347,SSRIs,ANTIDEPRESSANT_DRUG,therapeutic action,OUTCOME,POSITIVELY IMPACTS,166915e3d62065201e5352533cb4ea88d3675eba8079444e3272ec3cc6437593
2348,psilocybin,DRUG,therapeutic action,OUTCOME,POSITIVELY IMPACTS,166915e3d62065201e5352533cb4ea88d3675eba8079444e3272ec3cc6437593
2349,serotonergic antidepressant medications,ANTIDEPRESSANT_DRUG,anhedonia,HEALTH,NEGATIVELY IMPACTS,166915e3d62065201e5352533cb4ea88d3675eba8079444e3272ec3cc6437593
2350,psilocybin,DRUG,make emotional ‘confrontation’ more likely,OUTCOME,POSITIVELY IMPACTS,166915e3d62065201e5352533cb4ea88d3675eba8079444e3272ec3cc6437593
2351,psilocybin,DRUG,emotional breakthrough,OUTCOME,POSITIVELY IMPACTS,166915e3d62065201e5352533cb4ea88d3675eba8079444e3272ec3cc6437593
2352,psilocybin,DRUG,resolution,OUTCOME,POSITIVELY IMPACTS,166915e3d62065201e5352533cb4ea88d3675eba8079444e3272ec3cc6437593
2353,psilocybin,DRUG,resolution,OUTCOME,POSITIVELY IMPACTS,166915e3d62065201e5352533cb4ea88d3675eba8079444e3272ec3cc6437593
2354,psilocybin,DRUG,decreases in right amygdala responses,OUTCOME,THOUGHT TO CAUSE,166915e3d62065201e5352533cb4ea88d3675eba8079444e3272ec3cc6437593
2355,psilocybin,DRUG,antidepressant action,OUTCOME,POSITIVELY IMPACTS,166915e3d62065201e5352533cb4ea88d3675eba8079444e3272ec3cc6437593
2356,psilocybin,DRUG,changes in spontaneous brain function,OUTCOME,POSITIVELY IMPACTS,166915e3d62065201e5352533cb4ea88d3675eba8079444e3272ec3cc6437593
2357,psilocybin,DRUG,acute brain effects,OUTCOME,POSITIVELY IMPACTS,166915e3d62065201e5352533cb4ea88d3675eba8079444e3272ec3cc6437593
2358,psilocybin,DRUG,antidepressant action,OUTCOME,POSITIVELY IMPACTS,166915e3d62065201e5352533cb4ea88d3675eba8079444e3272ec3cc6437593
2359,psilocybin,DRUG,functional impairments,OUTCOME,THOUGHT TO CAUSE,166915e3d62065201e5352533cb4ea88d3675eba8079444e3272ec3cc6437593
2360,schizophrenia,HEALTH,functional impairments,OUTCOME,THOUGHT TO CAUSE,166915e3d62065201e5352533cb4ea88d3675eba8079444e3272ec3cc6437593
2361,receptor densities,NEURAL,post treatment brain changes,OUTCOME,NEEDS MORE RESEARCH BETWEEN,166915e3d62065201e5352533cb4ea88d3675eba8079444e3272ec3cc6437593
2362,receptor densities,NEURAL,functional brain measures,OUTCOME,NEEDS MORE RESEARCH BETWEEN,166915e3d62065201e5352533cb4ea88d3675eba8079444e3272ec3cc6437593
2363,psilocybin,DRUG,functional brain measures,OUTCOME,NEEDS MORE RESEARCH BETWEEN,166915e3d62065201e5352533cb4ea88d3675eba8079444e3272ec3cc6437593
2364,psilocybin,DRUG,post treatment brain changes,OUTCOME,POSITIVELY IMPACTS,166915e3d62065201e5352533cb4ea88d3675eba8079444e3272ec3cc6437593
2365,psilocybin,DRUG,functional brain measures,OUTCOME,POSITIVELY IMPACTS,166915e3d62065201e5352533cb4ea88d3675eba8079444e3272ec3cc6437593
2366,psilocybin,DRUG,depressed patients,HEALTH,POSITIVELY IMPACTS,166915e3d62065201e5352533cb4ea88d3675eba8079444e3272ec3cc6437593
2367,psilocybin,DRUG,novel intervention for major depression,OUTCOME,POSITIVELY IMPACTS,166915e3d62065201e5352533cb4ea88d3675eba8079444e3272ec3cc6437593
2368,psilocybin,DRUG,functional brain measures,OUTCOME,NEEDS MORE RESEARCH BETWEEN,166915e3d62065201e5352533cb4ea88d3675eba8079444e3272ec3cc6437593
2369,Psilocybin,DRUG,depressed patients,HEALTH,POSITIVELY IMPACTS,166915e3d62065201e5352533cb4ea88d3675eba8079444e3272ec3cc6437593
2370,Psilocybin,DRUG,novel intervention for major depression,OUTCOME,POSITIVELY IMPACTS,166915e3d62065201e5352533cb4ea88d3675eba8079444e3272ec3cc6437593
2371,Psilocybin,DRUG,"safe, rapid and potentially enduring in its antidepressant action",OUTCOME,POSITIVELY IMPACTS,166915e3d62065201e5352533cb4ea88d3675eba8079444e3272ec3cc6437593
2372,enhanced amygdala responsiveness,OUTCOME,enduring positive mood effects of psychedelics,OUTCOME,NEEDS MORE RESEARCH BETWEEN,166915e3d62065201e5352533cb4ea88d3675eba8079444e3272ec3cc6437593
2373,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2374,cancer-related psychiatric and existential distress,HEALTH,depression,HEALTH,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2375,psilocybin,DRUG,cancer-related psychiatric and existential distress,HEALTH,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2376,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2377,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2378,psilocybin,DRUG,hopelessness,OUTCOME,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2379,psilocybin,DRUG,demoralization,OUTCOME,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2380,psilocybin,DRUG,death anxiety,OUTCOME,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2381,psilocybin,DRUG,spiritual well-being,OUTCOME,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2382,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2383,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2384,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2385,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2386,hopelessness,OUTCOME,depression,HEALTH,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2387,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2388,antidepressant or anxiolytic response,OUTCOME,depression,HEALTH,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2389,subjective experiences of positive changes,OUTCOME,depression,HEALTH,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2390,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2391,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2392,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2393,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2394,psilocybin,DRUG,subjective experiences of positive changes,OUTCOME,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2395,psilocybin,DRUG,improved well-being,OUTCOME,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2396,psilocybin,DRUG,life satisfaction,OUTCOME,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2397,psilocybin,DRUG,personally meaningful and spiritually significant experiences,OUTCOME,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2398,psilocybin,DRUG,existential distress,HEALTH,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2399,personally meaningful and spiritually significant experiences,OUTCOME,depression,HEALTH,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2400,psilocybin,DRUG,subjective experiences of positive changes,OUTCOME,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2401,psilocybin,DRUG,improved well-being,OUTCOME,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2402,psilocybin,DRUG,life satisfaction,OUTCOME,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2403,psilocybin,DRUG,personally meaningful and spiritually significant experiences,OUTCOME,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2404,psilocybin,DRUG,existential distress,HEALTH,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2405,psilocybin,DRUG,cancer-related existential distress,HEALTH,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2406,cancer,HEALTH,treat this indication,OUTCOME,THOUGHT TO CAUSE,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2407,cancer,HEALTH,depression,HEALTH,THOUGHT TO CAUSE,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2408,cancer,HEALTH,hopelessness,HEALTH,THOUGHT TO CAUSE,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2409,cancer,HEALTH,suicidal ideation,OUTCOME,THOUGHT TO CAUSE,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2410,cancer,HEALTH,completed suicides,OUTCOME,THOUGHT TO CAUSE,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2411,psilocybin,DRUG,cancer,HEALTH,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2412,psilocybin,DRUG,promising protective strategy against suicides,OUTCOME,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2413,psilocybin,DRUG,passive suicidality,HEALTH,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2414,cancer,HEALTH,depression,HEALTH,THOUGHT TO CAUSE,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2415,cancer,HEALTH,hopelessness,HEALTH,THOUGHT TO CAUSE,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2416,cancer,HEALTH,completed suicides,OUTCOME,THOUGHT TO CAUSE,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2417,psilocybin,DRUG,promising protective strategy against suicides,OUTCOME,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2418,psilocybin,DRUG,cancer-related distress,HEALTH,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2419,psilocybin,DRUG,existential distress,HEALTH,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2420,psilocybin,DRUG,stronger reductions in subjective reports of depression,OUTCOME,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2421,psilocybin,DRUG,cancer-related distress,HEALTH,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2422,psilocybin,DRUG,existential distress,HEALTH,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2423,psilocybin,DRUG,anxiolytic and antidepressant effects,OUTCOME,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2424,mystical-type experience,SUBJECTIVE,anxiolytic and antidepressant effects,OUTCOME,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2425,psilocybin,DRUG,anxiolytic and antidepressant effects,OUTCOME,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2426,subjective experience,SUBJECTIVE,changes in psychiatric outcomes,OUTCOME,THOUGHT TO CAUSE,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2427,psilocybin,DRUG,addictive disorders,HEALTH,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2428,psilocybin,DRUG,increases in trait openness,OUTCOME,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2429,psilocybin,DRUG,cognitive flexibility,OUTCOME,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2430,Psychedelic-induced states of consciousness,SUBJECTIVE,increases in trait openness,OUTCOME,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2431,Psychedelic-induced states of consciousness,SUBJECTIVE,cognitive flexibility,OUTCOME,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2432,Psychedelic-induced states of consciousness,SUBJECTIVE,treatment-resistant depression,HEALTH,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2433,psilocybin,DRUG,dissolution of boundaries,SUBJECTIVE,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2434,psilocybin,DRUG,feelings of unity,SUBJECTIVE,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2435,psilocybin,DRUG,a new inner framework,OUTCOME,THOUGHT TO CAUSE,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2436,psilocybin,DRUG,cope with life stressors,OUTCOME,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2437,psilocybin,DRUG,cancer,HEALTH,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2438,cancer,HEALTH,a new inner framework,OUTCOME,THOUGHT TO CAUSE,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2439,psilocybin,DRUG,dissolution of boundaries,SUBJECTIVE,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2440,psilocybin,DRUG,feelings of unity,SUBJECTIVE,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2441,psilocybin,DRUG,a new inner framework,OUTCOME,THOUGHT TO CAUSE,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2442,psilocybin,DRUG,cope with life stressors,OUTCOME,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2443,psilocybin,DRUG,cancer,HEALTH,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2444,psilocybin,DRUG,emotional processing,OUTCOME,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2445,psilocybin,DRUG,emotional regulation in the long-term,OUTCOME,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2446,psilocybin,DRUG,cope with life stressors,OUTCOME,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2447,psilocybin,DRUG,cancer,HEALTH,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2448,psilocybin,DRUG,emotional processing,OUTCOME,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2449,cancer,HEALTH,a new inner framework,OUTCOME,THOUGHT TO CAUSE,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2450,serotonin 2A signaling,NEURAL,functional shifts in connectivity,OUTCOME,THOUGHT TO CAUSE,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2451,serotonin 2A signaling,NEURAL,increased entropy,OUTCOME,THOUGHT TO CAUSE,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2452,serotonin 2A signaling,NEURAL,disruption of activity within the default mode network,OUTCOME,THOUGHT TO CAUSE,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2453,serotonin 2A signaling,NEURAL,brain,NEURAL,THOUGHT TO CAUSE,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2454,psilocybin,DRUG,"highly memorable, meaningful, and spiritually significant effects",OUTCOME,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2455,psilocybin,DRUG,inherently confer therapeutic benefits,OUTCOME,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2456,contextual factors,OUTCOME,enduring therapeutic experience,OUTCOME,NEEDS MORE RESEARCH BETWEEN,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2457,contextual factors,OUTCOME,neurobiological,NEURAL,NEEDS MORE RESEARCH BETWEEN,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2458,contextual factors,OUTCOME,brain,NEURAL,NEEDS MORE RESEARCH BETWEEN,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2459,psilocybin,DRUG,"highly memorable, meaningful, and spiritually significant effects",OUTCOME,POSITIVELY IMPACTS,8893c45793706d9841a95bca79b08e902c00a1f1a4fe96a23dcbfd6a280cb076
2460,BDNF,DRUG,"protection, differentiation, viability and growth of new neurons",OUTCOME,NEEDS MORE RESEARCH BETWEEN,486f5a29d8a89eb5cb39b632fc93d40b9c92a72e59cbe7009451b33ba5a40bd7
2461,BDNF,DRUG,nervous system,NEURAL,NEEDS MORE RESEARCH BETWEEN,486f5a29d8a89eb5cb39b632fc93d40b9c92a72e59cbe7009451b33ba5a40bd7
2462,BDNF,DRUG,blood–brain barrier,NEURAL,NEEDS MORE RESEARCH BETWEEN,486f5a29d8a89eb5cb39b632fc93d40b9c92a72e59cbe7009451b33ba5a40bd7
2463,BDNF,DRUG,neuronal plasticity,OUTCOME,NEEDS MORE RESEARCH BETWEEN,486f5a29d8a89eb5cb39b632fc93d40b9c92a72e59cbe7009451b33ba5a40bd7
2464,BDNF,DRUG,neuroplasticity,OUTCOME,NEEDS MORE RESEARCH BETWEEN,486f5a29d8a89eb5cb39b632fc93d40b9c92a72e59cbe7009451b33ba5a40bd7
2465,BDNF,DRUG,neurogenesis,OUTCOME,NEEDS MORE RESEARCH BETWEEN,486f5a29d8a89eb5cb39b632fc93d40b9c92a72e59cbe7009451b33ba5a40bd7
2466,BDNF,DRUG,neuroplasticity,OUTCOME,NEEDS MORE RESEARCH BETWEEN,486f5a29d8a89eb5cb39b632fc93d40b9c92a72e59cbe7009451b33ba5a40bd7
2467,BDNF,DRUG,neurogenesis,OUTCOME,NEEDS MORE RESEARCH BETWEEN,486f5a29d8a89eb5cb39b632fc93d40b9c92a72e59cbe7009451b33ba5a40bd7
2468,BDNF,DRUG,neurogenesis,OUTCOME,NEEDS MORE RESEARCH BETWEEN,486f5a29d8a89eb5cb39b632fc93d40b9c92a72e59cbe7009451b33ba5a40bd7
2469,BDNF,DRUG,neurogenesis,OUTCOME,NEEDS MORE RESEARCH BETWEEN,486f5a29d8a89eb5cb39b632fc93d40b9c92a72e59cbe7009451b33ba5a40bd7
2470,psychedelic compounds,DRUG,neuronal plasticity,OUTCOME,POSITIVELY IMPACTS,486f5a29d8a89eb5cb39b632fc93d40b9c92a72e59cbe7009451b33ba5a40bd7
2471,psychedelic compounds,DRUG,antidepressants,ANTIDEPRESSANT_DRUG,POSITIVELY IMPACTS,486f5a29d8a89eb5cb39b632fc93d40b9c92a72e59cbe7009451b33ba5a40bd7
2472,psychedelic compounds,DRUG,monoaminergic enhancement,NEURAL,POSITIVELY IMPACTS,486f5a29d8a89eb5cb39b632fc93d40b9c92a72e59cbe7009451b33ba5a40bd7
2473,psychedelics,DRUG,neuronal plasticity,OUTCOME,POSITIVELY IMPACTS,486f5a29d8a89eb5cb39b632fc93d40b9c92a72e59cbe7009451b33ba5a40bd7
2474,psychedelics,DRUG,antidepressants,ANTIDEPRESSANT_DRUG,POSITIVELY IMPACTS,486f5a29d8a89eb5cb39b632fc93d40b9c92a72e59cbe7009451b33ba5a40bd7
2475,psychedelics,DRUG,monoaminergic enhancement,NEURAL,POSITIVELY IMPACTS,486f5a29d8a89eb5cb39b632fc93d40b9c92a72e59cbe7009451b33ba5a40bd7
2476,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,486f5a29d8a89eb5cb39b632fc93d40b9c92a72e59cbe7009451b33ba5a40bd7
2477,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,486f5a29d8a89eb5cb39b632fc93d40b9c92a72e59cbe7009451b33ba5a40bd7
2478,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,486f5a29d8a89eb5cb39b632fc93d40b9c92a72e59cbe7009451b33ba5a40bd7
2479,PLA,DRUG,rapid action,OUTCOME,POSITIVELY IMPACTS,486f5a29d8a89eb5cb39b632fc93d40b9c92a72e59cbe7009451b33ba5a40bd7
2480,BDNF,NEURAL,treatment resistant depression,HEALTH,NEEDS MORE RESEARCH BETWEEN,486f5a29d8a89eb5cb39b632fc93d40b9c92a72e59cbe7009451b33ba5a40bd7
2481,BDNF,NEURAL,BDNF,SUBJECTIVE,POSITIVELY IMPACTS,486f5a29d8a89eb5cb39b632fc93d40b9c92a72e59cbe7009451b33ba5a40bd7
2482,ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,486f5a29d8a89eb5cb39b632fc93d40b9c92a72e59cbe7009451b33ba5a40bd7
2483,ayahuasca,DRUG,lower symptoms of depression,OUTCOME,POSITIVELY IMPACTS,486f5a29d8a89eb5cb39b632fc93d40b9c92a72e59cbe7009451b33ba5a40bd7
2484,ayahuasca,DRUG,antidepressant,ANTIDEPRESSANT_DRUG,POSITIVELY IMPACTS,486f5a29d8a89eb5cb39b632fc93d40b9c92a72e59cbe7009451b33ba5a40bd7
2485,psilocybin,DRUG,cancer-related emotional distress,HEALTH,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2486,psilocybin,DRUG,"rapid, substantial, and enduring anxiolytic and antidepressant effects",OUTCOME,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2487,psilocybin,DRUG,cancer-related psychological and existential distress,HEALTH,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2488,psilocybin,DRUG,cancer-related emotional distress,HEALTH,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2489,psilocybin,DRUG,symptoms of distress,OUTCOME,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2490,psilocybin,DRUG,cancer,HEALTH,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2491,psilocybin,DRUG,death,OUTCOME,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2492,Chrissy,DRUG,death,HEALTH,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2493,cancer,HEALTH,cord to the universe,SUBJECTIVE,THOUGHT TO CAUSE,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2494,cord to the universe,SUBJECTIVE,death,HEALTH,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2495,cancer,HEALTH,cord to the universe,SUBJECTIVE,THOUGHT TO CAUSE,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2496,cancer,HEALTH,cancer,HEALTH,THOUGHT TO CAUSE,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2497,mystical-type experiences,SUBJECTIVE,death,HEALTH,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2498,psilocybin,DRUG,death,OUTCOME,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2499,psilocybin,DRUG,death,HEALTH,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2500,cancer,HEALTH,death,HEALTH,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2501,cancer,HEALTH,cancer,HEALTH,THOUGHT TO CAUSE,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2502,death,HEALTH,death,HEALTH,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2503,no longer being preoccupied or overwhelmed by fear,OUTCOME,death,HEALTH,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2504,psilocybin,DRUG,release of complicated emotions,OUTCOME,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2505,psilocybin,DRUG,cancer,HEALTH,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2506,psilocybin,DRUG,death,HEALTH,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2507,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2508,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2509,psilocybin,DRUG,expanded perspective on,OUTCOME,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2510,psilocybin,DRUG,Transcendence,SUBJECTIVE,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2511,psilocybin,DRUG,greater meaning to suffering,OUTCOME,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2512,psilocybin,DRUG,spiritually significant,OUTCOME,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2513,psilocybin,DRUG,personally meaningful experiences,OUTCOME,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2514,psilocybin,DRUG,spiritual significance,OUTCOME,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2515,psilocybin,DRUG,expanded life priorities,OUTCOME,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2516,psilocybin,DRUG,personally meaningful experiences,OUTCOME,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2517,psilocybin,DRUG,spiritual significance,OUTCOME,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2518,psilocybin,DRUG,expanded life priorities,OUTCOME,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2519,psilocybin,DRUG,emotions,SUBJECTIVE,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2520,psilocybin,DRUG,positive attributes in meaning,OUTCOME,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2521,psilocybin,DRUG,spiritual significance,OUTCOME,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2522,psilocybin,DRUG,expanded life priorities,OUTCOME,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2523,psilocybin,DRUG,emotions,SUBJECTIVE,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2524,psilocybin,DRUG,cancer diagnosis,HEALTH,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2525,psilocybin,DRUG,heightened sense of meaning and perspective,OUTCOME,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2526,psilocybin,DRUG,positive changes in individuals lives,OUTCOME,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2527,psilocybin,DRUG,increase in well-being,OUTCOME,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2528,psilocybin,DRUG,sense of life priority,OUTCOME,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2529,psilocybin,DRUG,heightened sense of meaning and perspective,OUTCOME,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2530,psilocybin,DRUG,sense of life priority,OUTCOME,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2531,psilocybin,DRUG,cancer,HEALTH,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2532,enduring effects,OUTCOME,cancer,HEALTH,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2533,psilocybin,DRUG,cancer,HEALTH,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2534,death,HEALTH,cancer,HEALTH,POSITIVELY IMPACTS,af462471689ed8d25bd8e22bfa793d7e3790c9388b1dce92d433cd1dc47c9a11
2535,psilocybin,DRUG,affect,SUBJECTIVE,NEEDS MORE RESEARCH BETWEEN,9c24766a2ef1bb8c7634120ef450461ddc16d650bae9f7e82001e007b0453714
2536,5-HT2A receptor,NEURAL,psilocin,DRUG,THOUGHT TO CAUSE,9c24766a2ef1bb8c7634120ef450461ddc16d650bae9f7e82001e007b0453714
2537,5-HT2A receptor,NEURAL,receptor trafficking,NEURAL,THOUGHT TO CAUSE,9c24766a2ef1bb8c7634120ef450461ddc16d650bae9f7e82001e007b0453714
2538,5-HT2A receptor,NEURAL,psilocin,DRUG,THOUGHT TO CAUSE,9c24766a2ef1bb8c7634120ef450461ddc16d650bae9f7e82001e007b0453714
2539,5-HT2A receptor,NEURAL,receptor trafficking,NEURAL,THOUGHT TO CAUSE,9c24766a2ef1bb8c7634120ef450461ddc16d650bae9f7e82001e007b0453714
2540,DLPFC,NEURAL,enhanced amygdala recruitment,OUTCOME,POSITIVELY IMPACTS,9c24766a2ef1bb8c7634120ef450461ddc16d650bae9f7e82001e007b0453714
2541,LSD,DRUG,network connectivity,NEURAL,NEEDS MORE RESEARCH BETWEEN,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2542,LSD,DRUG,visual networks,NEURAL,NEEDS MORE RESEARCH BETWEEN,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2543,RSNs,NEURAL,thalamus,NEURAL,POSITIVELY IMPACTS,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2544,LSD,DRUG,thalamus,NEURAL,POSITIVELY IMPACTS,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2545,psilocybin,DRUG,thalamus,NEURAL,POSITIVELY IMPACTS,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2546,sensorimotor network,NEURAL,decreases in coactivation,OUTCOME,THOUGHT TO CAUSE,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2547,sensorimotor network,NEURAL,functional relevance,OUTCOME,THOUGHT TO CAUSE,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2548,frontoparietal network,NEURAL,functional relevance,OUTCOME,THOUGHT TO CAUSE,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2549,RSNs,NEURAL,brain functioning,NEURAL,NEEDS MORE RESEARCH BETWEEN,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2550,RSNs,NEURAL,brain functioning,NEURAL,NEEDS MORE RESEARCH BETWEEN,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2551,striatum,NEURAL,brain functioning,NEURAL,NEEDS MORE RESEARCH BETWEEN,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2552,LSD,DRUG,brain functioning,NEURAL,NEEDS MORE RESEARCH BETWEEN,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2553,LSD,DRUG,thalamus,NEURAL,POSITIVELY IMPACTS,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2554,psilocybin,DRUG,thalamus,NEURAL,POSITIVELY IMPACTS,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2555,precuneus,NEURAL,brain functioning,NEURAL,NEEDS MORE RESEARCH BETWEEN,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2556,LSD,DRUG,brain functioning,NEURAL,NEEDS MORE RESEARCH BETWEEN,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2557,striatum,NEURAL,increased global connectivity,OUTCOME,THOUGHT TO CAUSE,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2558,thalamocortical FC,NEURAL,brain,NEURAL,NEEDS MORE RESEARCH BETWEEN,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2559,schizophrenia,HEALTH,brain,NEURAL,NEEDS MORE RESEARCH BETWEEN,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2560,cortico-striato-thalamo-cortical circuitry,NEURAL,brain,NEURAL,NEEDS MORE RESEARCH BETWEEN,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2561,schizophrenia,HEALTH,brain,NEURAL,NEEDS MORE RESEARCH BETWEEN,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2562,altered states of consciousness,SUBJECTIVE,brain,NEURAL,NEEDS MORE RESEARCH BETWEEN,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2563,LSD,DRUG,brain,NEURAL,NEEDS MORE RESEARCH BETWEEN,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2564,hallucinogenic drugs,DRUG,striatum,NEURAL,POSITIVELY IMPACTS,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2565,psychotic episodes,OUTCOME,brain,NEURAL,NEEDS MORE RESEARCH BETWEEN,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2566,altered hub connectivity,NEURAL,depression,HEALTH,POSITIVELY IMPACTS,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2567,altered hub connectivity,NEURAL,anxiety,HEALTH,POSITIVELY IMPACTS,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2568,altered hub connectivity,NEURAL,addiction,HEALTH,POSITIVELY IMPACTS,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2569,hallucinogens,DRUG,mental disorders,HEALTH,NEEDS MORE RESEARCH BETWEEN,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2570,hallucinogens,DRUG,depression,HEALTH,POSITIVELY IMPACTS,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2571,hallucinogens,DRUG,addiction,HEALTH,POSITIVELY IMPACTS,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2572,hallucinogens,DRUG,mental diseases,HEALTH,NEEDS MORE RESEARCH BETWEEN,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2573,altered hub connectivity,OUTCOME,depression,HEALTH,POSITIVELY IMPACTS,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2574,altered hub connectivity,OUTCOME,anxiety,HEALTH,POSITIVELY IMPACTS,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2575,altered hub connectivity,OUTCOME,addiction,HEALTH,POSITIVELY IMPACTS,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2576,LSD,DRUG,neurovascular coupling,NEURAL,POSITIVELY IMPACTS,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2577,LSD,DRUG,negatively influenced subjective drug effects,OUTCOME,POSITIVELY IMPACTS,9ddc53714afcfad671a669f599d4e3df97e56a3b2ac9b00266f7368adb8a504e
2578,psychedelics,DRUG,emotion,SUBJECTIVE,POSITIVELY IMPACTS,60c728c3c6e75c8f9ef83006b10dc02fb1c44bb226519cd151f4092ab56418b6
2579,psychedelics,DRUG,self-regulation,SUBJECTIVE,POSITIVELY IMPACTS,60c728c3c6e75c8f9ef83006b10dc02fb1c44bb226519cd151f4092ab56418b6
2580,psychedelics,DRUG,trans-diagnostic treatment mechanisms in psychiatry,OUTCOME,POSITIVELY IMPACTS,60c728c3c6e75c8f9ef83006b10dc02fb1c44bb226519cd151f4092ab56418b6
2581,psychedelics,DRUG,development of novel rapid-acting and long-lasting treatment approaches,OUTCOME,POSITIVELY IMPACTS,60c728c3c6e75c8f9ef83006b10dc02fb1c44bb226519cd151f4092ab56418b6
2582,psychedelics,DRUG,emotion,SUBJECTIVE,POSITIVELY IMPACTS,60c728c3c6e75c8f9ef83006b10dc02fb1c44bb226519cd151f4092ab56418b6
2583,psychedelics,DRUG,regulation,SUBJECTIVE,POSITIVELY IMPACTS,60c728c3c6e75c8f9ef83006b10dc02fb1c44bb226519cd151f4092ab56418b6
2584,psychedelics,DRUG,emotion,SUBJECTIVE,POSITIVELY IMPACTS,60c728c3c6e75c8f9ef83006b10dc02fb1c44bb226519cd151f4092ab56418b6
2585,psychedelics,DRUG,self-regulation,SUBJECTIVE,POSITIVELY IMPACTS,60c728c3c6e75c8f9ef83006b10dc02fb1c44bb226519cd151f4092ab56418b6
2586,psychedelics,DRUG,trans-diagnostic treatment mechanisms in psychiatry,OUTCOME,POSITIVELY IMPACTS,60c728c3c6e75c8f9ef83006b10dc02fb1c44bb226519cd151f4092ab56418b6
2587,psychedelics,DRUG,development of novel rapid-acting and long-lasting treatment approaches,OUTCOME,POSITIVELY IMPACTS,60c728c3c6e75c8f9ef83006b10dc02fb1c44bb226519cd151f4092ab56418b6
2588,psychedelics,DRUG,emotion,SUBJECTIVE,POSITIVELY IMPACTS,60c728c3c6e75c8f9ef83006b10dc02fb1c44bb226519cd151f4092ab56418b6
2589,psychedelics,DRUG,regulation,SUBJECTIVE,POSITIVELY IMPACTS,60c728c3c6e75c8f9ef83006b10dc02fb1c44bb226519cd151f4092ab56418b6
2590,5-HT2A receptor,NEURAL,the functional architecture of the brain,OUTCOME,THOUGHT TO CAUSE,60c728c3c6e75c8f9ef83006b10dc02fb1c44bb226519cd151f4092ab56418b6
2591,DMN,NEURAL,signal complexity,OUTCOME,POSITIVELY IMPACTS,60c728c3c6e75c8f9ef83006b10dc02fb1c44bb226519cd151f4092ab56418b6
2592,LSD,DRUG,signal complexity,OUTCOME,POSITIVELY IMPACTS,60c728c3c6e75c8f9ef83006b10dc02fb1c44bb226519cd151f4092ab56418b6
2593,psilocybin,DRUG,functional and directed connectivity,NEURAL,POSITIVELY IMPACTS,60c728c3c6e75c8f9ef83006b10dc02fb1c44bb226519cd151f4092ab56418b6
2594,psilocybin,DRUG,increased synchrony of sensory brain regions,NEURAL,POSITIVELY IMPACTS,60c728c3c6e75c8f9ef83006b10dc02fb1c44bb226519cd151f4092ab56418b6
2595,psilocybin,DRUG,decreased integrity of associative brain regions,NEURAL,POSITIVELY IMPACTS,60c728c3c6e75c8f9ef83006b10dc02fb1c44bb226519cd151f4092ab56418b6
2596,psilocybin,DRUG,entropy,OUTCOME,POSITIVELY IMPACTS,60c728c3c6e75c8f9ef83006b10dc02fb1c44bb226519cd151f4092ab56418b6
2597,psilocybin,DRUG,signal complexity,OUTCOME,POSITIVELY IMPACTS,60c728c3c6e75c8f9ef83006b10dc02fb1c44bb226519cd151f4092ab56418b6
2598,psilocybin,DRUG,neuronal dynamics,NEURAL,POSITIVELY IMPACTS,60c728c3c6e75c8f9ef83006b10dc02fb1c44bb226519cd151f4092ab56418b6
2599,LSD,DRUG,signal complexity,OUTCOME,POSITIVELY IMPACTS,60c728c3c6e75c8f9ef83006b10dc02fb1c44bb226519cd151f4092ab56418b6
2600,psilocybin,DRUG,entropy,OUTCOME,POSITIVELY IMPACTS,60c728c3c6e75c8f9ef83006b10dc02fb1c44bb226519cd151f4092ab56418b6
2601,psilocybin,DRUG,signal complexity,OUTCOME,POSITIVELY IMPACTS,60c728c3c6e75c8f9ef83006b10dc02fb1c44bb226519cd151f4092ab56418b6
2602,psilocybin,DRUG,neuronal dynamics,NEURAL,POSITIVELY IMPACTS,60c728c3c6e75c8f9ef83006b10dc02fb1c44bb226519cd151f4092ab56418b6
2603,psychedelics,DRUG,neuronal dynamics,NEURAL,POSITIVELY IMPACTS,60c728c3c6e75c8f9ef83006b10dc02fb1c44bb226519cd151f4092ab56418b6
2604,psychedelics,DRUG,modulate a person’s self-focus,OUTCOME,POSITIVELY IMPACTS,60c728c3c6e75c8f9ef83006b10dc02fb1c44bb226519cd151f4092ab56418b6
2605,psychedelics,DRUG,reduce negative emotional processing,OUTCOME,POSITIVELY IMPACTS,60c728c3c6e75c8f9ef83006b10dc02fb1c44bb226519cd151f4092ab56418b6
2606,psychedelics,DRUG,strengthen social,OUTCOME,POSITIVELY IMPACTS,60c728c3c6e75c8f9ef83006b10dc02fb1c44bb226519cd151f4092ab56418b6
2607,psychedelics,DRUG,trans-diagnostic mechanisms,OUTCOME,POSITIVELY IMPACTS,60c728c3c6e75c8f9ef83006b10dc02fb1c44bb226519cd151f4092ab56418b6
2608,psychedelics,DRUG,long-lasting effects,OUTCOME,POSITIVELY IMPACTS,60c728c3c6e75c8f9ef83006b10dc02fb1c44bb226519cd151f4092ab56418b6
2609,psychedelic,DRUG,"molecular, systems-level and functional alterations",OUTCOME,POSITIVELY IMPACTS,60c728c3c6e75c8f9ef83006b10dc02fb1c44bb226519cd151f4092ab56418b6
2610,psychedelics,DRUG,"molecular, systems-level and functional alterations",OUTCOME,POSITIVELY IMPACTS,60c728c3c6e75c8f9ef83006b10dc02fb1c44bb226519cd151f4092ab56418b6
2611,psychedelic substances,DRUG,"molecular, systems-level and functional alterations",OUTCOME,POSITIVELY IMPACTS,60c728c3c6e75c8f9ef83006b10dc02fb1c44bb226519cd151f4092ab56418b6
2612,psilocybin,DRUG,neuromodulator systems,DRUG,POSITIVELY IMPACTS,0c675192a661c9db15f6bf33104bfd1576824503205e28a897411d227114a860
2613,psilocybin,DRUG,brain,NEURAL,POSITIVELY IMPACTS,0c675192a661c9db15f6bf33104bfd1576824503205e28a897411d227114a860
2614,serotonin system,NEURAL,brain,NEURAL,POSITIVELY IMPACTS,0c675192a661c9db15f6bf33104bfd1576824503205e28a897411d227114a860
2615,receptor densities,NEURAL,neuronal system,NEURAL,NEEDS MORE RESEARCH BETWEEN,0c675192a661c9db15f6bf33104bfd1576824503205e28a897411d227114a860
2616,psilocybin,DRUG,multilevel plasticity,OUTCOME,POSITIVELY IMPACTS,0c675192a661c9db15f6bf33104bfd1576824503205e28a897411d227114a860
2617,psilocybin,DRUG,therapeutic action,OUTCOME,POSITIVELY IMPACTS,0c675192a661c9db15f6bf33104bfd1576824503205e28a897411d227114a860
2618,psilocybin,DRUG,multilevel plasticity,OUTCOME,POSITIVELY IMPACTS,0c675192a661c9db15f6bf33104bfd1576824503205e28a897411d227114a860
2619,psilocybin,DRUG,therapeutic action,OUTCOME,POSITIVELY IMPACTS,0c675192a661c9db15f6bf33104bfd1576824503205e28a897411d227114a860
2620,selective serotonin reuptake inhibitors,ANTIDEPRESSANT_DRUG,multilevel plasticity,OUTCOME,POSITIVELY IMPACTS,0c675192a661c9db15f6bf33104bfd1576824503205e28a897411d227114a860
2621,selective serotonin reuptake inhibitors,ANTIDEPRESSANT_DRUG,therapeutic action,OUTCOME,POSITIVELY IMPACTS,0c675192a661c9db15f6bf33104bfd1576824503205e28a897411d227114a860
2622,selective serotonin reuptake inhibitors,ANTIDEPRESSANT_DRUG,treatment-resistant depression,HEALTH,POSITIVELY IMPACTS,0c675192a661c9db15f6bf33104bfd1576824503205e28a897411d227114a860
2623,psilocybin,DRUG,treatment-resistant depression,HEALTH,POSITIVELY IMPACTS,0c675192a661c9db15f6bf33104bfd1576824503205e28a897411d227114a860
2624,psilocybin,DRUG,therapeutic action,OUTCOME,POSITIVELY IMPACTS,0c675192a661c9db15f6bf33104bfd1576824503205e28a897411d227114a860
2625,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,0c675192a661c9db15f6bf33104bfd1576824503205e28a897411d227114a860
2626,psilocybin,DRUG,multilevel plasticity,OUTCOME,POSITIVELY IMPACTS,0c675192a661c9db15f6bf33104bfd1576824503205e28a897411d227114a860
2627,psilocybin,DRUG,therapeutic action,OUTCOME,POSITIVELY IMPACTS,0c675192a661c9db15f6bf33104bfd1576824503205e28a897411d227114a860
2628,psilocybin,DRUG,treatment-resistant depression,HEALTH,POSITIVELY IMPACTS,0c675192a661c9db15f6bf33104bfd1576824503205e28a897411d227114a860
2629,receptor densities,NEURAL,treatment-resistant depression,HEALTH,NEEDS MORE RESEARCH BETWEEN,0c675192a661c9db15f6bf33104bfd1576824503205e28a897411d227114a860
2630,receptor densities,NEURAL,treatment-resistant depression,HEALTH,NEEDS MORE RESEARCH BETWEEN,0c675192a661c9db15f6bf33104bfd1576824503205e28a897411d227114a860
2631,psilocybin,DRUG,multilevel plasticity,OUTCOME,POSITIVELY IMPACTS,0c675192a661c9db15f6bf33104bfd1576824503205e28a897411d227114a860
2632,5-HT2A receptor,NEURAL,blockade of the inflammation,OUTCOME,THOUGHT TO CAUSE,6501155378f4718d68f2f1ea64935b7bcc7282625ecd69b24f9343a57123c9ce
2633,5-HT2A receptor,NEURAL,TNF-α,NEURAL,THOUGHT TO CAUSE,6501155378f4718d68f2f1ea64935b7bcc7282625ecd69b24f9343a57123c9ce
2634,5-HT2A receptor,NEURAL,(R)-DOI’s impact,NEURAL,THOUGHT TO CAUSE,6501155378f4718d68f2f1ea64935b7bcc7282625ecd69b24f9343a57123c9ce
2635,5-HT2A receptor activation,NEURAL,histone deacetylase (HDAC),ANTIDEPRESSANT_DRUG,THOUGHT TO CAUSE,6501155378f4718d68f2f1ea64935b7bcc7282625ecd69b24f9343a57123c9ce
2636,5-HT2A receptor activation,NEURAL,inflammation,SUBJECTIVE,THOUGHT TO CAUSE,6501155378f4718d68f2f1ea64935b7bcc7282625ecd69b24f9343a57123c9ce
2637,5-HT2A receptor activity,NEURAL,histone deacetylase (HDAC),ANTIDEPRESSANT_DRUG,THOUGHT TO CAUSE,6501155378f4718d68f2f1ea64935b7bcc7282625ecd69b24f9343a57123c9ce
2638,5-HT2A receptor activation,NEURAL,inflammation,SUBJECTIVE,THOUGHT TO CAUSE,6501155378f4718d68f2f1ea64935b7bcc7282625ecd69b24f9343a57123c9ce
2639,5-HT2A receptor activation,NEURAL,inflammation,SUBJECTIVE,THOUGHT TO CAUSE,6501155378f4718d68f2f1ea64935b7bcc7282625ecd69b24f9343a57123c9ce
2640,5-HT2A receptor,NEURAL,psychedelic effects,OUTCOME,THOUGHT TO CAUSE,6501155378f4718d68f2f1ea64935b7bcc7282625ecd69b24f9343a57123c9ce
2641,5-HT2A receptor,NEURAL,represses the expression of inflammatory mediators,OUTCOME,THOUGHT TO CAUSE,6501155378f4718d68f2f1ea64935b7bcc7282625ecd69b24f9343a57123c9ce
2642,5-HT2A receptor activation,NEURAL,psychedelic effects,OUTCOME,THOUGHT TO CAUSE,6501155378f4718d68f2f1ea64935b7bcc7282625ecd69b24f9343a57123c9ce
2643,5-HT2A receptor activation,NEURAL,represses the expression of inflammatory mediators,OUTCOME,THOUGHT TO CAUSE,6501155378f4718d68f2f1ea64935b7bcc7282625ecd69b24f9343a57123c9ce
2644,5-HT2A receptor activation,NEURAL,ovalbumin,DRUG,THOUGHT TO CAUSE,6501155378f4718d68f2f1ea64935b7bcc7282625ecd69b24f9343a57123c9ce
2645,5-HT2A receptor activation,NEURAL,Intracellular adhesion molecule-1 (ICAM-1),NEURAL,THOUGHT TO CAUSE,6501155378f4718d68f2f1ea64935b7bcc7282625ecd69b24f9343a57123c9ce
2646,5-HT2A receptor activation,NEURAL,cell adhesion molecule-1,OUTCOME,THOUGHT TO CAUSE,6501155378f4718d68f2f1ea64935b7bcc7282625ecd69b24f9343a57123c9ce
2647,Ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2648,Ayahuasca,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2649,Ayahuasca,DRUG,depression,HEALTH,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2650,Ayahuasca,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2651,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2652,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2653,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2654,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2655,LSD,DRUG,depression,HEALTH,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2656,LSD,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2657,LSD,DRUG,depression,HEALTH,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2658,LSD,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2659,psychedelics,DRUG,depression,HEALTH,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2660,psychedelic,DRUG,depression,HEALTH,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2661,psychedelic,DRUG,depression,HEALTH,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2662,psychedelic,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2663,psychedelic,DRUG,mood,OUTCOME,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2664,psychedelic,DRUG,reduced feelings of apprehension,OUTCOME,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2665,psychedelic,DRUG,mood,OUTCOME,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2666,psychedelic,DRUG,anti-depressant and anxiolytic effects,OUTCOME,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2667,psychedelic,DRUG,spiritually meaningful,OUTCOME,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2668,psychedelic,DRUG,decreased disease-related demoralisation,OUTCOME,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2669,psychedelic,DRUG,hopelessness,OUTCOME,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2670,psychedelic,DRUG,improved quality of life,OUTCOME,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2671,psychedelics,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2672,psychedelics,DRUG,depression,HEALTH,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2673,psychedelics,DRUG,self-resolving,OUTCOME,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2674,LSD,DRUG,depression,HEALTH,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2675,LSD,DRUG,paranoia,OUTCOME,NEGATIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2676,LSD,DRUG,illusions,OUTCOME,NEGATIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2677,LSD,DRUG,feeling cold,OUTCOME,NEGATIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2678,serotonin (5-HT2A) receptor downregulation,NEURAL,suicidality,OUTCOME,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2679,psychedelic users,HEALTH,lower rates of psychological distress,OUTCOME,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2680,psychedelic users,HEALTH,suicidality,OUTCOME,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2681,psychedelics,DRUG,suicidality,OUTCOME,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2682,psychedelics,DRUG,lower rates of psychological distress,OUTCOME,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2683,psychedelics,DRUG,suicidality,OUTCOME,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2684,psychedelics,DRUG,heightened state of consciousness,SUBJECTIVE,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2685,psychedelic,DRUG,heightened state of consciousness,SUBJECTIVE,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2686,psychedelic,DRUG,heightened state of consciousness,SUBJECTIVE,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2687,expectancy,OUTCOME,cancer patients,HEALTH,NEEDS MORE RESEARCH BETWEEN,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2688,expectancy,OUTCOME,suggestibility,OUTCOME,NEEDS MORE RESEARCH BETWEEN,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2689,expectancy,OUTCOME,suggestibility,OUTCOME,NEEDS MORE RESEARCH BETWEEN,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2690,expectancy,OUTCOME,suggestibility,OUTCOME,NEEDS MORE RESEARCH BETWEEN,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2691,expectancy,OUTCOME,suggestibility,OUTCOME,NEEDS MORE RESEARCH BETWEEN,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2692,expectancy,OUTCOME,suggestibility,OUTCOME,NEEDS MORE RESEARCH BETWEEN,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2693,expectancy,OUTCOME,suggestibility,OUTCOME,NEEDS MORE RESEARCH BETWEEN,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2694,expectancy,OUTCOME,somatic diseases,HEALTH,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2695,psilocybin,DRUG,too psychologically challenging experiences,OUTCOME,NEGATIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2696,psilocybin,DRUG,psychoactive effects,OUTCOME,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2697,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2698,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2699,psychedelics,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2700,psychedelics,DRUG,comparable anti-depressant and anxiolytic effects,OUTCOME,POSITIVELY IMPACTS,417400ff7a5a119e2fd52329d5213c150ec315e995845b5b3b479b9253579280
2701,Ayahuasca,DRUG,entropy increases,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2702,Ayahuasca,DRUG,geodesic distance,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2703,Ayahuasca,DRUG,clustering coefficient,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2704,Ayahuasca,DRUG,local efficiency,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2705,Ayahuasca,DRUG,global efficiency,OUTCOME,NEGATIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2706,Ayahuasca,DRUG,increase of local integration,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2707,Ayahuasca,DRUG,the entropy,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2708,global efficiency,OUTCOME,functional brain networks,NEURAL,NEEDS MORE RESEARCH BETWEEN,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2709,the entropy,OUTCOME,increase in entropy,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2710,Ayahuasca,DRUG,increase in entropy,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2711,Ayahuasca,DRUG,increase of geodesic distance,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2712,Ayahuasca,DRUG,decrease of global efficiency,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2713,Ayahuasca,DRUG,less globally integrated,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2714,modular structure of the network,NEURAL,"Locally, there is an increase in integration",OUTCOME,THOUGHT TO CAUSE,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2715,modular structure of the network,NEURAL,globally there is a decrease in integration,OUTCOME,THOUGHT TO CAUSE,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2716,modular structure of the network,NEURAL,increase of local robustness,OUTCOME,THOUGHT TO CAUSE,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2717,modular structure of the network,NEURAL,decrease of global integration,OUTCOME,THOUGHT TO CAUSE,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2718,modular structure of the network,NEURAL,the mental state,SUBJECTIVE,THOUGHT TO CAUSE,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2719,psychedelics,DRUG,brain,NEURAL,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2720,psychedelics,DRUG,elevated entropy,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2721,psychedelics,DRUG,brain,NEURAL,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2722,psychedelic state,SUBJECTIVE,elevated entropy,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2723,ordinary consciousness,SUBJECTIVE,elevated entropy,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2724,ordinary consciousness,SUBJECTIVE,reduction of freedom,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2725,ordinary consciousness,SUBJECTIVE,elevated entropy,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2726,ordinary consciousness,SUBJECTIVE,reduction of freedom,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2727,psychedelics,DRUG,elevated entropy,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2728,psychedelics,DRUG,reduction of freedom,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2729,ordinary consciousness,SUBJECTIVE,elevated entropy,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2730,ordinary consciousness,SUBJECTIVE,reduction of freedom,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2731,primary consciousness,SUBJECTIVE,elevated entropy,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2732,primary consciousness,SUBJECTIVE,reduction of freedom,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2733,ordinary consciousness,SUBJECTIVE,elevated entropy,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2734,ordinary consciousness,SUBJECTIVE,reduction of freedom,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2735,ordinary consciousness,SUBJECTIVE,increase in entropy,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2736,primary consciousness,SUBJECTIVE,elevated entropy,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2737,primary consciousness,SUBJECTIVE,reduction of freedom,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2738,primary consciousness,SUBJECTIVE,increase in entropy,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2739,ordinary consciousness,SUBJECTIVE,reduction of freedom,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2740,ordinary consciousness,SUBJECTIVE,increase in entropy,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2741,the entropy increases,OUTCOME,increase in entropy,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2742,the entropy increases,OUTCOME,more flexible state,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2743,entropy,OUTCOME,brain functional networks,NEURAL,NEEDS MORE RESEARCH BETWEEN,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2744,entropy,OUTCOME,brain,NEURAL,NEEDS MORE RESEARCH BETWEEN,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2745,psilocybin,DRUG,increases of a different entropy,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2746,functional network topology,NEURAL,functional connectivity,NEURAL,THOUGHT TO CAUSE,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2747,functional network topology,NEURAL,Default Mode Network,NEURAL,THOUGHT TO CAUSE,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2748,functional network topology,NEURAL,brain,NEURAL,NEEDS MORE RESEARCH BETWEEN,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2749,functional network topology,NEURAL,functional network topology,NEURAL,THOUGHT TO CAUSE,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2750,functional network topology,NEURAL,consciousness,SUBJECTIVE,THOUGHT TO CAUSE,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2751,functional network topology,NEURAL,brain,NEURAL,THOUGHT TO CAUSE,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2752,functional network topology,NEURAL,functional network topology,NEURAL,THOUGHT TO CAUSE,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2753,functional network topology,NEURAL,functional connectivity,NEURAL,THOUGHT TO CAUSE,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2754,functional network topology,NEURAL,Default Mode Network,NEURAL,THOUGHT TO CAUSE,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2755,functional network topology,NEURAL,brain,NEURAL,NEEDS MORE RESEARCH BETWEEN,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2756,functional network topology,NEURAL,functional network topology,NEURAL,THOUGHT TO CAUSE,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2757,consciousness,SUBJECTIVE,brain,NEURAL,NEEDS MORE RESEARCH BETWEEN,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2758,functional network topology,NEURAL,brain,NEURAL,NEEDS MORE RESEARCH BETWEEN,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2759,functional network topology,NEURAL,functional network topology,NEURAL,THOUGHT TO CAUSE,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2760,functional network topology,NEURAL,functional network topology,NEURAL,THOUGHT TO CAUSE,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2761,functional network topology,NEURAL,consciousness,SUBJECTIVE,THOUGHT TO CAUSE,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2762,consciousness,SUBJECTIVE,brain,NEURAL,NEEDS MORE RESEARCH BETWEEN,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2763,LSD,DRUG,increases in measures of entropy,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2764,LSD,DRUG,increases in measures of entropy,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2765,psilocybin,DRUG,increases in measures of entropy,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2766,ketamine,DRUG,increases in measures of entropy,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2767,psychedelics,DRUG,increase the entropy in brain functions,OUTCOME,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2768,psychedelics,DRUG,brain function,NEURAL,POSITIVELY IMPACTS,bee9d8b150f698a754ccb8bb4367320965765b7daba1551cbdd56214981eb9de
2769,SLN,NEURAL,the self,SUBJECTIVE,POSITIVELY IMPACTS,9e10cc85903aea35faa400f8c464ae20887f501db9e4826ffc8148d92e558a1e
2770,SLN,NEURAL,self-,SUBJECTIVE,POSITIVELY IMPACTS,9e10cc85903aea35faa400f8c464ae20887f501db9e4826ffc8148d92e558a1e
2771,psychedelic,DRUG,depression,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2772,psychedelic,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2773,psychedelic,DRUG,depression,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2774,mystical-type,SUBJECTIVE,depression,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2775,mystical-type,SUBJECTIVE,anxiety,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2776,mystical-type,SUBJECTIVE,depression,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2777,psychological insight experiences,SUBJECTIVE,depression,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2778,psychological insight experiences,SUBJECTIVE,anxiety,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2779,psychological insight experiences,SUBJECTIVE,depression,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2780,psychedelic,DRUG,depression,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2781,psychedelic,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2782,psychedelic,DRUG,depression,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2783,psychedelic,DRUG,depression,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2784,psychedelic,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2785,psychedelic,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2786,mystical experiences,SUBJECTIVE,depression,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2787,mystical experiences,SUBJECTIVE,depression,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2788,mystical experiences,SUBJECTIVE,anxiety,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2789,mystical experiences,SUBJECTIVE,depression,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2790,psychedelic,DRUG,depression,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2791,psychedelic,DRUG,depression,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2792,psychedelic,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2793,psychedelic,DRUG,depression,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2794,psychedelic,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2795,psychedelic,DRUG,depression,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2796,psychedelic,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2797,psychological insight,SUBJECTIVE,anxiety,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2798,insight,SUBJECTIVE,lasting changes in behavior or mental health functioning,OUTCOME,NEEDS MORE RESEARCH BETWEEN,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2799,insight,SUBJECTIVE,anxiety,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2800,mystical experiences,SUBJECTIVE,anxiety,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2801,Insightful as well as mystical-type experiences,SUBJECTIVE,depression,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2802,Insightful as well as mystical-type experiences,SUBJECTIVE,anxiety,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2803,psychedelic,DRUG,alcohol use disorder,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2804,psychedelic effects,OUTCOME,depression,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2805,psychedelic effects,OUTCOME,anxiety,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2806,psychological flexibility,OUTCOME,depression,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2807,psychological flexibility,OUTCOME,anxiety,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2808,psilocybin,DRUG,) addiction,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2809,psychedelics,DRUG,biologically verified abstinence at 6 months post-treatment,OUTCOME,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2810,psychedelics,DRUG,mindfulness/,SUBJECTIVE,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2811,psychedelics,DRUG,acceptance,SUBJECTIVE,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2812,psychedelics,DRUG,commitment and behavior change processes,OUTCOME,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2813,psychedelic,DRUG,depression,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2814,psychedelic,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2815,mystical experiences,SUBJECTIVE,anxiety,HEALTH,POSITIVELY IMPACTS,91b505828d6e5d2de4738b7d3a1631de383de3d810778d2bd585c75922646ffa
2816,psychedelic compounds,DRUG,"rapid, long-lasting changes in mood and behavior",OUTCOME,POSITIVELY IMPACTS,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2817,DMT,DRUG,increase swimming behavior in the forced swim test,OUTCOME,POSITIVELY IMPACTS,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2818,DMT,DRUG,"promoting the rapid growth of dendritic branches, spines, and synapses",OUTCOME,POSITIVELY IMPACTS,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2819,DMT,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2820,psychedelics,DRUG,increase swimming behavior in the forced swim test,OUTCOME,POSITIVELY IMPACTS,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2821,psychedelics,DRUG,"promoting the rapid growth of dendritic branches, spines, and synapses",OUTCOME,POSITIVELY IMPACTS,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2822,psychedelics,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2823,psychedelics,DRUG,"promoting the rapid growth of dendritic branches, spines, and synapses",OUTCOME,POSITIVELY IMPACTS,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2824,psychedelics,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2825,5-HT2A receptors,NEURAL,increase the excitability of pyramidal neurons,OUTCOME,THOUGHT TO CAUSE,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2826,5-HT2A receptors,NEURAL,behavioral changes,OUTCOME,THOUGHT TO CAUSE,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2827,5-HT2A receptors,NEURAL,fear extinction,OUTCOME,THOUGHT TO CAUSE,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2828,5-HT2A receptors,NEURAL,effortful response to behavioral challenge,OUTCOME,THOUGHT TO CAUSE,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2829,DMT,DRUG,"promoting the rapid growth of dendritic branches, spines, and synapses",OUTCOME,POSITIVELY IMPACTS,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2830,DMT,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2831,DMT,DRUG,spontaneous EPSCs,NEURAL,POSITIVELY IMPACTS,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2832,positive neuroadaptations in circuits,NEURAL,behavioral changes,OUTCOME,THOUGHT TO CAUSE,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2833,positive neuroadaptations in circuits,NEURAL,fear extinction,OUTCOME,THOUGHT TO CAUSE,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2834,positive neuroadaptations in circuits,NEURAL,effortful response to behavioral challenge,OUTCOME,THOUGHT TO CAUSE,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2835,DMT,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2836,DMT,DRUG,spontaneous EPSCs,NEURAL,POSITIVELY IMPACTS,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2837,DMT,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2838,DMT,DRUG,spontaneous EPSCs,NEURAL,POSITIVELY IMPACTS,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2839,DMT,DRUG,very different biochemical and structural phenotypes,OUTCOME,POSITIVELY IMPACTS,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2840,DMT,DRUG,promote sufficient plasticity to strengthen key circuits involved in the regulation of mood and fear,OUTCOME,POSITIVELY IMPACTS,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2841,DMT,DRUG,promote sufficient plasticity to strengthen key circuits involved in the regulation of mood and fear,OUTCOME,POSITIVELY IMPACTS,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2842,DMT,DRUG,increase glutamate release in the cortex,OUTCOME,POSITIVELY IMPACTS,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2843,psychedelics,DRUG,increase glutamate release in the cortex,OUTCOME,POSITIVELY IMPACTS,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2844,LSD,DRUG,hyperactivity,OUTCOME,NEGATIVELY IMPACTS,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2845,LSD,DRUG,anhedonia,OUTCOME,NEGATIVELY IMPACTS,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2846,LSD,DRUG,social deficits,OUTCOME,NEGATIVELY IMPACTS,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2847,psychedelic compounds,DRUG,behavioral outcomes,OUTCOME,POSITIVELY IMPACTS,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2848,psychedelic compounds,DRUG,gene expression of several genes related to neural plasticity,OUTCOME,POSITIVELY IMPACTS,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2849,minimal changes in BDNF expression in the cortex,OUTCOME,HTR2A,NEURAL,NEEDS MORE RESEARCH BETWEEN,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2850,minimal changes in BDNF expression in the cortex,OUTCOME,HTR2A,NEURAL,NEEDS MORE RESEARCH BETWEEN,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2851,increased BDNF expression,OUTCOME,HTR2A,NEURAL,NEEDS MORE RESEARCH BETWEEN,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2852,increased BDNF expression,OUTCOME,HTR2A,NEURAL,NEEDS MORE RESEARCH BETWEEN,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2853,selective serotonin reuptake inhibitors,ANTIDEPRESSANT_DRUG,tolerance in humans,OUTCOME,POSITIVELY IMPACTS,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2854,selective serotonin reuptake inhibitors,ANTIDEPRESSANT_DRUG,repair of damaged circuits relevant to mood and anxiety,OUTCOME,POSITIVELY IMPACTS,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2855,DMT,DRUG,tolerance in humans,OUTCOME,POSITIVELY IMPACTS,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2856,DMT,DRUG,repair of damaged circuits relevant to mood and anxiety,OUTCOME,POSITIVELY IMPACTS,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2857,changes in the expression of BDNF,OUTCOME,HTR2A,NEURAL,NEEDS MORE RESEARCH BETWEEN,c2909efcda6f4f4990dbe45ae15e50782f24c445278b2a734a79f7ab456c4613
2858,psychedelics,DRUG,therapeutic effects,OUTCOME,POSITIVELY IMPACTS,5c08b7e0b94bcd5d81878e15addbdc800809495ca717cc5e9f40034e1766d10d
2859,nonsubjective anesthesia,SUBJECTIVE,therapeutic effects,OUTCOME,POSITIVELY IMPACTS,5c08b7e0b94bcd5d81878e15addbdc800809495ca717cc5e9f40034e1766d10d
2860,nonhallucinogenic psychoplastogens,DRUG,therapeutic effects,OUTCOME,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2861,activation of 5-HT2A receptors.33,NEURAL,cortical neuron structural plasticity,OUTCOME,THOUGHT TO CAUSE,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2862,psychedelic compounds,DRUG,therapeutic effects,OUTCOME,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2863,TBG,DRUG,therapeutic effects,OUTCOME,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2864,TBG,DRUG,depression,HEALTH,NEEDS MORE RESEARCH BETWEEN,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2865,TBG,DRUG,alcohol use disorder,HEALTH,NEEDS MORE RESEARCH BETWEEN,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2866,TBG,DRUG,heroin use disorder.33,HEALTH,NEEDS MORE RESEARCH BETWEEN,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2867,functionally selective 5-HT2A receptor ligands,NEURAL,cortical neuron structural plasticity,OUTCOME,THOUGHT TO CAUSE,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2868,mystical-like experiences,SUBJECTIVE,therapeutic effects,OUTCOME,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2869,psychedelics,DRUG,enhanced neural plasticity,OUTCOME,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2870,hallucinogenic effects,OUTCOME,enhanced neural plasticity,OUTCOME,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2871,anesthetics,DRUG,neural plasticity,OUTCOME,NEEDS MORE RESEARCH BETWEEN,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2872,anesthetics,DRUG,antidepressant effects,OUTCOME,NEEDS MORE RESEARCH BETWEEN,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2873,serotonergic psychedelic,DRUG,enhanced neural plasticity,OUTCOME,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2874,serotonergic psychedelic,DRUG,postoperative mood,OUTCOME,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2875,serotonergic psychedelic,DRUG,depressed,HEALTH,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2876,ketamine,DRUG,postoperative mood,OUTCOME,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2877,ketamine-induced mystical experiences,OUTCOME,postoperative mood,OUTCOME,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2878,psychedelics,DRUG,postoperative mood,OUTCOME,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2879,psychedelics,DRUG,depressed,HEALTH,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2880,psychedelics,DRUG,therapeutic responses,OUTCOME,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2881,psychedelics,DRUG,therapeutic responses,OUTCOME,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2882,psychedelics,DRUG,exceptionally strong placebo effect,OUTCOME,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2883,psychedelics,DRUG,postoperative mood,OUTCOME,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2884,psychedelics,DRUG,depressed,HEALTH,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2885,psychedelics,DRUG,therapeutic responses,OUTCOME,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2886,psychedelics,DRUG,therapeutic responses,OUTCOME,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2887,psychedelics,DRUG,exceptionally strong placebo effect,OUTCOME,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2888,mystical-type experiences,SUBJECTIVE,therapeutic responses,OUTCOME,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2889,mystical-type experiences,SUBJECTIVE,therapeutic responses,OUTCOME,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2890,mystical-type experiences,SUBJECTIVE,therapeutic responses,OUTCOME,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2891,mystical-type experiences,SUBJECTIVE,therapeutic responses,OUTCOME,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2892,heightened neural plasticity,OUTCOME,therapeutic responses,OUTCOME,THOUGHT TO CAUSE,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2893,profound subjective experience,SUBJECTIVE,therapeutic responses,OUTCOME,THOUGHT TO CAUSE,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2894,drugs,DRUG,therapeutic responses,OUTCOME,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2895,drugs,DRUG,exceptionally strong placebo effect,OUTCOME,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2896,drugs,DRUG,heightened neural plasticity,OUTCOME,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2897,drugs,DRUG,treating,OUTCOME,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2898,drugs,DRUG,depression,HEALTH,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2899,drugs,DRUG,neuropsychiatric diseases,HEALTH,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2900,drugs,DRUG,neurobiology,NEURAL,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2901,drugs,DRUG,neural plasticity,OUTCOME,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2902,drugs,DRUG,therapeutic responses,OUTCOME,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2903,drugs,DRUG,treating,OUTCOME,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2904,drugs,DRUG,depression,HEALTH,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2905,drugs,DRUG,neuropsychiatric diseases,HEALTH,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2906,drugs,DRUG,neurobiology,NEURAL,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2907,rewiring pathological neural circuitry,OUTCOME,neuropsychiatric diseases,HEALTH,POSITIVELY IMPACTS,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2908,nonhallucinogenic analogues,DRUG,neural plasticity,OUTCOME,NEEDS MORE RESEARCH BETWEEN,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2909,psychedelics,DRUG,therapeutic responses,OUTCOME,THOUGHT TO CAUSE,03580f6108d360d1e01a1f1892488c04a3d79f0031aa21dc8f5842ddec4b6eb0
2910,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,8504094a91e9e3161a0512979b9068157aaae6cbdcd65b85c383fc6263a56b31
2911,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,8504094a91e9e3161a0512979b9068157aaae6cbdcd65b85c383fc6263a56b31
2912,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,8504094a91e9e3161a0512979b9068157aaae6cbdcd65b85c383fc6263a56b31
2913,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,8504094a91e9e3161a0512979b9068157aaae6cbdcd65b85c383fc6263a56b31
2914,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,8504094a91e9e3161a0512979b9068157aaae6cbdcd65b85c383fc6263a56b31
2915,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,8504094a91e9e3161a0512979b9068157aaae6cbdcd65b85c383fc6263a56b31
2916,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,8504094a91e9e3161a0512979b9068157aaae6cbdcd65b85c383fc6263a56b31
2917,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,8504094a91e9e3161a0512979b9068157aaae6cbdcd65b85c383fc6263a56b31
2918,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,8504094a91e9e3161a0512979b9068157aaae6cbdcd65b85c383fc6263a56b31
2919,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,8504094a91e9e3161a0512979b9068157aaae6cbdcd65b85c383fc6263a56b31
2920,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,8504094a91e9e3161a0512979b9068157aaae6cbdcd65b85c383fc6263a56b31
2921,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,8504094a91e9e3161a0512979b9068157aaae6cbdcd65b85c383fc6263a56b31
2922,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,8504094a91e9e3161a0512979b9068157aaae6cbdcd65b85c383fc6263a56b31
2923,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,8504094a91e9e3161a0512979b9068157aaae6cbdcd65b85c383fc6263a56b31
2924,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,8504094a91e9e3161a0512979b9068157aaae6cbdcd65b85c383fc6263a56b31
2925,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,8504094a91e9e3161a0512979b9068157aaae6cbdcd65b85c383fc6263a56b31
2926,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,8504094a91e9e3161a0512979b9068157aaae6cbdcd65b85c383fc6263a56b31
2927,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,8504094a91e9e3161a0512979b9068157aaae6cbdcd65b85c383fc6263a56b31
2928,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,8504094a91e9e3161a0512979b9068157aaae6cbdcd65b85c383fc6263a56b31
2929,psilocybin,DRUG,treatment-resistant depression,HEALTH,NEEDS MORE RESEARCH BETWEEN,8504094a91e9e3161a0512979b9068157aaae6cbdcd65b85c383fc6263a56b31
2930,psilocybin,DRUG,treatment-resistant depression,HEALTH,NEEDS MORE RESEARCH BETWEEN,8504094a91e9e3161a0512979b9068157aaae6cbdcd65b85c383fc6263a56b31
2931,psilocybin,DRUG,treatment-resistant depression,HEALTH,NEEDS MORE RESEARCH BETWEEN,8504094a91e9e3161a0512979b9068157aaae6cbdcd65b85c383fc6263a56b31
2932,psilocybin,DRUG,terminal cancer diagnoses,HEALTH,POSITIVELY IMPACTS,8504094a91e9e3161a0512979b9068157aaae6cbdcd65b85c383fc6263a56b31
2933,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,8504094a91e9e3161a0512979b9068157aaae6cbdcd65b85c383fc6263a56b31
2934,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,8504094a91e9e3161a0512979b9068157aaae6cbdcd65b85c383fc6263a56b31
2935,psilocybin,DRUG,reducing symptoms of anxiety,OUTCOME,POSITIVELY IMPACTS,8504094a91e9e3161a0512979b9068157aaae6cbdcd65b85c383fc6263a56b31
2936,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,8504094a91e9e3161a0512979b9068157aaae6cbdcd65b85c383fc6263a56b31
2937,Psychedelics,DRUG,disrupting ordinary language processes,OUTCOME,POSITIVELY IMPACTS,7716dbfe0fbf6dbf7fb285a37a641204132934d21ae1e061e23f3aee2221c94d
2938,Psychedelics,DRUG,enhance psychological flexibility,OUTCOME,POSITIVELY IMPACTS,7716dbfe0fbf6dbf7fb285a37a641204132934d21ae1e061e23f3aee2221c94d
2939,psilocybin,DRUG,psychological flexibility,OUTCOME,POSITIVELY IMPACTS,7716dbfe0fbf6dbf7fb285a37a641204132934d21ae1e061e23f3aee2221c94d
2940,psilocybin,DRUG,depression,HEALTH,POSITIVELY IMPACTS,7716dbfe0fbf6dbf7fb285a37a641204132934d21ae1e061e23f3aee2221c94d
2941,psilocybin,DRUG,"habits of acceptance, connection and embodiment",OUTCOME,POSITIVELY IMPACTS,7716dbfe0fbf6dbf7fb285a37a641204132934d21ae1e061e23f3aee2221c94d
2942,psilocybin,DRUG,transformational processes,OUTCOME,POSITIVELY IMPACTS,7716dbfe0fbf6dbf7fb285a37a641204132934d21ae1e061e23f3aee2221c94d
2943,LSD,DRUG,subjective effects,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2944,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2945,LSD,DRUG,subjective effects,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2946,LSD,DRUG,longer terminal elimination half-life,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2947,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2948,LSD,DRUG,subjective effects,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2949,LSD,DRUG,longer terminal elimination half-life,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2950,LSD,DRUG,longer terminal elimination half-life,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2951,LSD,DRUG,longer terminal elimination half-life,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2952,LSD,DRUG,increased subjective effects,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2953,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2954,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2955,LSD,DRUG,positive subjective effects,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2956,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2957,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2958,µg,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2959,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2960,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2961,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2962,LSD,DRUG,anxiety,HEALTH,NEGATIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2963,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2964,LSD,DRUG,ego dissolution,SUBJECTIVE,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2965,LSD,DRUG,disembodiment,SUBJECTIVE,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2966,LSD,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2967,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2968,LSD,DRUG,psychedelic doses,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2969,µg,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2970,µg,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2971,LSD,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2972,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2973,LSD,DRUG,insightfulness,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2974,LSD,DRUG,changed meaning of percepts,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2975,µg,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2976,µg,DRUG,insightfulness,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2977,µg,DRUG,changed meaning of percepts,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2978,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2979,LSD,DRUG,higher ratings of blissful state,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2980,LSD,DRUG,insightfulness,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2981,LSD,DRUG,changed meaning of percepts,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2982,LSD,DRUG,"fear, open, and trust on the VAS",OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2983,µg,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2984,µg,DRUG,changed meaning of percepts,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2985,LSD,DRUG,bad drug effects,OUTCOME,NEGATIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2986,µg,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2987,µg,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2988,µg,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2989,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2990,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2991,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2992,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2993,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2994,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2995,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2996,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2997,LSD,DRUG,positive effects,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2998,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
2999,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3000,LSD,DRUG,lower anxiety ratings,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3001,LSD,DRUG,positive mood effects,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3002,LSD,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3003,psychedelics,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3004,psychedelics,DRUG,lower anxiety ratings,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3005,psychedelics,DRUG,positive mood effects,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3006,psychedelics,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3007,µg,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3008,µg,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3009,µg,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3010,µg,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3011,µg,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3012,µg,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3013,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3014,LSD,DRUG,psychotropic effects,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3015,5-HT2A receptor antagonist,NEURAL,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3016,5-HT2A receptor antagonist,NEURAL,psychotropic effects,OUTCOME,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3017,5-HT2A receptor antagonist,NEURAL,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3018,5-HT2A receptor antagonist,NEURAL,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3019,5-HT2A receptor antagonist,NEURAL,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3020,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3021,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3022,LSD,DRUG,prevented the acute effects,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3023,µg,DRUG,psychotropic effects,OUTCOME,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3024,µg,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3025,µg,DRUG,psychotropic effects,OUTCOME,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3026,µg,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3027,µg,DRUG,psychedelic effects,OUTCOME,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3028,5-HT2A receptor activation,NEURAL,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3029,5-HT2A receptor activation,NEURAL,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3030,5-HT2A receptor activation,NEURAL,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3031,5-HT2A receptor activation,NEURAL,psychedelic effects,OUTCOME,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3032,ketanserin,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3033,ketanserin,DRUG,prevented the acute effects,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3034,ketanserin,DRUG,adverse effects,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3035,LSD,DRUG,prevented the acute effects,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3036,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3037,LSD,DRUG,prevented the acute effects,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3038,µg,DRUG,adverse effects,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3039,µg,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3040,µg,DRUG,lower depression ratings,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3041,ayahuasca,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3042,ayahuasca,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3043,BDNF response,OUTCOME,µg,DRUG,NEEDS MORE RESEARCH BETWEEN,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3044,BDNF response,OUTCOME,µg,DRUG,NEEDS MORE RESEARCH BETWEEN,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3045,BDNF response,OUTCOME,ayahuasca,DRUG,NEEDS MORE RESEARCH BETWEEN,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3046,BDNF response,OUTCOME,ayahuasca,DRUG,NEEDS MORE RESEARCH BETWEEN,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3047,BDNF response,OUTCOME,psychedelics,DRUG,NEEDS MORE RESEARCH BETWEEN,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3048,BDNF response,OUTCOME,antidepressant response,OUTCOME,NEEDS MORE RESEARCH BETWEEN,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3049,BDNF response,OUTCOME,µg,DRUG,NEEDS MORE RESEARCH BETWEEN,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3050,BDNF response,OUTCOME,subjective “any drug effects,OUTCOME,NEEDS MORE RESEARCH BETWEEN,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3051,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3052,LSD,DRUG,microdoses,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3053,Psychedelic microdoses,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3054,Psychedelic microdoses,DRUG,subjective “any drug effects,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3055,Psychedelic microdoses,DRUG,microdoses,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3056,Psychedelic microdoses,DRUG,prolonged effects on mood,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3057,Psychedelic microdoses,DRUG,adverse subjective effects,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3058,Psychedelic microdoses,DRUG,subjective effects,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3059,LSD,DRUG,subjective drug effects,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3060,LSD,DRUG,vigilance reduction,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3061,LSD,DRUG,subjective drug effects,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3062,LSD,DRUG,vigilance reduction,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3063,LSD,DRUG,subjective drug effects,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3064,LSD,DRUG,vigilance reduction,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3065,LSD,DRUG,dizziness,OUTCOME,NEGATIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3066,LSD,DRUG,changes in body feeling,OUTCOME,NEGATIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3067,LSD,DRUG,subjective drug effects,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3068,LSD,DRUG,vigilance reduction,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3069,LSD,DRUG,changes in body feeling,OUTCOME,NEGATIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3070,LSD,DRUG,subjective drug effects,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3071,LSD,DRUG,vigilance reduction,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3072,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3073,LSD,DRUG,feel drug,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3074,LSD,DRUG,drug,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3075,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3076,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3077,LSD,DRUG,tartrate,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3078,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3079,LSD,DRUG,tartrate,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3080,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3081,LSD,DRUG,feel drug,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3082,LSD,DRUG,drug,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3083,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3084,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3085,LSD,DRUG,tartrate,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3086,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3087,LSD,DRUG,tartrate,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3088,tartrate,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3089,tartrate,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3090,tartrate,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3091,tartrate,DRUG,tartrate,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3092,tartrate,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3093,tartrate,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3094,µg,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3095,µg,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3096,µg,DRUG,tartrate,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3097,µg,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3098,µg,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3099,LSD,DRUG,feel drug,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3100,LSD,DRUG,drug,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3101,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3102,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3103,LSD,DRUG,tartrate,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3104,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3105,LSD,DRUG,tartrate,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3106,LSD,DRUG,feel drug,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3107,LSD,DRUG,feel drug,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3108,LSD,DRUG,drug,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3109,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3110,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3111,LSD,DRUG,tartrate,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3112,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3113,LSD,DRUG,tartrate,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3114,µg,DRUG,tartrate,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3115,µg,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3116,µg,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3117,µg,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3118,µg,DRUG,tartrate,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3119,µg,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3120,µg,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3121,LSD,DRUG,psychoactive in,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3122,LSD,DRUG,tartrate,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3123,LSD,DRUG,psychoactive in,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3124,LSD,DRUG,psychoactive in,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3125,LSD,DRUG,microdoses,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3126,µg,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3127,µg,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3128,µg,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3129,µg,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3130,µg,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3131,LSD,DRUG,psychoactive in,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3132,LSD,DRUG,microdoses,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3133,LSD,DRUG,psychoactive in,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3134,LSD,DRUG,microdoses,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3135,LSD,DRUG,psychoactive in,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3136,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3137,LSD,DRUG,minidoses,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3138,LSD,DRUG,microdoses,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3139,LSD,DRUG,microdoses,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3140,µg,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3141,µg,DRUG,psychoactive in,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3142,µg,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3143,LSD,DRUG,psychoactive in,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3144,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3145,LSD,DRUG,minidoses,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3146,LSD,DRUG,microdoses,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3147,LSD,DRUG,microdoses,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3148,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3149,µg,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3150,µg,DRUG,psychoactive in,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3151,µg,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3152,LSD,DRUG,psychoactive in,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3153,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3154,LSD,DRUG,minidoses,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3155,LSD,DRUG,microdoses,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3156,LSD,DRUG,microdoses,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3157,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3158,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3159,µg,DRUG,µg,DRUG,THOUGHT TO CAUSE,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3160,µg,DRUG,psychoactive in,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3161,µg,DRUG,microdoses,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3162,LSD,DRUG,microdoses,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3163,LSD,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3164,LSD,DRUG,microdoses,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3165,LSD,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3166,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3167,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3168,LSD,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3169,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3170,LSD,DRUG,enhance blinding between the different conditions,OUTCOME,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3171,ketanserin-LSD,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3172,LSD,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3173,LSD,DRUG,µg,DRUG,POSITIVELY IMPACTS,3d85c85600e9af6d17fb89e7b5bb6b41262a7dbd37c72acfae67b9f8eaad4206
3174,serotoninergic hallucinogens,DRUG,antidepressive,OUTCOME,POSITIVELY IMPACTS,9fb60fc50979d2ddb238053fa3afca4b739432c7e034e5c91384a37b9c32796c
3175,serotoninergic hallucinogens,DRUG,anxiolytic,OUTCOME,POSITIVELY IMPACTS,9fb60fc50979d2ddb238053fa3afca4b739432c7e034e5c91384a37b9c32796c
3176,serotoninergic hallucinogens,DRUG,antiaddictive,OUTCOME,POSITIVELY IMPACTS,9fb60fc50979d2ddb238053fa3afca4b739432c7e034e5c91384a37b9c32796c
3177,psilocybin,DRUG,cancer-related depression,HEALTH,POSITIVELY IMPACTS,9fb60fc50979d2ddb238053fa3afca4b739432c7e034e5c91384a37b9c32796c
3178,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,9fb60fc50979d2ddb238053fa3afca4b739432c7e034e5c91384a37b9c32796c
3179,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,9fb60fc50979d2ddb238053fa3afca4b739432c7e034e5c91384a37b9c32796c
3180,psilocybin,DRUG,cancer-related depression,HEALTH,POSITIVELY IMPACTS,9fb60fc50979d2ddb238053fa3afca4b739432c7e034e5c91384a37b9c32796c
3181,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,9fb60fc50979d2ddb238053fa3afca4b739432c7e034e5c91384a37b9c32796c
3182,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,9fb60fc50979d2ddb238053fa3afca4b739432c7e034e5c91384a37b9c32796c
3183,ayahuasca,DRUG,cancer-related depression,HEALTH,POSITIVELY IMPACTS,9fb60fc50979d2ddb238053fa3afca4b739432c7e034e5c91384a37b9c32796c
3184,ayahuasca,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,9fb60fc50979d2ddb238053fa3afca4b739432c7e034e5c91384a37b9c32796c
3185,ayahuasca,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,9fb60fc50979d2ddb238053fa3afca4b739432c7e034e5c91384a37b9c32796c
3186,Available medications,ANTIDEPRESSANT_DRUG,ineffective for many patients,OUTCOME,NEGATIVELY IMPACTS,9fb60fc50979d2ddb238053fa3afca4b739432c7e034e5c91384a37b9c32796c
3187,Available medications,ANTIDEPRESSANT_DRUG,adverse reactions,OUTCOME,NEGATIVELY IMPACTS,9fb60fc50979d2ddb238053fa3afca4b739432c7e034e5c91384a37b9c32796c
3188,long-term efficacy and safety of these drugs,OUTCOME,ayahuasca,DRUG,NEEDS MORE RESEARCH BETWEEN,9fb60fc50979d2ddb238053fa3afca4b739432c7e034e5c91384a37b9c32796c
3189,psilocybin,DRUG,brain,NEURAL,NEEDS MORE RESEARCH BETWEEN,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3190,psilocybin,DRUG,mPFC,NEURAL,NEEDS MORE RESEARCH BETWEEN,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3191,psilocybin,DRUG,region-dependent alterations in neurometabolite concentrations,OUTCOME,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3192,5-HT2A agonist,NEURAL,excitation and inhibition of cortical pyramidal cells,OUTCOME,THOUGHT TO CAUSE,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3193,5-HT2A agonist,NEURAL,increased neural input or output,OUTCOME,THOUGHT TO CAUSE,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3194,GABA,DRUG,mPFC,NEURAL,NEEDS MORE RESEARCH BETWEEN,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3195,GABA,DRUG,mPFC,NEURAL,NEEDS MORE RESEARCH BETWEEN,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3196,GABA,DRUG,hippocampus,NEURAL,NEEDS MORE RESEARCH BETWEEN,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3197,5-HT2A receptors,NEURAL,excitation and inhibition of cortical pyramidal cells,OUTCOME,THOUGHT TO CAUSE,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3198,5-HT2A receptors,NEURAL,increased neural input or output,OUTCOME,THOUGHT TO CAUSE,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3199,5-HT2A receptors,NEURAL,glutamatergic increase,OUTCOME,THOUGHT TO CAUSE,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3200,5-HT2A receptors,NEURAL,mPFC,NEURAL,NEEDS MORE RESEARCH BETWEEN,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3201,5-HT2A receptors,NEURAL,excitation and inhibition of cortical pyramidal cells,OUTCOME,THOUGHT TO CAUSE,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3202,5-HT2A receptors,NEURAL,increased metabolic rate,OUTCOME,THOUGHT TO CAUSE,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3203,5-HT2A receptors,NEURAL,increased neural input or output,OUTCOME,THOUGHT TO CAUSE,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3204,5-HT2A receptors,NEURAL,decreases glutamate in this area,OUTCOME,THOUGHT TO CAUSE,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3205,mPFC,NEURAL,excitation and inhibition of cortical pyramidal cells,OUTCOME,THOUGHT TO CAUSE,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3206,mPFC,NEURAL,increased metabolic rate,OUTCOME,THOUGHT TO CAUSE,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3207,mPFC,NEURAL,increased neural input or output,OUTCOME,THOUGHT TO CAUSE,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3208,mPFC,NEURAL,decreases glutamate in this area,OUTCOME,THOUGHT TO CAUSE,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3209,psilocybin,DRUG,reduced absolute CBF,OUTCOME,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3210,psilocybin,DRUG,reduced absolute CBF,OUTCOME,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3211,5-HT2A receptor,NEURAL,neurons,NEURAL,THOUGHT TO CAUSE,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3212,GABA,NEURAL,brain,NEURAL,NEEDS MORE RESEARCH BETWEEN,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3213,GABA,NEURAL,hippocampus,NEURAL,NEEDS MORE RESEARCH BETWEEN,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3214,GABA,NEURAL,neurons,NEURAL,NEEDS MORE RESEARCH BETWEEN,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3215,GABA,NEURAL,hippocampus,NEURAL,NEEDS MORE RESEARCH BETWEEN,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3216,GABA,NEURAL,hippocampus,NEURAL,NEEDS MORE RESEARCH BETWEEN,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3217,psilocybin,DRUG,increases in feelings of ego dissolution,OUTCOME,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3218,psychedelic,DRUG,increases in feelings of ego dissolution,OUTCOME,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3219,psilocybin,DRUG,subjective experience of sense of self,SUBJECTIVE,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3220,psilocybin,DRUG,subjective experience of sense of self,SUBJECTIVE,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3221,psilocybin,DRUG,feelings of AED,OUTCOME,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3222,psilocybin,DRUG,ego pathology,OUTCOME,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3223,psilocybin,DRUG,feelings of anxiety,OUTCOME,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3224,AED-associated changes in mood,OUTCOME,paranoia,HEALTH,NEGATIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3225,AED-associated changes in mood,OUTCOME,anxiety,HEALTH,NEGATIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3226,psychedelic drugs,DRUG,feelings of AED,OUTCOME,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3227,psychedelic drugs,DRUG,ego pathology,OUTCOME,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3228,psychedelic drugs,DRUG,feelings of anxiety,OUTCOME,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3229,mPFC,NEURAL,feelings of anxiety,OUTCOME,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3230,mPFC,NEURAL,anxiety,HEALTH,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3231,mPFC,NEURAL,anxiety,HEALTH,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3232,mPFC,NEURAL,feelings of positively experienced ego dissolution,OUTCOME,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3233,psychedelic,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3234,psychedelic,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3235,psychedelic,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3236,psychedelic,DRUG,feelings of positively experienced ego dissolution,OUTCOME,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3237,long-term changes in 5-HT2A receptor function,OUTCOME,mPFC,NEURAL,NEEDS MORE RESEARCH BETWEEN,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3238,long-term changes in 5-HT2A receptor function,OUTCOME,subjective effects,OUTCOME,NEEDS MORE RESEARCH BETWEEN,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3239,long-term changes in 5-HT2A receptor function,OUTCOME,brain,NEURAL,NEEDS MORE RESEARCH BETWEEN,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3240,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3241,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3242,psilocybin,DRUG,feelings of positively experienced ego dissolution,OUTCOME,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3243,MTL,NEURAL,feelings of depersonalization,OUTCOME,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3244,DMN circuitry,NEURAL,feelings of positively experienced ego dissolution,OUTCOME,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3245,DMN circuitry,NEURAL,feelings of depersonalization,OUTCOME,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3246,psychedelic drug,DRUG,feelings of depersonalization,OUTCOME,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3247,psychedelic drug,DRUG,feelings of (positive) ego dissolution,OUTCOME,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3248,DMN,NEURAL,feelings of (positive) ego dissolution,OUTCOME,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3249,decreased FC between the parahippocampal formation,OUTCOME,ego dissolution,OUTCOME,THOUGHT TO CAUSE,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3250,sensorimotor network,NEURAL,ego dissolution,OUTCOME,THOUGHT TO CAUSE,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3251,sensorimotor network,NEURAL,post-traumatic stress disorders,HEALTH,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3252,neurobiology,NEURAL,post-traumatic stress disorders,HEALTH,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3253,psychedelic,DRUG,neurobiology,NEURAL,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3254,psychedelic,DRUG,therapeutic relief,OUTCOME,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3255,psychedelic,DRUG,depression,HEALTH,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3256,psychedelic,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3257,psychedelic,DRUG,addiction,HEALTH,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3258,psychedelic,DRUG,post-traumatic stress disorders,HEALTH,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3259,psychedelics,DRUG,depression,HEALTH,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3260,psychedelics,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3261,psychedelics,DRUG,addiction,HEALTH,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3262,psychedelics,DRUG,post-traumatic stress disorders,HEALTH,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3263,psychedelics,DRUG,neurobiology,NEURAL,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3264,psychedelics,DRUG,drug-induced ego dissolution,HEALTH,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3265,psychedelics,DRUG,therapeutic relief,OUTCOME,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3266,psychedelics,DRUG,depression,HEALTH,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3267,psychedelics,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3268,psychedelics,DRUG,addiction,HEALTH,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3269,psychedelics,DRUG,post-traumatic stress disorders,HEALTH,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3270,psychedelics,DRUG,increases in well-being,OUTCOME,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3271,5-HT2A receptor,NEURAL,neuroplasticity,OUTCOME,THOUGHT TO CAUSE,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3272,increased glutamatergic activity,OUTCOME,neuroplasticity,OUTCOME,THOUGHT TO CAUSE,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3273,5-HT2A receptor activation,NEURAL,neuroplasticity,OUTCOME,THOUGHT TO CAUSE,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3274,psilocybin,DRUG,disrupted neuronal function,OUTCOME,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3275,mPFC,NEURAL,neuroplasticity,OUTCOME,THOUGHT TO CAUSE,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3276,psilocybin,DRUG,disrupted neuronal function,OUTCOME,POSITIVELY IMPACTS,210f504aa98cb97716db2cda09147fadb889bf639917566f3b975f77b034d670
3277,LSD,DRUG,increased amygdala seed-based connectivity,OUTCOME,POSITIVELY IMPACTS,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3278,LSD,DRUG,decreased amygdala connectivity,OUTCOME,POSITIVELY IMPACTS,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3279,right middle frontal gyrus,NEURAL,microdose,DRUG,THOUGHT TO CAUSE,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3280,right middle frontal gyrus,NEURAL,right postcentral gyrus,NEURAL,THOUGHT TO CAUSE,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3281,right middle frontal gyrus,NEURAL,positive mood,OUTCOME,THOUGHT TO CAUSE,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3282,superior temporal gyrus,NEURAL,microdose,DRUG,THOUGHT TO CAUSE,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3283,superior temporal gyrus,NEURAL,right postcentral gyrus,NEURAL,THOUGHT TO CAUSE,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3284,superior temporal gyrus,NEURAL,positive mood,OUTCOME,THOUGHT TO CAUSE,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3285,increase in amygdala – middle frontal gyrus connectivity,OUTCOME,positive mood,OUTCOME,THOUGHT TO CAUSE,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3286,LSD,DRUG,resting state connectivity,NEURAL,POSITIVELY IMPACTS,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3287,LSD,DRUG,changes in amygdala responses,OUTCOME,POSITIVELY IMPACTS,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3288,LSD,DRUG,prefrontal cortex,NEURAL,POSITIVELY IMPACTS,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3289,LSD,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3290,LSD,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3291,LSD,DRUG,connectivity a,NEURAL,POSITIVELY IMPACTS,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3292,psilocybin,DRUG,resting state connectivity,NEURAL,POSITIVELY IMPACTS,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3293,psilocybin,DRUG,changes in amygdala responses,OUTCOME,POSITIVELY IMPACTS,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3294,psilocybin,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3295,psilocybin,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3296,psilocybin,DRUG,prefrontal cortex,NEURAL,POSITIVELY IMPACTS,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3297,psilocybin,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3298,psilocybin,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3299,psilocybin,DRUG,connectivity a,NEURAL,POSITIVELY IMPACTS,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3300,psilocybin,DRUG,modulated amygdala activation,OUTCOME,POSITIVELY IMPACTS,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3301,psilocybin,DRUG,decreased amygdala connectivity,OUTCOME,POSITIVELY IMPACTS,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3302,psilocybin,DRUG,decreased amygdala connectivity,OUTCOME,POSITIVELY IMPACTS,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3303,frontal pole,NEURAL,perception of emotions,SUBJECTIVE,THOUGHT TO CAUSE,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3304,decreases connectivity between the amygdala and the superior temporal gyrus,OUTCOME,perception of emotions,SUBJECTIVE,THOUGHT TO CAUSE,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3305,drugs,DRUG,decreased amygdala connectivity,OUTCOME,POSITIVELY IMPACTS,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3306,drugs,DRUG,"dampen, and thereby normalize, disrupted amygdala responses",OUTCOME,POSITIVELY IMPACTS,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3307,Amygdala hyperreactivity,NEURAL,changes in neural function,OUTCOME,NEGATIVELY IMPACTS,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3308,Amygdala hyperreactivity,NEURAL,negative processing bias,SUBJECTIVE,NEGATIVELY IMPACTS,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3309,Amygdala hyperreactivity,NEURAL,major depressive disorder,HEALTH,NEGATIVELY IMPACTS,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3310,Amygdala hyperreactivity,NEURAL,anxiety,HEALTH,NEGATIVELY IMPACTS,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3311,selective serotonin reuptake inhibitors (SSRIs),ANTIDEPRESSANT_DRUG,"dampen, and thereby normalize, disrupted amygdala responses",OUTCOME,POSITIVELY IMPACTS,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3312,selective serotonin reuptake inhibitors (SSRIs),ANTIDEPRESSANT_DRUG,"dampen, and thereby normalize, disrupted amygdala responses",OUTCOME,POSITIVELY IMPACTS,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3313,selective serotonin reuptake inhibitors (SSRIs),ANTIDEPRESSANT_DRUG,enhancing cortico-limbic connectivity in the brain,OUTCOME,POSITIVELY IMPACTS,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3314,LSD,DRUG,dampen amygdala activity and connectivity,OUTCOME,NEEDS MORE RESEARCH BETWEEN,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3315,LSD,DRUG,mood symptoms,OUTCOME,NEEDS MORE RESEARCH BETWEEN,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3316,SSRIs,ANTIDEPRESSANT_DRUG,enhancing cortico-limbic connectivity in the brain,OUTCOME,POSITIVELY IMPACTS,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3317,SSRIs,ANTIDEPRESSANT_DRUG,emotion regulation,OUTCOME,POSITIVELY IMPACTS,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3318,changes in amygdala-middle frontal gyrus connectivity,OUTCOME,changes in positive mood,OUTCOME,THOUGHT TO CAUSE,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3319,LSD,DRUG,emotional processing,OUTCOME,POSITIVELY IMPACTS,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3320,LSD,DRUG,depressed patients,HEALTH,POSITIVELY IMPACTS,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3321,LSD,DRUG,amygdala,NEURAL,POSITIVELY IMPACTS,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3322,LSD,DRUG,"connectivity,",NEURAL,POSITIVELY IMPACTS,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3323,LSD,DRUG,resting state functional connectivity,NEURAL,NEEDS MORE RESEARCH BETWEEN,54bd3929c63a47fa65fb32f7ce3c7a38f4417165f89c48795b9b9af77d581ef6
3324,subjective experience,SUBJECTIVE,sense of self,SUBJECTIVE,POSITIVELY IMPACTS,0882d46f46f833d2b422c8e7fc4a437fb855975f883e00f7b6e945b35ef10b86
3325,psilocybin,DRUG,sense of self,SUBJECTIVE,POSITIVELY IMPACTS,0882d46f46f833d2b422c8e7fc4a437fb855975f883e00f7b6e945b35ef10b86
3326,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,0882d46f46f833d2b422c8e7fc4a437fb855975f883e00f7b6e945b35ef10b86
3327,psilocybin,DRUG,improve they affective state,OUTCOME,POSITIVELY IMPACTS,0882d46f46f833d2b422c8e7fc4a437fb855975f883e00f7b6e945b35ef10b86
3328,psilocybin,DRUG,long lasting,OUTCOME,POSITIVELY IMPACTS,0882d46f46f833d2b422c8e7fc4a437fb855975f883e00f7b6e945b35ef10b86
3329,psilocybin,DRUG,long lasting antidepressant effects,OUTCOME,POSITIVELY IMPACTS,0882d46f46f833d2b422c8e7fc4a437fb855975f883e00f7b6e945b35ef10b86
3330,psilocybin,DRUG,symptoms of depression,OUTCOME,POSITIVELY IMPACTS,0882d46f46f833d2b422c8e7fc4a437fb855975f883e00f7b6e945b35ef10b86
3331,psilocybin,DRUG,cellular proliferation,NEURAL,POSITIVELY IMPACTS,0882d46f46f833d2b422c8e7fc4a437fb855975f883e00f7b6e945b35ef10b86
3332,psilocybin,DRUG,increased synaptic connectivity,NEURAL,POSITIVELY IMPACTS,0882d46f46f833d2b422c8e7fc4a437fb855975f883e00f7b6e945b35ef10b86
3333,psilocybin,DRUG,anti-inflammatory effects,NEURAL,POSITIVELY IMPACTS,0882d46f46f833d2b422c8e7fc4a437fb855975f883e00f7b6e945b35ef10b86
3334,psilocybin,DRUG,long lasting,OUTCOME,POSITIVELY IMPACTS,0882d46f46f833d2b422c8e7fc4a437fb855975f883e00f7b6e945b35ef10b86
3335,psilocybin,DRUG,symptoms of depression,OUTCOME,POSITIVELY IMPACTS,0882d46f46f833d2b422c8e7fc4a437fb855975f883e00f7b6e945b35ef10b86
3336,psilocybin,DRUG,long lasting,OUTCOME,POSITIVELY IMPACTS,0882d46f46f833d2b422c8e7fc4a437fb855975f883e00f7b6e945b35ef10b86
3337,psilocybin,DRUG,cellular proliferation,NEURAL,POSITIVELY IMPACTS,0882d46f46f833d2b422c8e7fc4a437fb855975f883e00f7b6e945b35ef10b86
3338,psilocybin,DRUG,behavioral flexibility,OUTCOME,POSITIVELY IMPACTS,0882d46f46f833d2b422c8e7fc4a437fb855975f883e00f7b6e945b35ef10b86
3339,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,0882d46f46f833d2b422c8e7fc4a437fb855975f883e00f7b6e945b35ef10b86
3340,psilocybin,DRUG,behavioral flexibility,OUTCOME,POSITIVELY IMPACTS,0882d46f46f833d2b422c8e7fc4a437fb855975f883e00f7b6e945b35ef10b86
3341,psilocybin,DRUG,anxiety,HEALTH,POSITIVELY IMPACTS,0882d46f46f833d2b422c8e7fc4a437fb855975f883e00f7b6e945b35ef10b86
3342,psilocybin,DRUG,threat of drowning,SUBJECTIVE,POSITIVELY IMPACTS,0882d46f46f833d2b422c8e7fc4a437fb855975f883e00f7b6e945b35ef10b86
3343,psilocybin,DRUG,coping strategy,OUTCOME,POSITIVELY IMPACTS,0882d46f46f833d2b422c8e7fc4a437fb855975f883e00f7b6e945b35ef10b86
3344,psilocybin,DRUG,threat of drowning,SUBJECTIVE,POSITIVELY IMPACTS,0882d46f46f833d2b422c8e7fc4a437fb855975f883e00f7b6e945b35ef10b86
3345,psilocybin,DRUG,coping strategy,OUTCOME,POSITIVELY IMPACTS,0882d46f46f833d2b422c8e7fc4a437fb855975f883e00f7b6e945b35ef10b86
3346,psilocybin,DRUG,threat of drowning,SUBJECTIVE,POSITIVELY IMPACTS,0882d46f46f833d2b422c8e7fc4a437fb855975f883e00f7b6e945b35ef10b86
3347,psilocybin,DRUG,coping strategy,OUTCOME,POSITIVELY IMPACTS,0882d46f46f833d2b422c8e7fc4a437fb855975f883e00f7b6e945b35ef10b86
